
<html lang="en"     class="pb-page"  data-request-id="148e55ae-be8f-4461-a69c-db8f4cf59ba7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2013.56.issue-15;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm400380m;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="The Discovery of PLK4 Inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as Novel Antiproliferative Agents" /></meta><meta name="dc.Creator" content="Radoslaw  Laufer" /></meta><meta name="dc.Creator" content="Bryan  Forrest" /></meta><meta name="dc.Creator" content="Sze-Wan  Li" /></meta><meta name="dc.Creator" content="Yong  Liu" /></meta><meta name="dc.Creator" content="Peter  Sampson" /></meta><meta name="dc.Creator" content="Louise  Edwards" /></meta><meta name="dc.Creator" content="Yunhui  Lang" /></meta><meta name="dc.Creator" content="Donald E.  Awrey" /></meta><meta name="dc.Creator" content="Guodong  Mao" /></meta><meta name="dc.Creator" content="Olga  Plotnikova" /></meta><meta name="dc.Creator" content="Genie  Leung" /></meta><meta name="dc.Creator" content="Richard  Hodgson" /></meta><meta name="dc.Creator" content="Irina  Beletskaya" /></meta><meta name="dc.Creator" content="Jacqueline M.  Mason" /></meta><meta name="dc.Creator" content="Xunyi  Luo" /></meta><meta name="dc.Creator" content="Xin  Wei" /></meta><meta name="dc.Creator" content="Yi  Yao" /></meta><meta name="dc.Creator" content="Miklos  Feher" /></meta><meta name="dc.Creator" content="Fuqiang  Ban" /></meta><meta name="dc.Creator" content="Reza  Kiarash" /></meta><meta name="dc.Creator" content="Erin  Green" /></meta><meta name="dc.Creator" content="Tak W.  Mak" /></meta><meta name="dc.Creator" content="Guohua  Pan" /></meta><meta name="dc.Creator" content="Henry W.  Pauls" /></meta><meta name="dc.Description" content="The family of Polo-like kinases is important in the regulation of mitotic progression; this work keys on one member, namely Polo-like kinase 4 (PLK4). PLK4 has been identified as a candidate antica..." /></meta><meta name="Description" content="The family of Polo-like kinases is important in the regulation of mitotic progression; this work keys on one member, namely Polo-like kinase 4 (PLK4). PLK4 has been identified as a candidate antica..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 26, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400380m" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400380m" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400380m" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400380m" /></link>
        
    
    

<title>The Discovery of PLK4 Inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as Novel Antiproliferative Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400380m" /></meta><meta property="og:title" content="The Discovery of PLK4 Inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as Novel Antiproliferative Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0014.jpeg" /></meta><meta property="og:description" content="The family of Polo-like kinases is important in the regulation of mitotic progression; this work keys on one member, namely Polo-like kinase 4 (PLK4). PLK4 has been identified as a candidate anticancer target which prompted a search for potent and selective inhibitors of PLK4. The body of the paper describes lead generation and optimization work which yielded nanomolar PLK4 inhibitors. Lead generation began with directed virtual screening, using a ligand-based focused library and a PLK4 homology model. Validated hits were used as starting points for the design and discovery of PLK4 inhibitors of novel structure, namely (E)-3-((1H-indazol-6-yl)methylene)indolin-2-ones. Computational models, based on a published X-ray structure (PLK4 kinase domain), were used to understand and optimize the in vitro activity of the series; potent antiproliferative activity was obtained. The kinase selectivity profile and cell cycle analysis of selected inhibitors are described. The results of a xenograft study with an optimized compound 50 (designated CFI-400437) support the potential of these novel PLK4 inhibitors for cancer therapy." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400380m"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400380m">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400380m&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400380m&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400380m&amp;href=/doi/10.1021/jm400380m" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 6069-6087</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm4006719" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm4004347" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">The Discovery of PLK4 Inhibitors: (<i>E</i>)-3-((1<i>H</i>-Indazol-6-yl)methylene)indolin-2-ones as Novel Antiproliferative Agents</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Radoslaw++Laufer">Radoslaw Laufer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bryan++Forrest">Bryan Forrest</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sze-Wan++Li">Sze-Wan Li</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yong++Liu">Yong Liu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Sampson">Peter Sampson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Louise++Edwards">Louise Edwards</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yunhui++Lang">Yunhui Lang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald+E.++Awrey">Donald E. Awrey</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guodong++Mao">Guodong Mao</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Olga++Plotnikova">Olga Plotnikova</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Genie++Leung">Genie Leung</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Hodgson">Richard Hodgson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Irina++Beletskaya">Irina Beletskaya</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacqueline+M.++Mason">Jacqueline M. Mason</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xunyi++Luo">Xunyi Luo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Wei">Xin Wei</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yi++Yao">Yi Yao</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Miklos++Feher">Miklos Feher</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fuqiang++Ban">Fuqiang Ban</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Reza++Kiarash">Reza Kiarash</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Erin++Green">Erin Green</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tak+W.++Mak">Tak W. Mak</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guohua++Pan">Guohua Pan</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Henry+W.++Pauls">Henry W. Pauls</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Campbell Family Institute for Breast Cancer Research, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div><div class="corresp-info"><strong>*</strong>Phone: 416-581-7620. E-mail: <a href="/cdn-cgi/l/email-protection#4d253d2c38213e0d3825233f283e282c3f2e25632e2c"><span class="__cf_email__" data-cfemail="620a1203170e1122170a0c100711070310010a4c0103">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400380m&amp;href=/doi/10.1021%2Fjm400380m" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 6069–6087</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 6, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 March 2013</li><li><span class="item_label"><b>Published</b> online</span>26 July 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 August 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400380m" title="DOI URL">https://doi.org/10.1021/jm400380m</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6069%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRadoslaw%2BLaufer%252C%2BBryan%2BForrest%252C%2BSze-Wan%2BLi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D15%26contentID%3Djm400380m%26title%3DThe%2BDiscovery%2Bof%2BPLK4%2BInhibitors%253A%2B%2528E%2529-3-%2528%25281H-Indazol-6-yl%2529methylene%2529indolin-2-ones%2Bas%2BNovel%2BAntiproliferative%2BAgents%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6087%26publicationDate%3DAugust%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400380m"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3299</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">41</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400380m" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;The Discovery of PLK4 Inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as Novel Antiproliferative Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Radoslaw&quot;,&quot;last_name&quot;:&quot;Laufer&quot;},{&quot;first_name&quot;:&quot;Bryan&quot;,&quot;last_name&quot;:&quot;Forrest&quot;},{&quot;first_name&quot;:&quot;Sze-Wan&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yong&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Sampson&quot;},{&quot;first_name&quot;:&quot;Louise&quot;,&quot;last_name&quot;:&quot;Edwards&quot;},{&quot;first_name&quot;:&quot;Yunhui&quot;,&quot;last_name&quot;:&quot;Lang&quot;},{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;E. Awrey&quot;},{&quot;first_name&quot;:&quot;Guodong&quot;,&quot;last_name&quot;:&quot;Mao&quot;},{&quot;first_name&quot;:&quot;Olga&quot;,&quot;last_name&quot;:&quot;Plotnikova&quot;},{&quot;first_name&quot;:&quot;Genie&quot;,&quot;last_name&quot;:&quot;Leung&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Hodgson&quot;},{&quot;first_name&quot;:&quot;Irina&quot;,&quot;last_name&quot;:&quot;Beletskaya&quot;},{&quot;first_name&quot;:&quot;Jacqueline&quot;,&quot;last_name&quot;:&quot;M. Mason&quot;},{&quot;first_name&quot;:&quot;Xunyi&quot;,&quot;last_name&quot;:&quot;Luo&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Wei&quot;},{&quot;first_name&quot;:&quot;Yi&quot;,&quot;last_name&quot;:&quot;Yao&quot;},{&quot;first_name&quot;:&quot;Miklos&quot;,&quot;last_name&quot;:&quot;Feher&quot;},{&quot;first_name&quot;:&quot;Fuqiang&quot;,&quot;last_name&quot;:&quot;Ban&quot;},{&quot;first_name&quot;:&quot;Reza&quot;,&quot;last_name&quot;:&quot;Kiarash&quot;},{&quot;first_name&quot;:&quot;Erin&quot;,&quot;last_name&quot;:&quot;Green&quot;},{&quot;first_name&quot;:&quot;Tak&quot;,&quot;last_name&quot;:&quot;W. Mak&quot;},{&quot;first_name&quot;:&quot;Guohua&quot;,&quot;last_name&quot;:&quot;Pan&quot;},{&quot;first_name&quot;:&quot;Henry&quot;,&quot;last_name&quot;:&quot;W. Pauls&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;6069-6087&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400380m&quot;},&quot;abstract&quot;:&quot;The family of Polo-like kinases is important in the regulation of mitotic progression; this work keys on one member, namely Polo-like kinase 4 (PLK4). PLK4 has been identified as a candidate anticancer target which prompted a search for potent and selective inhibitors of PLK4. The body of the paper describes lead generation and optimization work which yielded nanomolar PLK4 inhibitors. Lead generation began with directed virtual screening, using a ligand-based focused library and a PLK4 homology model. Validated hits were used as starting points for the design and discovery of PLK4 inhibitors of novel structure, namely (E)-3-((1H-indazol-6-yl)methylene)indolin-2-ones. Computational models, based on a published X-ray structure (PLK4 kinase domain), were used to understand and optimize the in vitro activity of the series; potent antiproliferative activity was obtained. The kinase selectivity profile and cell cycle analysis of selected inhibitors are described. The results of a xenograft study with an optimized &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400380m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400380m" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400380m&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400380m" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400380m&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400380m" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400380m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400380m&amp;href=/doi/10.1021/jm400380m" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400380m" /></input><a href="/doi/pdf/10.1021/jm400380m" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400380m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400380m%26sid%3Dliteratum%253Aachs%26pmid%3D23829549%26genre%3Darticle%26aulast%3DLaufer%26date%3D2013%26atitle%3DThe%2BDiscovery%2Bof%2BPLK4%2BInhibitors%253A%2B%2528E%2529-3-%2528%25281H-Indazol-6-yl%2529methylene%2529indolin-2-ones%2Bas%2BNovel%2BAntiproliferative%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D15%26spage%3D6069%26epage%3D6087%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jmcmar.2013.56.issue-15/production/jmcmar.2013.56.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The family of Polo-like kinases is important in the regulation of mitotic progression; this work keys on one member, namely Polo-like kinase 4 (PLK4). PLK4 has been identified as a candidate anticancer target which prompted a search for potent and selective inhibitors of PLK4. The body of the paper describes lead generation and optimization work which yielded nanomolar PLK4 inhibitors. Lead generation began with directed virtual screening, using a ligand-based focused library and a PLK4 homology model. Validated hits were used as starting points for the design and discovery of PLK4 inhibitors of novel structure, namely (<i>E</i>)-3-((1<i>H</i>-indazol-6-yl)methylene)indolin-2-ones. Computational models, based on a published X-ray structure (PLK4 kinase domain), were used to understand and optimize the in vitro activity of the series; potent antiproliferative activity was obtained. The kinase selectivity profile and cell cycle analysis of selected inhibitors are described. The results of a xenograft study with an optimized compound <b>50</b> (designated CFI-400437) support the potential of these novel PLK4 inhibitors for cancer therapy.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17621" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17621" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A number of therapeutic agents used in the treatment of cancer target tubulin assembly during mitosis.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> These include the tubulin destabilizers, such as vinca alkaloids, and newer agents, such as the taxols, which stabilize microtubules. These successes have encouraged research into nonstructural mechanisms of inducing aberrant mitosis in tumor cells. As our understanding of mitosis has matured and the discrete morphological processes have been linked to biochemical reactions, attention has focused on the mitotic kinesins<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and kinases.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The coordinated action of the mitotic kinases from the cyclin-dependent kinase<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> (CDK), Aurora kinase<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> (AURK), and Polo-like kinase<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> (PLK) families is required for normal mitosis. A priori, any one of the members of the mitotic kinases can be considered as a legitimate target for therapeutic intervention.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Much attention has focused on the Aurora kinase family in recent years, in particular Auroras A and B. Pan Aurora inhibitors have been described as well as compounds selective for one or other of this pair; a number of these agents have entered the clinic.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">PLKs are a conserved family of serine/threonine kinases that function at the intersection of mitosis and DNA damage pathways and are often deregulated in cancer.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Mammalian cells contain five proteins: PLK1, Snk/PLK2, Prk/Fnk/PLK3, Sak/PLK4, and PLK5, of which PLK1 is the most extensively characterized. A number of PLK1 inhibitors have been reported, and work has progressed to the stage that some have been taken into the clinic.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> By contrast, PLK4 has not, as yet, received much attention; this enzyme is structurally the most distinct member of the family.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Unlike PLK1, 2, and 3, PLK4 has only one polo-box and an active site with high homology to the Aurora kinases. PLK4 localizes to the centriole and is essential for controlling centriole duplication and mitotic progression.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17">(13-17)</a> It is a low abundance protein in normal adult tissues and autoregulates its own stability.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21 ref22">(18-22)</a></div><div class="NLM_p">Overexpression of PLK4 causes centriole overduplication,<a onclick="showRef(event, 'ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16">(13-16)</a> which directly results in chromosome segregation errors<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> that may lead to the evolution of more malignant phenotypes. We found that PLK4 depletion caused the death of breast cancer cell lines but not of normal breast cells.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> Examination of microarray data sets demonstrated that PLK4 is up regulated in breast tumors and specifically the triple-negative/basal-like (TNBC) subtype and that high PLK4 levels in breast tumors are associated with poor survival.<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26-28)</a> Together, these observations identified PLK4 as a potential target for the development of therapeutics for cancer, and we validated this hypothesis through a series of in vitro and in vivo experiments. RNAi-mediated depletion of PLK4 in breast cancer cells was found to prevent centriole duplication, causing mitotic defects and cell death and growth suppression of breast cancer xenografts in vivo.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a></div><div class="NLM_p">The potential importance of this enzyme in the development of drugs acting on the human kinome was underscored by Johnson’s publication,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> which screened a number of known kinase inhibitors against the PLK family. A striking result was the propensity of this collection to inhibit PLK4, and the rest of the Polo-like kinases were more or less resistant. Three compounds in particular were potent inhibitors of PLK4, namely <b>1</b>, <b>2</b>, and <b>3</b>, which have been developed as an antiangiogenic, an antimitotic agent, and PKC inhibitor, respectively (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>). This result raises the question of the potential mechanistic importance of PLK4 inhibition when interpreting the in vitro and in vivo effects of these molecules. For example, a multikinase inhibitor <b>4</b> of very different structure has been shown to be potent against PLK4,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and the authors have speculated that the antimitotic effect of this compound may be due, at least in part, to this activity. Isolated reports on PLK4 inhibitors have appeared in the patent literature; compounds <b>5</b> and <b>6</b> are representative of the macrocyclic inhibitors described by Janssen Pharmaceuticals.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> These compounds are relatively selective for PLK4 vis a vis other members of the PLK family and inhibit cancer cell growth, but little is known about their general properties or in vivo activity.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0016.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Reported PLK4 Activity of Known Kinase Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The discovery of potent and selective PLK4 inhibitors would help to further understanding of the role of this enzyme in cancer cell proliferation. Our efforts in the identification of novel PLK4 inhibitors began with a focused screening approach described herein. One series that emerged from our compound screens were the indolinones, a well described class of ATP-competitive kinase inhibitors. These compounds offered several advantages for lead series generation including acceptable ligand efficiencies, a testable binding hypothesis, and ready synthetic accessibility. Given the relatively large number of commercial indolinones available, we had the additional advantage of generating SAR with little to no synthetic effort. The results of our lead generation and subsequent optimization efforts have been preliminarily disclosed<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and are fully described in the body of this paper. The initial synthetic work was driven by several goals, namely a desire to identify new chemotypes for subsequent elaboration, verifying binding hypotheses, and ultimately the identification of drug like inhibitors.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82660" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82660" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Lead Finding</h3><div class="NLM_p">As a starting point in our lead-finding effort, we built a focused kinase library using two different approaches: (1) a ligand-based library of ∼6000 potential kinase inhibitors using molecular fingerprint consensus scoring<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and (2) a target-based virtual screening set of ∼1700 molecules identified through an in-house PLK4 homology model. This homology model was built following a well described method<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> using multiple stages of tethered refinement. This process is highly conservative; it ensures that initial clashes are resolved and do not lead to sudden large structural changes during molecular dynamics. The homology model generated in this manner was validated by docking available PLK4 ligands and inspecting the consistency of their binding modes. When the first X-ray structure of PLK4 became available during the course of this work (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK">3COK</a>), an overlay of the PLK4 homology model to this structure was performed. This exercise revealed that the two were in good agreement, with the heavy atom RMS distance of the two active site structures being a mere 0.8 Å. Another retrospective validation of the homology model was obtained using GOLD<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and Glide XP<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> docking: the binding modes of the PLK4 ligands, when docked into the homology model and the X-ray structure, were identical. This model also provided an understanding of the interactions between screening hits and the kinase active site and was used in subsequent inhibitor design.</div><div class="NLM_p">The focused kinase libraries generated above were augmented with a commercial collection of ∼280 known kinase inhibitors. The merged compound collection was screened against PLK4 using an indirect ELISA assay. Compounds inhibiting >75% at the screening dose of 10 μM were defined as hits and subjected to a validation exercise. Hits were clustered into chemical series using the SAR report within MOE; IC<sub>50</sub>s were determined for selected inhibitors and their chemical integrity checked by LCMS. Representative compounds from series of further interest were subjected to kinetic analysis in the biochemical assay, and their potential binding modes were determined in a PLK4 homology model.</div><div class="NLM_p">Of the several series identified by the focused screening exercise, the 4-hydroxybenzylideneindolin-2-ones held the most promise. The indolinone hits were present in all three sources of molecules, i.e., the ligand and homology model-based libraries as well as the known kinase inhibitors. A kinetic characterization of a representative 4-hydroxybenzylideneindolin-2-one <b>7</b> indicated that this compound was an ATP competitive inhibitor of PLK4 (<i>K</i><sub>i</sub> = 0.7 μM). The initial screening hits were augmented by the acquisition of additional commercially available indolinones. SAR relationships (for PLK4 and PLK1) could be discerned; the key points are illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. It appears that the indolinone NH is important for activity against both PLK4 and PLK1 (compounds <b>8</b> vs <b>9</b>), as is the phenolic hydroxyl (compound <b>10</b>). A flat SAR was observed for PLK1 and PLK4 with respect to changes in substitution patterns of the phenolic ring (<b>11</b>–<b>13</b>); PLK4 was tolerant of an additional hydroxyl on the ring, whereas PLK1 was not (compound <b>14</b>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. 3-(Benzylidene)indolin-2-one Hits from Focused Screening against PLK4 and PLK1</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0010.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R′</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char=".">PLK4</th><th class="colsep0 rowsep0" align="center" char=".">PLK1</th><th class="colsep0 rowsep0" align="center">   </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">R<sup>4</sup></th><th class="colsep0 rowsep0" align="center" char=".">PLK4</th><th class="colsep0 rowsep0" align="center" char=".">PLK1</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="char" char=".">0.23</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="center">   </td><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.86</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">49</td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.66</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr></tbody></table></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Inhibitor Design</h3><div class="NLM_p">Compound <b>11</b> was used as the starting point for new inhibitor design. Indolinones of this sort exist as <i>Z</i> or <i>E</i> isomers,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and an equilibrium mixture, generally 1:1, is attained in aqueous solution. It was not possible to unequivocally determine the favored binding configuration of the 4-hydroxybenzylideneindolin-2-ones, however, our working model (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) was consistent with preferential binding of the <i>Z</i> geometric isomer. The essential features of the SAR were in agreement with our PLK4 binding model (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, left panel), which ascribed a role for the indolinone amido function (i.e., hydrogen bonding to Glu90 and Cys92 of the hinge region) and the phenolic hydroxyl (weak interaction with His93). Our design idea was to morph the phenol into bioisosteric heterocycles <b>15</b>–<b>17</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, right panel), which could retain the H-bonding capability of the parent. A model of triazole <b>15</b> bound into the active site of PLK4 overlays well with the binding mode of compound <b>11</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, left panel). These new compounds embody additional improvements in that the undesirable phenol is replaced and they represent unexplored IP space. The synthesis of these molecules proved to be straightforward (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), and it was possible to further derivatize this core in the pursuit of more potent congeners (vida infra).</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (left panel) Overlay of the highest scoring binding modes of compounds <b>11</b> (green) and <b>15</b> (gray) in the PLK4 homology (generated from Aurora-A structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BMC">2BMC</a>). H-bonds to hinge region shown as dashed lines. (right panel) Bioisosteric replacement of phenol with benzotriazole and indazoles.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of (1<i>H</i>-Indazol-6-yl)methylene)indolin-2-ones</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Chemical Synthesis</h3><div class="NLM_p">Triazole <b>15</b>, (1<i>H</i>-indazol-5-yl-methylene)indolin-2-one <b>16</b>, and the simple (1<i>H</i>-indazol-6-yl-methylene)indolin-2-ones <b>17</b> and <b>20</b>–<b>27</b> can be readily obtained by a one-step Knoevenagel condensation between the requisite aldehydes <b>18</b> and indolinones <b>19</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). In all instances, the <i>E</i> geometric isomer predominates; occasionally a significant amount of <i>Z</i> is also present. For compounds <b>20</b> and <b>21</b>, the stereoisomers were separated chromatographically. Stereoisomeric (arylmethylene)indolin-2-ones can be characterized by their <sup>3</sup><i>J</i>(C═O, H) couplings, measured through proton-detected heteronuclear experiments such as HMBC.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Excitation-sculptured indirect-detection experiment (EXSIDE) NMR can also be employed to determine long-range CH coupling constant measurements;<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> this technique was used to determine the <sup>3</sup><i>J</i>(C═O, H) couplings for <b>20</b> and <b>21</b> as 6.4 and 13.2 Hz, respectively. Alternatively, and more generally, the <i>Z</i>-isomer was identified by a diagnostic peak for proton 7 of the indazole ring at 8.9–9.0 ppm. The downfield shift of proton 7 is attributed to the proximity of the carbonyl of the indolinone in the <i>Z</i>-isomer;<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> this deshielding effect is not observed in the <i>E</i>-isomer and hence the chemical shift of indazole proton 7 in this configuration is observed upfield of 8.0 ppm.</div><div class="NLM_p">Several pathways (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) were employed to synthesize compounds with aryl vinyl substitution on the indazole ring. For example, 3-iodo-1<i>H</i>-indazole-6-carbaldehyde <b>28</b> was protected with a SEM group to give a mixture of regioisomers <b>29</b> that could be used in subsequent Heck couplings without prior separation. The protected aryl vinyl indazoles <b>30</b> were subjected to Knoevenagel condensation with indolinones <b>31</b> to yield intermediates <b>32</b>. Deprotection of the SEM group was effected by various treatments (e.g., Lewis acid; HCl or TBAF/THF) to yield the desired compounds <b>41</b>–<b>45</b> and <b>48</b>–<b>50</b>. In a further variation of this route, deprotection of intermediate <b>30</b> to <b>33</b> (Ar = pyridin-2-yl, Ph and <i>p</i>-(Me<sub>2</sub>NCH<sub>2</sub>)Ph) preceded the final condensation to give inhibitors <b>37</b>, <b>46</b>, and <b>47</b> respectively.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Approach to Substituted (1<i>H</i>-Indazol-6-yl)methylene)indolin-2-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Me<sub>3</sub>SiCH<sub>2</sub>CH<sub>2</sub>OCH<sub>2</sub>Cl, DCM, H<sub>2</sub>O, KOH, TBAB; (b) Pd(OAc)<sub>2</sub>, P(<i>o</i>-tol)<sub>3</sub>, DIPEA, DMF, 100 °C, vinylarene; (c) piperidine, MeOH, Δ; (d) TBAF, THF, Δ or BF<sub>3</sub>OEt<sub>2</sub>, DCM; 2 M aq HCl, EtOH, Δ; (e) dialkyl arylmethylphosphonate, <i>t</i>-BuOK, DMF; (f) Ra-Ni, Na<sub>2</sub>PO<sub>2</sub>H<sub>2</sub>, Δ; (g) NaOH, H<sub>2</sub>O, THF, MeOH.</p></p></figure><div class="NLM_p last">An alternate route began with Horner–Wadsworth–Emmons olefination of aldehyde <b>34</b> to give intermediates <b>35</b>. In this procedure, subsequent reduction of the pendant nitrile yielded aldehydes <b>33</b>. The standard Knoevenagel condensation gave final products <b>38</b>–<b>40</b>. In the case of inhibitor <b>51</b> (Ar = 4-carboxyphenyl), the desired carboxylic acid <b>36</b> was revealed by base hydrolysis of the precursor ester prior to the Knoevenagel condensation.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Lead Optimization</h3><div class="NLM_p">We were gratified to see that these new compounds, e.g., <b>15</b>–<b>17</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), inhibited PLK4 in the single-digit micromolar range or better. Our working models (Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, left panel) suggested that 5 or 6 substitution of the indolinone with H-bond acceptors could result in additional interactions with Lys and compounds were prepared to explore this hypothesis. Analogues of the most potent indazole <b>17</b> were rapidly synthesized to yield a collection of inhibitors <b>20</b>–<b>27</b> with IC<sub>50</sub>s ranging from double-digit nanomolar to micromolar (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The selectivity of the inhibitors against the Polo-like kinase family members, namely PLK1, -2, and -3, increased with increasing PLK4 potency.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Kinase Activity of Indazol-6-yl Indolinones</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0011.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">kinase IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">isomer</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R′</th><th class="colsep0 rowsep0" align="center">PLK4<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">PLK1</th><th class="colsep0 rowsep0" align="center">PLK2</th><th class="colsep0 rowsep0" align="center">PLK3</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">not applicable</td><td class="colsep0 rowsep0" align="left">not applicable</td><td class="colsep0 rowsep0" align="left">not applicable</td><td class="colsep0 rowsep0" align="center">2.2</td><td class="colsep0 rowsep0" align="center">29</td><td class="colsep0 rowsep0" align="center">8.9</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">not applicable</td><td class="colsep0 rowsep0" align="left">not applicable</td><td class="colsep0 rowsep0" align="left">not applicable</td><td class="colsep0 rowsep0" align="center">0.39</td><td class="colsep0 rowsep0" align="center">20</td><td class="colsep0 rowsep0" align="center">1.9</td><td class="colsep0 rowsep0" align="center">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left"><i>E</i></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.29 ± 0.02</td><td class="colsep0 rowsep0" align="center">24</td><td class="colsep0 rowsep0" align="center">5.7</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left"><i>E</i><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.06 ± 0.02</td><td class="colsep0 rowsep0" align="center">15</td><td class="colsep0 rowsep0" align="center">4.4</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left"><i>Z</i></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.24</td><td class="colsep0 rowsep0" align="center">15</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left"><i>E</i></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.054</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left"><i>E</i></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="center">1.3</td><td class="colsep0 rowsep0" align="center">∼26</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left"><i>E</i>/<i>Z</i><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.047</td><td class="colsep0 rowsep0" align="center">∼10</td><td class="colsep0 rowsep0" align="center"><10</td><td class="colsep0 rowsep0" align="center"><10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left"><i>E</i></td><td class="colsep0 rowsep0" align="left">CONHMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="center">∼49</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left"><i>E</i>/<i>Z</i><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">NHAc</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">6.3 ± 2.5</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">∼10</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left"><i>E</i></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NHAc</td><td class="colsep0 rowsep0" align="center">1.2 ± 0.2</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">∼10</td><td class="colsep0 rowsep0" align="center">>10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last"><i>E</i> predominates.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">No isomerization under the buffer condition mimicking the PLK4 kinase assay.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">IC<sub>50</sub> values are single determinations unless the standard deviation for three replicates is given</p></div></div></div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding modes of (<i>E</i>)-3-((1<i>H</i>-indazol-6-yl)methylene)indolin-2-one, compound <b>17</b>, in PLK4 homology model (generated from Aurora-A structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BMC">2BMC</a>). (left panel) Mode 1 with H-bonds from indolinone moiety to hinge region and H-bond to Leu18. (right panel) Mode 2 with H-bonds from indazole moiety to the hinge region and H-bonds to Lys41 and Asp154.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">These encouraging results were tempered by the observation that the discernible SAR appeared to be at odds with our working models on several points. First, the predominance of the <i>E</i> isomer negates any possible interaction between His93 and the heterocyclic H-bond donor. Yet, in a head to head comparison, the <i>E</i> isomer, compound <b>20</b>, was somewhat more potent than the <i>Z</i> isomer, <b>21</b>. The double bond of (arylmethylene)indolin-2-ones has the potential to isomerize in aqueous and alcoholic media,<a onclick="showRef(event, 'ref38 ref42'); return false;" href="javascript:void(0);" class="ref ref38 ref42">(38, 42)</a> and we have observed the conversion of homogeneous compound <b>20</b> to a 3:2 <i>E</i>/<i>Z</i> mixture within 6 h in DMSO-<i>d</i><sub>6</sub> at rt. Despite the potential for isomeric lability in solution, it appears that the geometric configuration of the starting solid informs in vitro results. This is consistent with the observation that no isomerization occurs upon incubation of compound <b>20</b> under the buffer condition mimicking the PLK4 kinase assay.</div><div class="NLM_p">H-Bond acceptors/donors at position 5 and 6 of the indolinone resulted in a loss of activity (compounds <b>25</b>–<b>27</b>), whereas hydrophobes and halogens were favored at the 5 position (compounds <b>20</b>, <b>22</b>, and <b>24</b>). These observations were also inconsistent with the original binding hypothesis. To begin to understand the nature of the binding of the 3-((1<i>H</i>-indazol-6-yl)methylene)indolin-2-ones, a kinetic analysis of compound <b>17</b> was performed (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). This study showed that compound <b>17</b> displays kinetics consistent with direct competition for ATP binding to the active site of PLK4 with an apparent <i>K</i><sub>i</sub> of 22 nM. These results, coupled with an understanding that indazoles are capable of making hinge region interactions in their own right, prompted a reexamination of the binding models. The two possibilities are illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>: the left panel shows the indolinone making two H-bonds to the hinge region (Glu90 and Cys92); the right panel shows the indazole interacting with the hinge region and also ascribes a role for the indolinone, i.e., H-bond to Asp154. Using the homology model, it was not possible to distinguish between these two modes by computational docking alone.</div><div class="NLM_p">The publication of Johnson’s seminal work on the inhibition of the PLK family by kinase inhibitors<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> suggested a way to test the binding model corresponding to Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, right panel. This work reported that Axitinib, an RTK inhibitor and antiangiogenic agent, was also a potent inhibitor of PLK4 (IC<sub>50</sub> = 46 nM in our hands) and it docked and scored highly in our binding model. Overlay of Axitinib (an indazole with putative hinge region interactions) with our own inhibitors generates a hybrid target molecule, namely <b>37</b>. This pyridin-2-yl vinyl analogue was docked into the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK">3COK</a> model using GlideXP and was predicted to potently inhibit PLK4 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, left panel). The <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK">3COK</a> model, generated from the PLK4 X-ray structure, was optimized to improve quantitative predictivity as measured by the correlation of docking scores and pIC<sub>50</sub> values (see <a class="ref internalNav" href="#sec4_1" aria-label="Computational Methods">Computational Methods</a> in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). Whereas the position of the indazole and indolinone groups are unchanged from the parent <b>17</b> (i.e., the H-bonds to the hinge are retained), the vinyl linker places the pyridyl group in a good position for hydrophobic interactions (e.g., with Leu18). In the event, compound <b>37</b> inhibited PLK4 with an IC<sub>50</sub> of 13 nM (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). This 20-fold improvement in activity is in good agreement with the log unit increase predicted by the model. It should be noted that the PLK4 IC<sub>50</sub> of the styryl compound <b>46</b> suffers in comparison to <b>37</b> by 3-fold but still represents a significant improvement over the parent, <b>17</b>.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding modes of PLK4 inhibitors in the modified <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK">3COK</a> PLK4 structure. (left panel) Compound <b>37</b> with H-bonds to hinge region and Asp154; hydrophobic interaction between the side chain of Leu18 and pyridyl ring shown by a dotted line. (right panel) Compound <b>44</b> with a surface on PLK4 active site; pyridyl nitrogen sits at enzyme/solvent interface and the OMe moiety nestles in a groove bounded by the protein backbone and the side chains of Leu143 and Glu96.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Attenuation of Cancer Cell Proliferation by PLK4 Inhibitors<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0012.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0013.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">*E predominates. **IC<sub>50</sub> values are single determinations unless the standard deviation for three replicates is given; PLK1, -2, and -3 IC<sub>50</sub>s > 10 μM for all compounds in table.</p></div></div><div></div></div><div class="NLM_p">This result prompted the synthesis of the other pyridine positional isomers. The pyridin-(3 and 4)-yl isomers <b>38</b> and <b>41</b>, respectively, were more active than the pyridin-2-yl isomer (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Presumably, the polar nitrogen is more readily accommodated in the aqueous milieu at the protein surface. An additional increase in potency was realized by incorporation of the 5-methoxy substitution on the indolinone ring (compounds <b>40</b> and <b>44</b>); alkyl groups (<b>39</b>, <b>43</b>), chlorine (<b>42</b>) and hydroxy (<b>45</b>) were somewhat less effective. Once again, our model correctly predicted the improvement observed upon substitution of a methoxy group at the 5-position of the indolinone. However, the measured IC<sub>50</sub>s for inhibitors <b>40</b> and <b>44</b> must be viewed as apparent values because they approach the nominal concentration of enzyme in the assay, i.e., 0.4 nM. Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, right panel, displays compound <b>44</b> docked into the active site of the PLK4 enzyme. Apart from the usual hinge-binding to the backbones of Glu90 and Cys92, there is also a hydrogen bond to the side chain of Asp154. There is extensive hydrophobic contact between the enzyme and the ligand, especially at the aromatic rings and the methoxy group which nestles in a groove bounded by the protein backbone and the side chains of Leu143 and Glu96. In contrast, the <i>Z</i>-isomers of the aryl vinyl indazoles given in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> generally did not dock into the PLK4 active site and those that did had docking scores up to 3 log units lower than the <i>E</i>-isomers.</div><div class="NLM_p">Compounds <b>37</b>–<b>45</b> represented a significant advance; however, their potent PLK4 inhibition did not result in a uniformly potent antiproliferative effect on breast cancer cell lines. As a group, these compounds had variable effects on cell growth inhibition; GI<sub>50</sub>s were in the submicromolar range for the MCF-7 and MDA-MB-468 cell lines, only marginally better than Axitinib. A correlation between PLK4 potency and GI<sub>50</sub>s was discernible in the MCF-7 and MDA-MB-468 cell lines, but the MDA-MB-231, SKBr-3, and HCC-1954 lines appeared to be less responsive. The effects of the potent PLK4 inhibitor <b>41</b> on cell cycling of MDA-MB-468 cells are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. Concentrations of <b>41</b> at 0.5 μM and above cause mitotic checkpoint loss, polyploidy and death, underscored by the accumulation of 8N and 16N peaks.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cell Cycle analysis of in MDA-MB-468 cells treated with PLK4 inhibitor <b>41</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another drawback to the pyridinyl inhibitors is captured in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Compound <b>41</b>, for example, demonstrated significant inhibitory effects on CYP450s 2C9 and 2C19, which is ascribed to the aromatic ring nitrogen. With a view to attenuating this activity, and understanding that biochemical potency does not always translate into cellular activity, the physicochemical properties of the PLK4 inhibitors were calculated. Data on representative compounds is given in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. The physicochemical properties of the series were modified by incorporation of water-solubilizing substituents on the phenyl ring distal from the indazole core. The beneficial effects of these substitutions on solubility are captured by the ACD calculated values given in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> and that this is achieved without sacrificing lipophilicity is reflected by the calculated log <i>P</i>. Molecular modeling indicated that this region of the inhibitor was projected into solvent and would have no deleterious effect on PLK4 potency (see Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, right panel). For example, the addition of tertiary amines at this position yielded potent PLK4 inhibitors <b>47</b>–<b>50</b>, moreover, their inhibition of cell growth was significantly better than pyridinyl compounds <b>37</b>–<b>45</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). In contrast, appending a carboxylic acid function at the <i>para</i> position of the phenyl ring yielded a subnanomolar inhibitor <b>51</b>, however, a decrease in cellular activity was observed. Once again, not all breast cancer cell lines were responsive to compounds <b>47</b>–<b>50</b> to the same degree. MCF-7, MDA-MB-468, and MDA-MB-231 had GI<sub>50</sub>s in the double-digit nanomolar range; growth inhibition of SKBR-3 and HCC-1954 was observed only at micromolar concentrations. No relationship was observed between response to inhibitors and PLK4 mRNA levels, which are comparable across the cell lines tested (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). A lack of correlation between target expression and responsiveness of cancer cells to pharmacologic inhibition of the target has been reported for other mitotic kinases.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Gratifyingly, compounds <b>47</b> and <b>50</b> demonstrated not only enhanced growth inhibitory activity but also attenuated CYP450 inhibition (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Physicochemical and CYP Inhibition Data for Selected PLK4 Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="char" char="." /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">calculated physicochemical properties (ACD<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a>)</th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">CYP<sub>450</sub> IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center">solubility (μg/mL)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>a</sub></th><th class="colsep0 rowsep0" align="center" char=".">log <i>P</i><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">pH 7.4</th><th class="colsep0 rowsep0" align="center">pH 4.0</th><th class="colsep0 rowsep0" align="center">PAMPA @ pH 7.4 (10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center">1A2</th><th class="colsep0 rowsep0" align="center">3A4</th><th class="colsep0 rowsep0" align="center">2C9</th><th class="colsep0 rowsep0" align="center">2C19</th><th class="colsep0 rowsep0" align="center">2D6</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="center">5.2, 9.7</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="center">2.3</td><td class="colsep0 rowsep0" align="center">32</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="center">4.2</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="center">89</td><td class="colsep0 rowsep0" align="center">0.2</td><td class="colsep0 rowsep0" align="center">2.1</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="center">5.2</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="center">1.1</td><td class="colsep0 rowsep0" align="center">15</td><td class="colsep0 rowsep0" align="center">197</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">2.7</td><td class="colsep0 rowsep0" align="center">0.02</td><td class="colsep0 rowsep0" align="center">0.13</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="center">8.7</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="center">6.1</td><td class="colsep0 rowsep0" align="center">370</td><td class="colsep0 rowsep0" align="center">276</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">∼10</td><td class="colsep0 rowsep0" align="center">1.3</td><td class="colsep0 rowsep0" align="center">1.0</td><td class="colsep0 rowsep0" align="center">9.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="center">6.1, 7.5</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="center">9.4</td><td class="colsep0 rowsep0" align="center">28000</td><td class="colsep0 rowsep0" align="center">335</td><td class="colsep0 rowsep0" align="center">∼10</td><td class="colsep0 rowsep0" align="center">0.8</td><td class="colsep0 rowsep0" align="center">0.9</td><td class="colsep0 rowsep0" align="center">0.44</td><td class="colsep0 rowsep0" align="center">∼10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="center">6.1, 7.5</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="center">8.6</td><td class="colsep0 rowsep0" align="center">26000</td><td class="colsep0 rowsep0" align="center">164</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">∼10</td><td class="colsep0 rowsep0" align="center">0.8</td><td class="colsep0 rowsep0" align="center">1.6</td><td class="colsep0 rowsep0" align="center">>10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Version A of log <i>P</i> calculator.</p></div></div></div><div class="NLM_p">Across a broad range of chemotypes and biochemical activities, we were able to show a correlation between the measured GI<sub>50</sub> in MDA-MB-468 cells and pGI<sub>50</sub> calcd (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). QSAR analysis established that calculated pGI<sub>50</sub> was best described by three independent variables, namely PLK4 pIC<sub>50</sub>, molecular volume, and log <i>P</i>, with an <i>R</i><sup>2</sup> of 0.52 and RMSE of 0.62. The level of variance observed indicates that additional unrecognized factors may be important. According to the predictive equation given in the <a class="ref internalNav" href="#sec4_1" aria-label="Computational Methods">Computational Methods</a>, PLK4 inhibition was the most important contributor. However, it is expected that the ability of a PLK4 inhibitor to cross cellular membranes (as reflected by its log <i>P</i>) would factor into antiproliferative activity.</div><div class="NLM_p last">To further illustrate this point, PAMPA values were obtained on representative compounds given in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. All six are potent PLK4 inhibitors; however, the compounds with low permeability (hydroxy substituted indolinone <b>45</b> and carboxylate <b>51</b>) showed correspondingly poor activity in the cell growth assays. Pyridine <b>41</b> is 2 orders of magnitude more permeable, but this did not translate into potent cell growth inhibition. Some of the most potent inhibitors of breast cancer cell growth, tertiary amines <b>47</b>, <b>49</b>, and <b>50</b>, also had high PAMPA values; it would appear that permeability and potent PLK4 inhibition are necessary but not sufficient for robust cell activity (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).<figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Correlation of pGI<sub>50</sub> measured with pGI<sub>50</sub> calculated for PLK4 inhibitors in the MDA-MB-468 cell line. QSAR analysis established that three independent variables are sufficient to describe pGI<sub>50</sub> calcd, namely pIC<sub>50</sub>PLK4, molecular volume, and log <i>P</i> with <i>R</i><sup>2</sup> of 0.52 and RMSE of 0.62 (<i>n</i> = 181).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Kinase Selectivity</h3><div class="NLM_p">The PLK4 inhibitor, <b>50</b> and was profiled against a panel of 274 protein kinases at a screening concentration of 1 μM. This data is presented as a heat map (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) which indicates that compound <b>50</b> displayed better selectivity than Sunitinib and somewhat less than Axitinib, two ATP competitive kinase inhibitors used clinically. Of the 274 kinases tested, 30 were inhibited at greater than 90%, at the screening concentration of 1 μM (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). For a subset of the more potently inhibited kinases of interest, IC<sub>50</sub>s were determined using in-house assays. Compound <b>50</b> inhibited Aurora A, Aurora B, KDR, and FLT-3, with IC<sub>50</sub>s of 0.37, 0.21, 0.48, and 0.18 μM, respectively, i.e., 2 orders of magnitude higher than its IC<sub>50</sub> of 0.6 nM against PLK4.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Heat map showing % inhibition of 274 human kinases at a screening concentration of 1 μM for compound <b>50</b> in comparison to Axitinib and Sunitinib. Compounds were individually sorted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vivo Efficacy</h3><div class="NLM_p">Given its potent antiproliferative activity against the MDA-MB-468 breast cancer cell line, compound <b>50</b> was selected for testing in the corresponding mouse xenograft model. In preparation for this in vivo experiment, we determined the plasma levels of compound <b>50</b> in mice upon IP dosing at 50 mg/kg; a <i>C</i><sub>max</sub> of 92 ng/mL and AUC of 190 ng·h/mL were observed. The mouse plasma protein binding measurement for compound <b>50</b> is 99%, i.e., unbound compound in plasma is 1%. Thus, the extrapolated <i>C</i><sub>max</sub> for the xenograft IP dose (25 mg/kg) would equate to the single-digit nanomolar range, well below the off-target kinase activities measured (>100 nM). At this point, we can say nothing definitive about target engagement by the PLK4 inhibitor <b>50</b> because compound enrichment in tumors and/or kinase active sites is possible. Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a> shows the in vivo efficacy results using an MDA-MB-468 mouse xenograft model; at 50 mg/kg daily IP dose, VX680, a literature standard, achieved a substantial reduction in tumor volume compared to the negative control (70% TGI). Upon dosing the PLK4 inhibitor <b>50</b> at 25 mg/kg IP, no increase in tumor volume was observed; in fact, the tumor regressed in size (120% TGI). There was no significant weight loss in any of the arms of the study. Clearly, the PLK4 inhibitor <b>50</b> compared favorably with VX680 in this xenograft model.</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Average tumor volume (TV) and average weight (Wt) vs days of treatment with compound <b>50</b> (25 mg/kg IP) and VX680 (50 mg/kg IP) in an MDA-MB-468 mouse xenograft model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70038" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70038" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">PLK4, identified by an in-house siRNA screen and supporting validation efforts as a tractable, novel target for drug discovery, was subjected to a lead generation effort. A two pronged focused screening campaign identified 3-(hydroxybenzylidene)indolin-2-one hits for subsequent validation work. Bioisosteric replacement of the phenolic function of the validated hits resulted in the identification of (<i>E</i>)-3-((1<i>H</i>-indazol-6-yl)methylene)indolin-2-ones as a novel class of kinase inhibitors. Systematic optimization of this series yielded inhibitors with nanomolar activity against PLK4 and concomitant antiproliferative effects against a panel of breast cancer cell lines. Models of the inhibitor series in a <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK">3COK</a> derived structure help explain and predict the observed PLK4 activity.</div><div class="NLM_p last">One inhibitor was selected for detailed study; compound <b>50</b> (designated CFI-400437) is potent against PLK4 (IC<sub>50</sub> = 0.6 nM) and selective against other members of the PLK family (>10 μM). Against a broad panel of kinases, only a small subset is significantly inhibited. However, like other ATP competitive kinase inhibitors, the cell activity and in vivo effects seen with <b>50</b> cannot be ascribed solely to the inhibition of PLK4. Compound <b>50</b> is a potent inhibitor of MCF-7, MDA-MB-468, and MDA-MB-231 cell growth and very effective in a mouse xenograft model of tumor growth. The data reported herein on this new class of antimitotic agents, culminating in the in vivo efficacy for compound <b>50</b>, illustrates the potential of these novel PLK4 inhibitors for cancer therapy. Further optimization work toward the identification of a development candidate will be disclosed in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17530" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17530" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Computational Methods</h3><div class="NLM_p">Most of the computational processes, including ligand preparation, ligand-based virtual screening, homology model building, and QSAR-type analyses were performed using the MOE software.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><div class="NLM_p">A focused kinase library was generated using a ligand-based virtual screening approach<a onclick="showRef(event, 'ref34 ref45'); return false;" href="javascript:void(0);" class="ref ref34 ref45">(34, 45)</a> with the aim of identifying a diverse set of readily available compounds with reasonable physicochemical properties that are “kinase inhibitor-like”. This approach began with selecting a training set of 379 diverse compounds that have better than 100 nM activities in different protein kinase assays, drawn from a collection of ∼2700 known kinase inhibitors in the Wombat database.<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46, 47)</a> This training set was utilized in molecular fingerprint based consensus scoring using the MACCSF, TGTFO, and MP61 fingerprints.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The screened data set comprised of ∼3 million commercially available compounds, put together from 12 leading compound vendors. The initial hit-set of ∼50000 compounds was obtained by selecting the top scoring ∼30000 hits each from the MACCSF and TGTFO hit lists as well as the consensus list obtained using the sum rank of all three. This set further was reduced utilizing property filters (250 < MW < 600, number of H-bond donors <5, number of H-bond acceptors <10, number of chiral centers <5, total number of rotatable bonds <11, and total number of contiguous rotatable bonds <7, as well as a substructure-based filter to remove reactive molecules, based on the MOE descriptor “reactive” with some in-house modifications). The remaining compounds were clustered using the MACCS fingerprint into ∼6500 clusters using the top scoring hits from each, and then some compounds were removed after manual selection, yielding ∼6000 compounds, purchased from commercial sources.</div><div class="NLM_p">A homology model of the PLK4 kinase domain was generated. The PLK4 homology model was built using the X-ray structure of Aurora-A cocrystallized with PHA-680632<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BMC">2BMC</a>). This structure has 37% residue identity in the kinase domain with PLK4, using the blosum35 substitution matrix. Primary sequence alignment was followed by threading the PLK4 residues to the Aurora-A structure, fully preserving the main chain secondary structure (i.e., no minimizations were performed on the intermediate and final structures). The solution with the best packing score was selected. After this, a three-stage refinement process was performed using tethered molecular dynamics (MD) and energy minimizations using the MMFFx forcefield in MOE. These tethers were added to all dihedral connections within the protein structure in order to prevent significant perturbations and movements in the positions of heavy atoms. First, strong dihedral tethers were used (for the backbone a force constant of 100 kcal/mol/deg, applied on torsional angle changes over 0.2°, whereas for the side chains and ligand they were 10 kcal/mol/deg and 0.5°, respectively), then somewhat weaker ones (backbone 10 kcal/mol/deg and 0.5°, side chains and ligand 1 kcal/mol/deg and 1°, respectively), and finally no tethers at all. The dynamics runs included 100 ps heating to 300 K, followed by a simulation carried on until the energy seemed to stay constant, followed by energy minimization to a gradient of 0.05 kcal/mol/Å. In the first stage, the simulation took 150 ps, in the second it was 900 ps, and in the third 2340 ps. Docking was performed using the GOLD<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and Glide<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> software using standard settings. In all cases, constraints were applied for the hinge binding contacts (at least one contact from the list of Glu90 carbonyl, Cys92 NH or carbonyl), to ensure that all solutions have the expected hinge binding mode. An overlay of the homology model to the first X-ray structure of PLK4 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK">3COK</a>: 2.25 Å resolution, cocrystallized with an ATP analogue) was performed. The RMS distance of two active sites was 0.8 Å when considering heavy atoms for residues within 12 Å of the cognate ligand.</div><div class="NLM_p">The homology model described above was used for virtual screening purposes. Approximately 3 million commercial compounds were initially considered. Using somewhat different property filters than above (250 < MW < 600, number of chiral centers <3, and the same substructure-based reactivity filter), 2 million molecules were further considered. These were protonated/deprotonated using the Wash process, built into 3D using stereoisomer generation with the stergen setting in Corina,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> and minimized using the MMFF94x forcefield in MOE. These molecules were then docked with GlideSP using the hinge binding constraints on the carbonyl of Glu90 and the carbonyl and NH of Cys92 (at least one of these to be satisfied). The obtained hit list was filtered using the GlideSP score, corresponding to 15 μM activity on the training set, yielding ∼158000 compounds. This set was then docked using two methods: GlideXP and GOLD (using default settings), again using hinge-binding constraints. To ensure that a balanced set of hits is identified, the following selection process was applied: the top 500 molecules were selected using the top scoring GOLD poses rescored using the dockpKi function in MOE,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> the top 1000 using the GlideXP score, the top 500 using calculated ligand efficiency in GlideXP, and the top 2500 using sum rank consensus score the GOLD/dockpKi and GlideXP. The hits were then filtered to select molecules with hinge binding interactions precedented in the literature,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> yielding ∼3100 ligands. After removing duplicate molecules, clustering using the MACCS fingerprints and manual selection, 1956 compounds were purchased. Compounds of Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> were purchased from the following sources: <b>7</b>, <b>9</b>, <b>11</b>, and <b>14</b>, ChemDiv, San Diego, CA, USA; <b>13</b>, Life Chemicals, Burlington, ON, Canada; <b>12</b>, Enamine Ltd., Kiev, Ukraine; <b>8</b>, Ambintner, c/o Greenpharma, Orléans, FRANCE; <b>10</b>, ChemBridge Corporation, San Diego, CA, USA. LCMS data (i.e., purities and parent masses) can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div><div class="NLM_p">A second model was generated using the PLK4 <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK">3COK</a> X-ray structure deposited in the PDB. The X-ray structure differed significantly from the homology model above at two residues namely, Lys41 and Asp154. The <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK">3COK</a> structure was modified by generating rotamers of these side chains with the MOE rotamer explorer, minimized in place with the rest of the structure fixed, and the structures obtained were then used to generate docking models. These docking models were compared using the correlation of docking scores and pIC<sub>50</sub>s on 270 ligands. The best quantitative predictivity was obtained when the Lys41 rotamer was similar to that in the homology model, and the Asp154 was left in its original position. With this modification, the predictive performance of the X-ray structure-based model using GlideXP improved dramatically (<i>R</i><sup>2</sup> of 0.54 and RMSE of 0.82 on the same set). The performance of this model was monitored throughout the course of this work, and the correlation coefficient did not deviate significantly from an <i>R</i><sup>2</sup> of 0.5. This compares favorably to the initial homology model, which had modest predictive power on the ligand set available at the time (<i>R</i><sup>2</sup> of 0.3 and RMSE of 0.93 on 270 ligands).</div><div class="NLM_p">QSAR models for GI<sub>50</sub> data were generated using standard procedures, only using a small pool of ∼15 descriptors from four categories that were expected to contribute to cell growth inhibition. These included the biochemical IC<sub>50</sub> for PLK4, a measure of size (e.g., molecular weight, volume, number of rotatable bonds), a measure of lipophilicity (log <i>P</i>, log <i>D</i>), and calculated solubility. The model was initially built using a training set of 110 compounds and was validated using forward prediction.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The best model on the training set included PLK4 activity, as well as the McGowan characteristic molecular volume and log <i>P</i>.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> The predictive equation is given below:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/jm-2013-00380m_m001.gif" alt="" /></img></span></div><div class="NLM_p last">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> displays the performance of the same model on the full set of 181 molecules, obtained at a later time point, and includes all molecules available at the time. Note that the performance of the model remained substantially unchanged at later time points (<i>n</i> > 400, not shown).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Synthesis</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General Experimental Methods</h4><div class="NLM_p">Commercially available starting materials, reagents, and solvents were used as received, with the exception of <i>N</i>,<i>N</i>-dimethyl-1-(4-vinylphenyl)methanamine, which was purified by chromatography on silica gel prior to use in Heck reactions. In general, anhydrous reactions were performed under an inert atmosphere such as nitrogen or argon. Microwave reactions were performed with a Biotage Initiator microwave reactor. Yields were not optimized. Reaction progress was generally monitored by TLC using Merck silica gel plates with visualization by UV at 254 nm, by analytical HPLC or by LCMS (Bruker Exquire 4000). Flash column chromatographic purification of intermediates or final products was performed using 230–400 mesh silica gel 60 from EMD chemicals. Final products were sometimes purified by preparative reverse-phase HPLC. Purification was performed on a Varian PrepStar model SD-1 HPLC system with a Varian Monochrom 10μ C-18 reverse-phase column using a gradient of about 5–30% acetonitrile/0.05% TFA water to 70–100% acetonitrile/0.05% TFA water over a 20–40-min period at a flow rate of 30–50 mL/min. Fractions containing the desired material were concentrated and/or lyophilized to obtain the final products.</div><div class="NLM_p">Proton nuclear magnetic resonance (<sup>1</sup>H NMR) spectra were recorded on a Bruker AV 400 MHz or Agilent DD2–500 spectrometers. Chemical shifts were reported in parts per million (ppm) from tetramethylsilane. Proton coupling patterns were described as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), and broad (b). The <i>E</i>:<i>Z</i> configuration of (indazolyl)methylene indolinone linker was determined by <sup>1</sup>H NMR spectroscopy. Stereoisomers were characterized by their <sup>3</sup><i>J</i>(C═O, H) couplings, measured through EXSIDE NMR experiments: The <sup>3</sup><i>J</i><sub>cis</sub> = 7–8 Hz for the <i>E</i> isomer and <sup>3</sup><i>J</i><sub>trans</sub> = 10–12 Hz for the <i>Z</i> isomer.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> The configuration of the alkene linker could also be assigned by the shift of a diagnostic peak for proton 7 of the indazole ring: 8.9–9.1 ppm for the <i>Z</i>-isomer and 7.8–8.1 ppm for the <i>E</i>-isomer.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p">The purity of compounds described within was determined by one of two HPLC methods: (A) using a Phenomenex Gemini C18 column (50 mm × 4.6 mm, 3 μm) with a gradient of 10–90% acetonitrile in water (with 0.1% formic acid in each mobile phases), with UV detection at λ = 254 or 214 on an Agilent 1100 series, and/or (B) using a Varian MonoChrom C18 column (100 mm × 4.6 mm, 10 μm) with a gradient of 10–90% acetonitrile in water (with 0.1% TFA in each mobile phases), with UV detection at λ = 254 and 214 on a Varian ProStar 335 LC detector. The purity of all final compounds was shown by HPLC to be ≥95%.</div><div class="NLM_p last">Low resolution mass spectra (MS ESI) were obtained using a Bruker Esquire 4000 spectrometer under electron spray ionization conditions. High resolution mass spectra (HRMS) were obtained by a Waters Acquity UPLC coupled with a Waters Synapt G2 time-of-flight mass spectrometer, using an ESI source. Compounds in DMSO solutions (5 mg/mL) were diluted to 0.01 mg/mL; 5 uL was injected on to a Waters BEH C18 1.7 μm 2.1 mm × 100 mm column equilibrated at 10% acetonitrile in water, spiked with 0.1% formic acid at a flow rate of 0.5 mL/min. Bound analytes were eluted by a linear gradient of 10 to 95% acetonitrile in water, between 1 and 8 min. The mass spectrum was calibrated using formate clusters; leucine enkephalin was used as a “lock mass” for additional, real-time, accurate-mass correction.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (<i>E</i>)-3-((1<i>H</i>-Benzo[<i>d</i>][1,2,3]triazol-5-yl)methylene)indolin-2-one (<b>15</b>)</h4><div class="NLM_p last">An EtOH (4 mL) solution of indolin-2-one (101 mg, 0.76 mmol), 1<i>H</i>-benzo[<i>d</i>][1,2,3]triazole-5-carbaldehyde (123 mg, 0.84 mmol), and piperidine (7.5 μL, 0.08 mmol) in a sealed scintillation vial was heated at 90 °C for 2 h. The resulting precipitate was washed with EtOH (20 mL) and dried to yield the title compound as a yellow solid (149 mg, 75%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 15.94 (s, 1H), 10.65 (s, 1H), 8.27 (bs, 1H), 8.05 (bs, 1H), 7.80 (s, 1H), 7.77 (bs, 1H), 7.51 (d, <i>J</i> = 7.6 Hz, 1H), 7.24 (t, <i>J</i> = 7.6 Hz, 1H), 6.88 (d, = 7.6 Hz, 1 H), 6.84 (d, <i>J</i> = 7.6 Hz, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>23</sub>H<sub>16</sub>N<sub>4</sub>O + H]<sup>+</sup> 263.0933, found 263.0931. HPLC A: 98A% at 254 nm.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (<i>E</i> and <i>Z</i>)-3-((1<i>H</i>-Indazol-5-yl)methylene)indolin-2-one (<b>16</b>)</h4><div class="NLM_p last">An EtOH (2 mL) solution of indolin-2-one (67 mg, 0.50 mmol), 1<i>H</i>-indazole-5-carbaldehyde (73 mg, 0.50 mmol), and piperidine (5.0 μL, 0.05 mmol) was heated at 90 °C in a sealed scintillation vial for 2 h. The EtOH was removed under reduced pressure, and the crude mixture was purified by preparative reverse phase HPLC to give the title compound as a yellow solid (10 mg, 7.6%) with a 12:1 <i>E</i> to <i>Z</i> ratio. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.20–8.18 (m, 2H), 7.89 (s, 1H), 7.76 (d, <i>J</i> = 7.9 Hz, 1H), 7.71–7.67 (m, 2H), 7.24 (t, <i>J</i> = 7.4 Hz, 1H), 6.93 (d, <i>J</i> = 7.7 Hz, 1H), 6.90 (t, <i>J</i> = 7.5 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>16</sub>H<sub>11</sub>N<sub>3</sub>O + H]<sup>+</sup> 262.1, found 262.0. HPLC A: >95A% at 214 nm.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<i>E</i>)-3-((1<i>H</i>-Indazol-6-yl)methylene)indolin-2-one (<b>17</b>)</h4><div class="NLM_p last">According to the method described for compound <b>15</b>, the title compound was prepared as a yellow solid (35 mg, 27%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.14 (s, 1H), 7.91 (d, <i>J</i> = 8.5 Hz, 1H), 7.89 (s, 2H), 7.65 (d, <i>J</i> = 7.6 Hz, 1H), 7.47 (d, <i>J</i> = 8.4 Hz, 1H), 7.25 (t, <i>J</i> = 7.7 Hz, 1H), 6.93 (d, <i>J</i> = 7.8 Hz, 1H), 6.87 (t, <i>J</i> = 7.6 Hz, 1H). HRMS (EI) <i>m</i>/<i>z</i> calcd for [C<sub>16</sub>H<sub>11</sub>N<sub>3</sub>O]<sup>+</sup> 261.0902, found 261.0908. HPLC A: >95A% at 214 nm.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>E</i>)-3-((1<i>H</i>-Indazol-6-yl)methylene)-5-fluoroindolin-2-one (<b>20</b>) and (<i>Z</i>)-3-((1<i>H</i>-Indazol-6-yl)-methylene)-5-fluoroindolin-2-one (<b>21</b>)</h4><div class="NLM_p">A scintillation vial was charged with 5-fluoroindolin-2-one (40 mg, 0.26 mmol) in MeOH (2 mL), 1<i>H</i>-indazole-6-carbaldehyde (43 mg, 0.292 mmol), and piperidine (3 uL, 0.03 mmol) The reaction was heated to 60 °C for 2 h, cooled to rt, and filtered (LCMS analysis of the yellow solid that formed indicated a 9:1 mixture of geometric isomers). The mixture was separated by prep HPLC to give of the <i>E</i> isomer, <b>20</b> as yellow solid (11 mg, 15%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.31 (s, 1H), 10.66 (s, 1H), 8.18 (s, 1H), 7.92 (d, <i>J</i> = 8.7 Hz, 1H), 7.91 (s, 1H), 7.86 (s, 1H), 7.42 (d, <i>J</i> = 8.5 Hz, 1H), 7.29 (d, <i>J</i> = 9.5 Hz, 1H), 7.10 (t, <i>J</i> = 6.8 Hz, 1H), 6.88 (dd, <i>J</i><sub>1</sub> = 8.8 Hz, <i>J</i><sub>2</sub> = 4.7, 1H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>16</sub>H<sub>10</sub>FN<sub>3</sub>O + H]<sup>+</sup> 280.1, found 280.0. HPLC A: 95A% at 214 nm. The minor fraction was also isolated to give predominantly the <i>Z</i> isomer, <b>21</b>, as a yellow solid; a trace of the <i>E</i> isomer was evident (6.1 mg, 8.0%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.94 (s, 1H), 8.07 (s, 1H), 7.94–7.85 (m, 2H), 7.80 (d, <i>J</i> = 8.6 Hz, 1H), 7.49 (d, <i>J</i> = 8.8 Hz, 1H), 6.97 (t, <i>J</i> = 9.2 Hz, 1H), 6.87–6.81 (m, 1H). MS (ESI) calcd for [C<sub>16</sub>H<sub>10</sub>FN<sub>3</sub>O+ H]<sup>+</sup> 280.09, found 280.0. HPLC A: >95A% at 214 nm.</div><div class="NLM_p">Alternatively, compound <b>20</b> was prepared by heating a solution of 5-fluoroindolin-2-one (0.60g, 4.0 mmol), 1<i>H</i>-indazole-6-carbaldehyde (0.58 g, 4.0 mmol), and piperidine (0.04 mL, 0.4 mmol) in MeOH (50 mL) at 60 °C overnight. The precipitate obtained upon cooling to rt was collected by filtration, rinsed with excess MeOH, and dried to yield a yellow solid, (0.66 g, 58%). The material was identical to that described above for the <i>E</i> isomer. HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>16</sub>H<sub>11</sub>N<sub>3</sub>O + H]<sup>+</sup> 280.0886, found 280.0889. HPLC A: 96A% at 254 nm. Incubation of compound <b>20</b> (0.2 mM) under PLK4 assay conditions (2% DMSO, 50 mM Hepes pH 7.5; 1 mM EGTA, 10 mM MgCl<sub>2</sub>, 0.01% Brij-35, 0.1 mM ATP) at 29 °C for 4 h was monitored: 96A% at 254 nm.</div><div class="NLM_p last">The filtrate was concentrated and triturated (Et<sub>2</sub>O) multiple times with sonication to afford an orange solid (0.37 g, 33%) as a 3:2 mixture of <b>20</b> and <b>21</b> (peaks 1 and 2, respectively, by HPLC 98A% at 254 nm). For peak 2, HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>16</sub>H<sub>11</sub>N<sub>3</sub>O + H]<sup>+</sup> 280.0886, found 280.0875. EXSIDE NMR experiment on the 3:2 mixture (125.66 MHz, 499.67 MHz, DMSO-<i>d</i><sub>6</sub>). Compound <b>20</b>: δ 7.87, 169.08 (d, <sup>3</sup><i>J</i>(C═O, H) = 6.4 Hz). HPLC <i>R</i><sub>t</sub>: 1.58 min. Compound <b>21</b>: δ 8.04, 167.69 (d, <sup>3</sup><i>J</i>(C═O, H) 13.2 Hz). HPLC <i>R</i><sub>t</sub>: 1.73 min.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>E</i>)-3-((1<i>H</i>-Indazol-6-yl)methylene)-5-chloroindolin-2-one (<b>22</b>)</h4><div class="NLM_p last">According to the method for compound <b>15</b>, using 5-chlorooxindole (21 mg, 0.13 mmol), the title compound was obtained as a yellow solid (6.3 mg, 29%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.17 (s, 1H), 7.96 (s, 1H), 7.94 (d, <i>J</i> = 8.0 Hz, 1H), 7.88 (s, 1H), 7.59 (d, <i>J</i> = 4.0 Hz, 1H), 7.45 (d, <i>J</i> = 8.0 Hz, 1H), 7.25 (dd, <i>J</i> = 8.0, 4.0 Hz, 1H), 6.92 (d, <i>J</i> = 4.0 Hz, 1H). MS (ESI) calcd for [C<sub>16</sub>H<sub>10</sub>ClN<sub>3</sub>O + H]<sup>+</sup> 296.1, found 296.0. HPLC B: > 99A% at 214 nm.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>E</i>)-3-((1<i>H</i>-Indazol-6-yl)methylene)-6-chloroindolin-2-one (<b>23</b>)</h4><div class="NLM_p last">According to the method for compound <b>20</b>, the title compound was obtained as a yellow solid (22 mg, 42%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.3 (s, 1H), 10.8 (s, 1H), 8.16 (s, 1H), 7.90–7.87 (m, 2H), 7.83 (s, 1H), 7.56 (d, <i>J</i> = 8.0 Hz, 1H), 7.41 (d, <i>J</i> = 8.8 Hz, 1H), 6.93–6.88 (m, 2H). MS (ESI) calcd for [C<sub>16</sub>H<sub>10</sub>ClN<sub>3</sub>O + H]<sup>+</sup> 296.1, found 296.0. HPLC A: 95A% at 214 nm.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>E</i> and <i>Z</i>)-3-((1<i>H</i>-Indazol-6-yl)methylene)-5-methoxyindolin-2-one (<b>24</b>)</h4><div class="NLM_p last">According to the method for compound <b>15</b>, except substituting 5-methoxyoxindole (22 mg, 0.14 mmol), the title compound was obtained as a yellow solid (12.3 mg, 31%), determined to be a mixture of <i>E</i> and <i>Z</i> isomers (8.5:1.5) by NMR. <sup>1</sup>H NMR for the major isomer (400 MHz, CD<sub>3</sub>OD) δ 8.14 (s, 1H), 7.95–7.87 (m, 3H), 7.46 (d, <i>J</i> = 8.8 Hz, 1H), 7.23 (s, 1H), 6.84 (s, 2H), 3.62 (s, 3H); a signal at δ 9.0 (s, 1H) indicated the presence of the <i>Z</i> isomer. HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>17</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub>]<sup>+</sup> 291.1008, found 291.1009. HPLC B: 98A% at 214 nm.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Synthesis of (<i>E</i>)-3-((1<i>H</i>-Indazol-6-yl)methylene)-<i>N</i>-methyl-2-oxoindoline-5-carboxamide (<b>25</b>)</h4><div id="sec4_2_9_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> <i>N</i>-Methyl-2-oxoindoline-5-carboxamide</h5><div class="NLM_p last">An oven-dried round-bottom flask was charged with 2-oxoindoline-5-carboxylic acid (89 mg, 0.50 mmol), TBTU (193 mg, 0.60 mmol), HOBt hydrate (81 mg, 0.60 mmol), DIPEA (0.13 mL, 0.75 mmol), and DMF (3.0 mL) and stirred for 5 min. MeNH<sub>2</sub> (0.75 mL of a 2.0 M solution in THF) was then added, and the reaction was stirred for 4 h. Saturated NaHCO<sub>3</sub> solution (2 mL) was added, solvents were removed in vacuo, and the residue was purified by column chromatography (SiO<sub>2</sub>, 92:8 CH<sub>2</sub>Cl<sub>2</sub>/MeOH) to afford <i>N</i>-methyl-2-oxoindoline-5-carboxamide (11 mg, 12%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.69–7.75 (m, 2 H), 6.94 (d, <i>J</i> = 8.1 Hz, 1 H), 3.58 (s, 2 H), 2.97 (s, 3 H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>10</sub>H<sub>10</sub>N<sub>2</sub>O<sub>2</sub> + H]<sup>+</sup> 191.1, found 191.0.</div></div><div id="sec4_2_9_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> (<i>E</i>)-3-((1<i>H</i>-Indazol-6-yl)methylene)-<i>N</i>-methyl-2-oxoindoline-5-carboxamide (<b>25</b>)</h5><div class="NLM_p last">According to the method for compound <b>20</b>, using <i>N</i>-methyl-2-oxoindoline-5-carboxamide (11 mg, 0.0578 mmol) and 1<i>H</i>-indazole-6-carbaldehyde (10 mg, 0.0636 mmol), the title compound was obtained as an orange solid (3.0 mg, 17%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.33 (s, 1H), 10.88 (s, 1H), 8.24–8.22 (m, 1H), 8.18 (s, 2H), 7.93–7.88 (m, 2H), 7.84 (s, 1H), 7.72 (d, <i>J</i> = 7.9 Hz, 1H), 7.46 (d, <i>J</i> = 8.0 Hz, 1H), 6.91 (d, <i>J</i> = 8.0 Hz, 1H), 2.68 (d, <i>J</i> = 4.0 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>18</sub>H<sub>14</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 319.1, found 319.1. HPLC A: 98A% at 214 nm.</div></div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>E</i>)-<i>N</i>-(3-((1<i>H</i>-Indazol-6-yl)methylene)-2-oxoindolin-5-yl)acetamide (<b>26</b>)</h4><div class="NLM_p last">A solution of <i>N</i>-(2-oxoindolin-5-yl)acetamide (19 mg, 0.1 mmol) was treated with 1<i>H</i>-indazole-6-carbaldehyde (16 mg, 0.12 mmol), piperidine (2 uL, 0.011 mmol), and MeOH (2 mL). The reaction was then heated to 85 °C for 30 min. The MeOH was removed in vacuo and the solid triturated with ether to give 11 mg, 34% of the title compound as an orange solid with a 13:1 <i>E</i> to <i>Z</i> ratio. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.13 (s, 1H), 8.06 (s, 1H), 7.92–7.88 (m, 2H), 7.84 (s, 1H), 7.49 (d, <i>J</i> = 8.6 Hz, 1H), 7.35 (d, 1H), 6.88 (d, <i>J</i> = 8.3 Hz, 1H), 2.04 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>18</sub>H<sub>17</sub>N<sub>5</sub>O<sub>3</sub>S + H]<sup>+</sup> 319.1, found 319.1. HPLC B: 97A% at 214 nm.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>E</i>)-<i>N</i>-(3-((1<i>H</i>-Indazol-6-yl)methylene)-2-oxoindolin-6-yl)acetamide (<b>27</b>)</h4><div class="NLM_p last">According to the method for compound <b>20</b> except substituting <i>N</i>-(2-oxoindolin-6-yl)acetamide (25 mg, 0.131 mmol), the title compound was obtained (12 mg, 29%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.25 (s, 1H), 10.59 (s, 1H), 10.08 (s, 1H), 8.15 (s, 1H), 7.88 (s, 2H), 7.62 (s, 1H), 7.54 (d, <i>J</i> = 6.9 Hz, 1H), 7.50 (s, 1H), 7.41 (d, <i>J</i> = 7.9 Hz, 1H), 6.87 (d, <i>J</i> = 7.0 Hz, 1H), 2.04 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>18</sub>H<sub>14</sub>N<sub>4</sub>O<sub>2</sub>+ H]<sup>+</sup> 319.1, found 319.1. HPLC A: 95A% at 214 nm.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Synthesis of (<i>E</i>)-3-((3-((<i>E</i>)-2-(Pyridin-2-yl)vinyl)-1<i>H</i>-indazol-6-yl)methylene)indolin-2-one (<b>37</b>)</h4><div id="sec4_2_12_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> 3-Iodo-(1 and 2)-(2-(trimethylsilyl)ethyl)-2<i>H</i>-indazole-6-carbaldehyde (<b>29</b>)</h5><div class="NLM_p last">To a stirred suspension of 3-iodo-1<i>H</i>-indazole-6-carbaldehyde <b>28</b> (3.01 g, 11.1 mmol) and TBAB (36 mg, 0.11 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (70 mL) and 50% aq KOH (20 mL) was added, dropwise, (2-(chloromethoxy)ethyl)trimethylsilane (2.3 mL, 13.3 mmol) at 0 °C. The stirring was continued at 0 °C for 3 h. The solution was then diluted with CH<sub>2</sub>Cl<sub>2</sub> (200 mL), the layers were separated, and the organic phase was washed with brine (2 × 100 mL), dried (MgSO<sub>4</sub>), and concentrated under reduced pressure. The resulting residue was purified by column chromatography (SiO<sub>2</sub>, 100% CH<sub>2</sub>Cl<sub>2</sub>) to give of the N-1 isomer (higher eluting spot, 2.88 g, 65%) and the N-2 isomer (lower eluting spot, 757 mg, 17%). Typically, the crude regioisomeric mixture was purified by chromatography and used in subsequent reactions without separation into its constituent isomers. <sup>1</sup>H NMR N-1 isomer: (400 MHz, CDCl<sub>3</sub>) δ 10.18 (s, 1H), 8.11 (s, 1H), 7.81 (d, <i>J</i> = 8.4 Hz, 1H), 7.65 (d, <i>J</i> = 8.4 Hz, 1H), 5.82 (s, 2H), 3.60 (m, 2H), 0.91 (m, 2H), −0.042 (s, 9H). MS ESI 425.0 [M + Na]<sup>+</sup>, calcd for [C<sub>14</sub>H<sub>19</sub>IN<sub>2</sub>O<sub>2</sub>Si + Na]<sup>+</sup> 425.02. N-2 isomer: (400 MHz, CD<sub>3</sub>OD) 10.09 (s, 1H), 8.31 (s, 1H), 7.62 (m, 2H), 5.91 (s, 2H), 3.71 (m, 2H), 0.92 (m, 2H), −0.039 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>14</sub>H<sub>19</sub>IN<sub>2</sub>O<sub>2</sub>Si + Na]<sup>+</sup>, 425.0, found 425.0.</div></div><div id="sec4_2_12_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> (<i>E</i>)-3-(2-(Pyridin-2-yl)vinyl)-1<i>H</i>-indazole-6-carbaldehyde</h5><div class="NLM_p last">A 4:1 mixture of 3-iodo-(1 and 2)-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-indazole-6-carbaldehyde (0.42 g, 1.0 mmol, <b>29</b>), 2-vinylpyridine (0.143 g, 1.3 mmol), DIPEA (0.36 mL, 2.1 mmol) in DMF (3 mL) was purged with a slow stream of Ar for 20 min. Pd(OAc)<sub>2</sub> (23 mg, 0.10 mmol) and P(<i>o</i>-tol)<sub>3</sub> (95 mg, 0.31 mmol) were added, and the reaction was heated to 100 °C for 5.5 h. The reaction was cooled to rt, concentrated under reduced pressure, and purified by column chromatography (SiO<sub>2</sub>, 0–2% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to give the title compound as a 4:1 mixture of (1:4) as light-yellow solid (4:1 mixture of regioisomers) which was used without further purification. MS ESI 380.2 [M + H]<sup>+</sup>, calcd for [C<sub>21</sub>H<sub>25</sub>N<sub>3</sub>O<sub>2</sub>Si <sup>+</sup> H]<sup>+</sup> 380.2. This material was heated overnight with TBAF (1.0 M in THF, 4.5 mL, 4.5 mmol) at 60 °C under argon in a sealed vial. The reaction mixture was concentrated under reduced pressure and purified by flash chromatography (SiO<sub>2</sub>, 0–4% MeOH in DCM) to afford (<i>E</i>)-3-(2-(pyridin-2-yl)vinyl)-1<i>H</i>-indazole-6-carbaldehyde (98 mg, 44%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 10.1 (s, 1 H), 8.54 (m, <i>J</i> = 4.8 Hz, 1 H), 8.19 (d, <i>J</i> = 8.5 Hz, 1 H), 8.08 (s, 1 H), 7.86 (d, <i>J</i> = 16.6 Hz, 1 H), 7.78–7.83 (m, 1 H), 7.76 (d, <i>J</i> = 8.5 Hz, 1 H), 7.64 (d, <i>J</i> = 7.3 Hz, 1 H), 7.58 (d, <i>J</i> = 16.6 Hz, 1 H), 7.21–7.30 (m, 1 H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>15</sub>H<sub>11</sub>N<sub>3</sub>O + H]<sup>+</sup> 250.1, found 250.1.</div></div><div id="sec4_2_12_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> (<i>E</i>)-3-((3-((<i>E</i>)-2-(Pyridin-2-yl)vinyl)-1<i>H</i>-indazol-6-yl)methylene)indolin-2-one</h5><div class="NLM_p last">An EtOH (10 mL) solution of (<i>E</i>)-3-(2-(pyridin-2-yl)vinyl)-1<i>H</i>-indazole-6-carbaldehyde (98 mg, 0.39 mmol), indolin-2-one (52 mg, 0.39 mmol), and piperidine (3 drops) was heated in a sealed vial under Ar at 70 °C overnight. Upon cooling to rt, the precipitated solid was collected, rinsed with EtOH, then triturated in sequence with MeCN, DCM, MeOH–DCM (1:1 v/v), MeOH, PhMe, hexanes, Et<sub>2</sub>O, and DCM to provide the title compound as a yellow solid (62.9 mg, 44%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 13.52 (bs., 1 H), 10.65 (s, 1 H), 8.62 (d, <i>J</i> = 4.3 Hz, 1 H), 8.34 (d, <i>J</i> = 8.5 Hz, 1 H), 8.00 (d, <i>J</i> = 16.3 Hz, 1 H), 7.93 (s, 1 H), 7.84 (d, <i>J</i> = 7.8 Hz, 1 H), 7.81 (s, 1 H), 7.69 (d, <i>J</i> = 7.8 Hz, 1 H), 7.64 (d, <i>J</i> = 8.0 Hz, 1 H), 7.62 (s, 1 H), 7.55 (d, <i>J</i> = 7.8 Hz, 1 H), 7.21–7.31 (m, 2 H), 6.83–6.92 (m, 2 H). HRMS (EI) <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>16</sub>N<sub>4</sub>O (M+) 364.1324, found 364.1323. HPLC A: 95A% at 254 nm.</div></div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Synthesis of (<i>E</i>)-3-((3-((<i>E</i>)-2-(Pyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)methylene)-indolin-2-one (<b>38</b>)</h4><div id="sec4_2_13_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> (<i>E</i>)-3-(2-(Pyridin-3-yl)vinyl)-1<i>H</i>-indazole-6-carbonitrile</h5><div class="NLM_p last">A suspension of 3-(chloromethyl)pyridine hydrochloride (6.54 g, 40 mmol) in benzene (75 mL) was treated with 40% NaOH (2.7 mL); the resulting mixture was sonicated for 10 min and filtered. The residue was treated with additional benzene (25 mL), sonicated, and filtered; the combined benzene layers were dried (Na<sub>2</sub>SO<sub>4</sub>) to give a solution of 3-(chloromethyl)pyridine in benzene. The solution was added dropwise (over 15 min) to a solution of sodium diethyl phosphate (prepared from diethyl phosphate (6.06 g, 44 mmol) in benzene (50 mL) and 1.02 g (44 mmol) of freshly cut Na), refluxed (oil temp. 95 °C) for 30 min, then cooled to 0 °C. The resulting mixture was refluxed for 2 h (oil temp 100 °C) until LC-MS indicated the completion of reaction. After cooling to rt, the resulting white precipitate (NaCl) was removed by filtration and rinsed with benzene (50 mL). The filtrate was concentrated and dried under high vacuum to give 6.30 g of diethyl pyridin-3-ylmethylphosphonate as a light-yellow liquid. The liquid was dissolved in DMF (50 mL), cooled to 0 °C, and treated with <sup><i>t</i></sup>BuOK (6.72 g, 60 mmol) portionwise over 3 min; the reaction turned a dark reddish–brown. After stirring for 3 min at 0 °C, a solution of 3-formyl-1<i>H</i>-indazole-6-carbonitrile<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> (<b>34</b>, 3.42 g, 20 mmol) in DMF (25 mL) was added dropwise by pipet over 5 min. The resulting mixture was stirred for 1 h at 0 °C before quenching with ice (100 mL). The reaction mixture was cooled to 0 °C and slowly acidified with 2 M HCl to pH 5. During this addition, a copious amount of precipitate was formed. After stirring for 2 min at this temperature, satd NaHCO<sub>3</sub> was slowly added to attain a pH of 8; the mixture was stirred for additional 2 min. Water was added until the total volume reached 600 mL. After stirring for 10 min, the resulting precipitate was collected, rinsed thoroughly with water, then dried under high vacuum to give the title compound (3.30 g, 67%) as a beige solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.80 (s, 1H, NH), 8.89 (s, 1H), 8.48 (d, <i>J</i> = 4.4 Hz, 1H), 4.42 (d, <i>J</i> = 8.4 Hz, 1H), 8.22–8.17 (m, 2H), 7.74 (d, <i>J</i> = 16.8 Hz, 1H), 7.59 (d, <i>J</i> = 18 Hz, 1H, partially overlapping with the doublet at 7.55 ppm), 7.55 (d, <i>J</i> = 10 Hz, 1H, partially overlapping with the doublet at 7.59 ppm), 7.43 (dd, <i>J</i> = 8.0 Hz, 5.6 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>15</sub>H<sub>10</sub>N<sub>4</sub> + H]<sup>+</sup> 247.1, found 247.0.</div></div><div id="sec4_2_13_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> (<i>E</i>)-3-(2-(Pyridin-3-yl)vinyl)-1<i>H</i>-indazole-6-carbaldehyde</h5><div class="NLM_p last">A suspension of (<i>E</i>)-3-(2-(pyridin-4-yl)vinyl)-1<i>H</i>-indazole-6-carbonitrile (984 mg, 3 mmol) pyridine (30 mL) was treated with HOAc (8 mL) and DMF (30 mL). The resulting mixture was heated and sonicated to make a clear solution. After cooling to 0 °C, a solution of sodium hypophosphite (1.41 g, 16 mmol) in H<sub>2</sub>O (8 mL) was added, followed by Raney-Nickel 2400 (slurry in H<sub>2</sub>O, 0.8 mL). The resulting mixture was heated at 60 °C (oil temp) for 1 h before cooling to rt. Water (50 mL) was added, and the mixture was extracted with EtOAc (100 mL + 50 mL × 2). The combined organic extracts were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated to give a yellow solution in DMF (about 30 mL); H<sub>2</sub>O (500 mL) was added with swirling, and a yellow precipitate formed. After standing 10 min, the resulting precipitate was collected by suction filtration, rinsed with H<sub>2</sub>O, and dried under high vacuum to give the title compound (500 mg, 50%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.79 (s, 1H, NH), 10.14 (s, 1H, CHO), 8.48 (d, <i>J</i> = 4.8 Hz, 1H), 8.39 (d, <i>J</i> = 8.0 Hz, 1H), 8.19 (d, <i>J</i> = 9.2 Hz, 1H, partially overlapping with the singlet at 8.18 ppm), 8.18 (s, 1H, partially overlapping with the doublet at 8.19 ppm), 7.75 (d, <i>J</i> = 16.4 Hz, 1H), 7.69 (d, <i>J</i> = 8.4 Hz, 1H), 7.59 (d, <i>J</i> = 16.8 Hz, 1H), 7.43 (dd, <i>J</i> = 8.0 Hz, 5.2 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>15</sub>H<sub>11</sub>N<sub>3</sub>O + H]<sup>+</sup> 250.1, found 250.0.</div></div><div id="sec4_2_13_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> (<i>E</i>)-3-((3-((<i>E</i>)-2-(Pyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)methylene)-indolin-2-one (<b>38</b>)</h5><div class="NLM_p last">A mixture of oxindole (26.6 mg, 0.2 mmol) and (<i>E</i>)-3-(2-(pyridin-3-yl)vinyl)-1<i>H</i>-indazole-6-carbaldehyde (49.8 mg, 0.2 mmol) was treated with a drop of piperidine. The resulting mixture was refluxed for 2 h (oil temp 70 °C) and then cooled to rt. The resulting precipitate was collected by suction filtration to give the title compound as a yellow solid (61 mg, 84%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.46 (s, 1H, NH), 10.64 (s, 1H, NH), 8.91 (s, 1H), 8.48 (d, <i>J</i> = 4.4 Hz, 1H), 8.36 (d, <i>J</i> = 8.4 Hz, 1H), 8.20 (d, <i>J</i> = 8.4 Hz, 1H), 7.90 (s, 1H), 7.80 (s, 1H), 7.73 (d, <i>J</i> = 17 Hz, 1H), 7.61 (d, <i>J</i> = 7.2 Hz, 1H, partially overlapping with the peak at 7.60 ppm), 7.60 (d, <i>J</i> = 17.2 Hz, 1H, partially overlapping with the peak at 7.61 ppm), 7.54 (d, <i>J</i> = 8.4 Hz, 1H), 7.43 (dd, <i>J</i> = 7.8 Hz, 4.8 Hz, 1H), 7.24 (t, <i>J</i> = 7.8 Hz, 1H), 6.89 (d, <i>J</i> = 7.6 Hz, 1H), 6.85 (t, <i>J</i> = 7.8 Hz, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>16</sub>N<sub>4</sub>O (M+) 365.1402, found 365.1399. HPLC B: 99A% at 214 nm.</div></div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>E</i>)-5-Ethyl-3-((3-((<i>E</i>)-2-(pyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)methylene)indolin-2-one (<b>39</b>)</h4><div class="NLM_p last">According to the method for compound <b>38</b>, part 3 (oil temp 70 °C, reflux 2 h), using 5-ethylindolin-2-one (77 mg, 0.48 mmol) and (<i>E</i>)-3-(2-(pyridin-3-yl)vinyl)-1<i>H</i>-indazole-6-carbaldehyde (100 mg, 0.4 mmol), the title compound (35 mg, 67%) was synthesized as yellow solid (only <i>E</i> isomer was detected by <sup>1</sup>H NMR). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.50 (bs, 1H, NH), 10.55 (s, 1H, NH), 8.91 (d, <i>J</i> = 1.6 Hz, 1H), 8.48 (dd, <i>J</i> = 4.8, 1.2 Hz, 1H), 8.35 (d, <i>J</i> = 8.4 Hz, 1H), 8.20 (d, <i>J</i> = 8.0 Hz, 1H), 7.91 (s, 1H), 7.76 (s, 1H, overlapping with peak at 7.74), 7.74 (d, <i>J</i> = 15.2 Hz, 1H, overlapping with peak at 7.76), 7.59 (d, <i>J</i> = 16.8 Hz, 1H), 7.55 (d, <i>J</i> = 8.4 Hz, 1H),), 7.44 (s, 1H), 7.43 (dd, <i>J</i> = 7.8, 4.2 Hz, 1H), 7.09 (d, <i>J</i> = 7.2 Hz, 1H), 6.81 (d, <i>J</i> = 8.0 Hz, 1H), 2.43 (q, <i>J</i> = 7.6 Hz, 2H), 1.06 (t, <i>J</i> = 7.6 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>25</sub>H<sub>20</sub>N<sub>4</sub>O + H]<sup>+</sup> 393.2, found 393.1. HPLC B: 95% at 254 nm.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (<i>E</i> and <i>Z</i>)-5-Methoxy-3-((3-((<i>E</i>)-2-(pyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)methylene)indolin-2-one (<b>40</b>)</h4><div class="NLM_p last">According to the method for compound <b>38</b>, part 3 (90 min at 75 °C), using 5-methyoxyoxindole (32.6 mg, 0.2 mmol) and (<i>E</i>)-3-(2-(pyridin-3-yl)vinyl)-1<i>H</i>-indazole-6-carbaldehyde (49.8 mg, 0.2 mmol), the title compound was synthesized as a 4:1 mixture of <i>E</i>/<i>Z</i> isomers (orange solid, 53 mg, 67%). For the <i>E</i> isomer: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.50 (bs, 1H, NH), 10.44 (s, 1H, NH), 8.91 (d, 1H), 8.48 (d, <i>J</i> = 4.8 Hz, 1H), 8.36 (d, <i>J</i> = 8.4 Hz, 1H), 8.20 (d, <i>J</i> = 7.6 Hz, 1H), 7.92 (s, 1H), 7.79 (s, 1H), 7.73 (d, <i>J</i> = 16.8 Hz, 1H), 7.59 (d, <i>J</i> = 16.4 Hz, 1H), 7.54 (d, <i>J</i> = 8.8 Hz, 1H), 7.43 (dd, <i>J</i> = 8.0 Hz, 5.2 Hz, 1H), 7.19 (d, 1H), 6.86 (dd, <i>J</i> = 8.4 Hz, 2.0 Hz, 1H), 6.81 (d, <i>J</i> = 8.4 Hz, 1H), 3.78 (s, 3H). A diagnostic signal at δ 9.01 (s, 1H) indicated the presence of the <i>Z</i> isomer. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub> (M+) 394.1430, found 394.1432. HPLC B: 99% at 214 nm.</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Synthesis of (<i>E</i>)-3-((3-((<i>E</i>)-2-(Pyridin-4-yl)vinyl)-1<i>H</i>-indazol-6-yl)methylene)-indolin-2-one (<b>41</b>)</h4><div id="sec4_2_16_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> (<i>E</i>)-3-(2-(Pyridin-4-yl)vinyl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-indazole-6-carbaldehyde</h5><div class="NLM_p last">A solution of 3-iodo-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-indazole-6-carbaldehyde (2.0 g, 4.98 mmol), 4-vinylpyridine (0.69 mL, 6.47 mmol), DIPEA (1.74 mL, 9.96 mmol), and DMF (50 mL) was purged with Ar gas for 20 min, at which time Pd(OAc)<sub>2</sub> (112 mg, 0.500 mmol) and P(<i>o</i>-tol)<sub>3</sub> (457 mg, 1.50 mmol) were added, and the reaction heated to 100 °C for 20 h. The reaction was cooled to room temperature and partitioned between EtOAc and NH<sub>4</sub>Cl. The aqueous layer was extracted with EtOAc (3×) and the combined organics washed with water (2×) and brine (2×). The organic layer was dried over MgSO<sub>4</sub>, and the EtOAc removed in vacuo. The residue was purified by column chromatography (silica gel, 97:3 CH<sub>2</sub>Cl<sub>2</sub>/MeOH) to give the title compound (0.93g, 49%), which was used without further purification. MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>21</sub>H<sub>25</sub>N<sub>3</sub>O<sub>2</sub>Si + H]<sup>+</sup> 380.2, found 380.2.</div></div><div id="sec4_2_16_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> (<i>E</i>)-3-((3-((<i>E</i>)-2-(Pyridin-4-yl)vinyl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-indazol-6-yl)methylene)-indolin-2-one</h5><div class="NLM_p last">A solution of (<i>E</i>)-3-(2-(pyridin-4-yl)vinyl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-indazole-6-carbaldehyde (927 mg, 2.44 mmol), oxindole (325 mg, 2.44 mmol), and MeOH (20 mL) was treated with piperidine (24 μL, 0.244 mmol) and heated to 60 °C for 4 h. A yellow precipitate formed, which was filtered and washed with MeOH to give the title compound (960 mg, 79%) as a yellow solid. MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>29</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub>Si + H]<sup>+</sup> 495.2, found 495.3.</div></div><div id="sec4_2_16_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> (<i>E</i>)-3-((3-((<i>E</i>)-2-(Pyridin-4-yl)vinyl)-1<i>H</i>-indazol-6-yl)methylene)-indolin-2-one (<b>41</b>)</h5><div class="NLM_p last">A dry round-bottom was charged with (<i>E</i>)-3-((3-((<i>E</i>)-2-(pyridin-4-yl)vinyl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-indazol-6-yl)methylene)indolin-2-one (906 mg, 1.83 mmol) and CH<sub>2</sub>Cl<sub>2</sub> (100 mL) under an atmosphere of N<sub>2</sub>. Boron trifluoride etherate (2.3 mL, 18.3 mmol) was added dropwise, and the reaction was stirred for 4 h, at which time LC-MS indicated complete conversion to the partially deprotected material (<i>E</i>)-3-((1-(hydroxymethyl)-3-((<i>E</i>)-2-(pyridin-4-yl)vinyl)-1<i>H</i>-indazol-6-yl)methylene)-indolin-2-one. The CH<sub>2</sub>Cl<sub>2</sub> was removed in vacuo, and 150 mL of a 2:1 mixture of EtOH/2 M HCl was added to the residue. The resulting solution was heated to 50 °C for 3 h, at which time LC-MS indicated complete conversion to product. The reaction was cooled with an ice bath and neutralized with NH<sub>4</sub>OH to pH ∼8; the EtOH was removed to yield a suspension. The solid was collected by filtration, washed with water, dried, and triturated several times with 90:10 CH<sub>2</sub>Cl<sub>2</sub>/MeOH. Drying under vacuum yielded the title compound as an orange solid (353 mg, 53%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.57 (s, 1H), 10.64 (s, 1H), 8.57 (d, <i>J</i> = 5.2 Hz, 2H), 8.38 (d, <i>J</i> = 8.1 Hz, 1H), 7.92 (s, 1H), 7.87 (d, <i>J</i> = 16.7 Hz, 1H), 7.80 (s, 1H), 7.71 (d, <i>J</i> = 5.2 Hz, 2H), 7.53–7.62 (m, 3H), 7.23 (t, <i>J</i> = 8.3 Hz, 1H), 6.82–6.91 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>23</sub>H<sub>16</sub>N<sub>4</sub>O + H]<sup>+</sup> 364.1324, found 364.1320. HPLC A: 95A% at 214 nm.</div></div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (<i>E</i>)-5-Chloro-3-((3-((<i>E</i>)-2-(pyridin-4-yl)vinyl)-1<i>H</i>-indazol-6-yl)methylene)indolin-2-one (<b>42</b>)</h4><div class="NLM_p last">According to the method for compound <b>41</b> using 5-chlorooxindole (14 mg, 0.08 mmol), the title compound was prepared as an orange solid (13.5 mg, 42%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.63 (bs, 1H), 10.78 (bs, 1H), 8.56 (d, <i>J</i> = 4.0 Hz, 2H), 8.40 (d, <i>J</i> = 10 Hz, 1H), 7.91 (s, 1H), 7.89 (d, <i>J</i> = 13 Hz, 2 H), 7.72 (d, <i>J</i> = 3.5 Hz, 2H), 7.57 (d, <i>J</i> = 12 Hz, 1H), 7.52 (d, <i>J</i> = 12 Hz, 2H), 7.30 (d, <i>J</i> = 10.0 Hz, 1H), 6.90 (d, <i>J</i> = 11.5 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>23</sub>H<sub>15</sub>ClN<sub>4</sub>O + H]<sup>+</sup> 399.1, found 399.2. HPLC B: 99A% at 214 nm.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (<i>E</i>)-5-Methyl-3-((3-((<i>E</i>)-2-(pyridin-4-yl)vinyl)-1<i>H</i>-indazol-6-yl)-methylene)indolin-2-one (<b>43</b>)</h4><div class="NLM_p last">According to the method for compound <b>41</b>, using 5-methyloxindole (9 mg, 0.060 mmol), the title compound was prepared as a yellow powder (5.9 mg, 29%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.59 (bs, 1H), 10.54 (bs, 1H), 8.57 (bs, 2H), 8.3–8.4 (m, 1H), 7.95–7.32 (m, 8H), 7.12–7.01 (m, 1 H), 6.73–6.84 (m, 1H), 2.16 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>24</sub>H<sub>18</sub>N<sub>4</sub>O + H]<sup>+</sup> 379.4, found 379.2. HPLC B: >99A% at 214 nm.</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (<i>E</i>)-5-Methoxy-3-((3-((<i>E</i>)-2-(pyridin-4-yl)vinyl)-1<i>H</i>-indazol-6-yl)methylene)indolin-2-one (<b>44</b>)</h4><div class="NLM_p last">According to the method for compound <b>41</b>, using 5-methoxyoxindole (11 mg, 0.068 mmol), the title compound was obtained as an orange solid (13.6 mg, 51%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.58 (bs, 1H), 10.45 (bs, 1H), 8.57 (d, <i>J</i> = 6.0 Hz, 2H), 8.37 (d, <i>J</i> = 8.5 Hz, 1H), 7.93 (s, 1H), 7.87 (d, <i>J</i> = 16.6 Hz, 1 H), 7.79 (s, 1H), 7.71 (d, <i>J</i> = 6.0 Hz, 2H), 7.57 (d, <i>J</i> = 2.3 Hz, 1H), 7.54 (d, <i>J</i> = 6.3 Hz, 2H), 7.18 (d, <i>J</i> = 10.0 Hz, 1H), 6.86 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H) 6.80 (d, <i>J</i> = 8.3 Hz, 1H), 3.6 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>24</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 395.1, found 395.2. HPLC B: >99A% at 214 nm.</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (<i>E</i>)-5-Hydroxy-3-((3-((<i>E</i>)-2-(pyridin-4-yl)vinyl)-1<i>H</i>-indazol-6-yl)methylene)indolin-2-one (<b>45</b>)</h4><div class="NLM_p last">The title compound was synthesized according to the method described for compound <b>41</b>, parts 2 and 3, using 5-hydroxyindolin-2-one (10 mg, 0.067 mmol) and (<i>E</i>)-3-(2-(pyridin-4-yl)vinyl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-indazole-6-carbaldehyde (25 mg, 0.067 mmol). The crude material was purified by reverse-phase HPLC to give TFA salt of the desired product as a yellow solid (10 mg, 30%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.73 (d, <i>J</i> = 6.5 Hz, 2 H), 8.35 (d, <i>J</i> = 8.8 Hz, 1 H), 8.27 (d, <i>J</i> = 6.5 Hz, 2 H), 8.24 (d, <i>J</i> = 16.4 Hz, 1 H), 7.94 (s, 1 H), 7.88 (s, 1 H), 7.83 (d, <i>J</i> = 16.4 Hz, 1 H), 7.61 (d, <i>J</i> = 8.1 Hz, 1 H), 7.13 (s, 1 H), 6.77 (d, <i>J</i> = 8.2 Hz, 1 H), 6.71 (d, <i>J</i> = 8.2 Hz, 1 H). MS ESI 381.1 [M + H]+, calcd for [C<sub>23</sub>H<sub>16</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup> 381.1. HPLC A: >98A% at 214 nm.</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Synthesis of (<i>E</i> and <i>Z</i>)-3-((<i>E</i>)-(3-Styryl-1<i>H</i>-indazol-6-yl)methylene)indolin-2-one (<b>46</b>)</h4><div id="sec4_2_21_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> (<i>E</i>)-3-Styryl-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-indazole-6-carbaldehyde</h5><div class="NLM_p last">A solution of 3-iodo-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-indazole-6-carbaldehyde (100 mg, 0.25 mmol), styrene (37 uL, 0.32 mmol), diisopropylethylamine (87 μL, 0.32 mmol), and DMF (2.5 mL) was purged with Ar gas for 20 min. Pd(OAc)<sub>2</sub> (2.8 mg, 0.0125 mmol) and P(<i>o</i>-tol)<sub>3</sub> (11 mg, 0.0374 mmol) were added, and the reaction heated to 100 °C for 20 h. The reaction was cooled to room temperature and partitioned between EtOAc and NH<sub>4</sub>Cl. The aqueous layer was extracted with EtOAc (3×), and the combined organics were washed with water (2×) and brine (2×). The organic layer was dried (MgSO<sub>4</sub>) and the EtOAc removed in vacuo. The residue was purified by column chromatography (SiO<sub>2</sub>, 5:1 hexanes/EtOAc) to give the title compound (63 mg, 67%), which was used without further purification. MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>22</sub>H<sub>26</sub>N<sub>2</sub>O<sub>2</sub>Si +H]<sup>+</sup> 379.2, found 379.2.</div></div><div id="sec4_2_21_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> (<i>E</i>)-3-Styryl-1<i>H</i>-indazole-6-carbaldehyde</h5><div class="NLM_p last">A solution of (<i>E</i>)-3-styryl-1-((2-(trimethylsilyl)ethoxy)-methyl)-1<i>H</i>-indazole-6-carbaldehyde (63 mg, 0.166 mmol) in THF (2.0 mL) was treated with TBAF (0.83 mL of a 1 M THF solution) and refluxed overnight. The solvent was removed, and the residue was dissolved in EtOAc. The organics were washed with water (2×) and brine (2×) and dried over MgSO<sub>4</sub>. The solvent was removed and the residue purified by column chromatography (SiO<sub>2</sub>, 98:2 CH<sub>2</sub>Cl<sub>2</sub>/MeOH) to give the title compound (27 mg, 66%), which was used without further purification. MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>16</sub>H<sub>12</sub>N<sub>2</sub>O + H]<sup>+</sup> 249.1, found 249.0.</div></div><div id="sec4_2_21_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> (<i>E</i> and <i>Z</i>)-3-((<i>E</i>)-(3-Styryl-1<i>H</i>-indazol-6-yl)methylene)indolin-2-one (<b>46</b>)</h5><div class="NLM_p last">A solution of (<i>E</i>)-3-styryl-1<i>H</i>-indazole-6-carbaldehyde (27 mg, 0.109 mmol) and oxindole (15 mg, 0.109 mmol) in MeOH (1.0 mL) was treated with piperidine (1 μL, 0.011 mmol) and the reaction stirred at 60 °C for 4 h. The MeOH was removed and the residue purified by prep HPLC to give the title compound as a yellow powder (4.7 mg, 12%, <i>E</i>/<i>Z</i> 7:1). For the <i>E</i> isomer: <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.26 (d, <i>J</i> = 8.4 Hz, 2H), 7.91–7.86 (m, 2H), 7.71–7.64 (m, 3H), 7.60–7.49 (m, 2H), 7.42 (t, <i>J</i> = 7.4 Hz, 2H), 7.31 (t, <i>J</i> = 7.5 Hz, 1H), 7.26 (t, <i>J</i> = 7.9 Hz, 1H), 6.94 (d, <i>J</i> = 7.8 Hz, 1H), 6.89 (t, <i>J</i> = 6.9 Hz, 1H); a signal at δ 9.0 (s, 1H) indicated the presence of the <i>Z</i> isomer. HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>24</sub>H<sub>17</sub>N<sub>3</sub>O + H]<sup>+</sup> 364.1450, found 364.1462. HPLC A: 95A% at 214 nm.</div></div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Synthesis of (<i>E</i>)-3-((3-((<i>E</i>)-4-((Dimethylamino)methyl)styryl)-1<i>H</i>-indazol-6-yl)methylene)-indolin-2-one 2,2,2-trifluoroacetate (<b>47</b>)</h4><div id="sec4_2_22_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> (<i>E</i>)-3-(4-((Dimethylamino)methyl)styryl)-1-((2-(trimethylsilyl)-ethoxy)methyl)-1<i>H</i>-indazole-6-carbaldehyde</h5><div class="NLM_p last">Commercial, 90% technical grade <i>N</i>,<i>N</i>-dimethyl-1-(4-vinylphenyl)methanamine was purified by a flash chromatography (SiO<sub>2</sub>, 0–10% MeOH in DCM). A degassed mixture of 3-iodo-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-indazole-6-carbaldehyde (70 mg, 0.17 mmol), <i>N</i>,<i>N</i>-dimethyl-1-(4-vinylphenyl)methanamine (42 mg, 0.26 mmol), DIPEA (33 mg, 0.26 mmol), Pd(OAc)<sub>2</sub> (3.9 mg, 0.017 mmol), and P(<i>o</i>-MeC<sub>6</sub>H<sub>4</sub>)<sub>3</sub> (16 mg, 0.052 mmol) in anhydrous acetonitrile (2 mL) was heated with stirring in a sealed tube under Ar at 90 °C for 1 d. The crude mixture was concentrated under reduced pressure and purified by prep TLC (SiO<sub>2</sub> 10% MeOH/DCM) to provide the title compound to as a pale-orange gum (33.4 mg, 44%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 10.13 (s, 1H), 8.27 (m, 2H), 7.81 (d, <i>J</i> = 9.3 Hz, 1H), 7.69 (d, <i>J</i> = 8.3 Hz, 2H), 7.61 (d, <i>J</i> = 16.6 Hz, 1H), 7.50 (d, <i>J</i> = 16.6 Hz, 1H), 7.43 (d, <i>J</i> = 8.3 Hz, 2H), 5.86 (s, 2H), 3.82 (s, 2H), 3.62 (t, <i>J</i> = 8.0 Hz, 1H), 2.50 (s, 6H), 0.87 (t, <i>J</i> = 8.0 Hz, 2H), −0.09 (s, 9 H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>25</sub>H<sub>33</sub>N<sub>3</sub>O<sub>2</sub>Si + H]<sup>+</sup> 436.6, found 436.3.</div></div><div id="sec4_2_22_99" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> (<i>E</i>)-3-(4-((Dimethylamino)methyl)styryl)-1<i>H</i>-indazole-6-carbaldehyde</h5><div class="NLM_p last">A degassed solution of (<i>E</i>)-3-(4-((dimethylamino)m) ethyl)styryl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-indazole-6-carbaldehyde (0.31 g, 0.71 mmol) and TBAF (1 M in THF, 4.0 mL, 4.0 mmol in anhyd THF (24 mL) was heated at reflux under Ar overnight. The reaction mixture was then diluted with DCM and washed with H<sub>2</sub>O (5×) before it was concentrated and purified by flash chromatography (SiO<sub>2</sub>, 0–10% MeOH/DCM) to afford (<i>E</i>)-3-(4-((dimethylamino)methyl)styryl)-1<i>H</i>-indazole-6-carbaldehyde a light-orange gum (0.38 g) with a trace of TBAF. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 10.10 (s, 1H), 8.24 (d, <i>J</i> = 8.5 Hz, 1H), 8.12 (s, 1H), 7.74 (d, <i>J</i> = 8.5 Hz, 1H), 7.64 (d, <i>J</i> = 7.8 Hz, 2H), 7.56 (d, <i>J</i> = 16.8 Hz, 1H), 7.49 (d, <i>J</i> = 16.8 Hz, 1H), 7.39 (d, <i>J</i> = 8.0 Hz, 2H), 3.60 (s, 2H), 2.33 (s, 6H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O + H]<sup>+</sup> 306.1, found 306.1.</div></div><div id="sec4_2_22_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> 3-((3-((<i>E</i>)-4-((Dimethylamino)methyl)styryl)-1<i>H</i>-indazol-6-yl)methylene)indolin-2-one 2,2,2-trifluoroacetate (<b>47</b>)</h5><div class="NLM_p last">(<i>E</i>)-3-((3-((<i>E</i>)-4-((Dimethylamino)methyl)styryl)-1<i>H</i>-indazol-6-yl)methylene)-indolin-2-one was synthesized according to the method of compound <b>38</b>, step 3, utilizing indolin-2-one (111 mg, 0.83 mmol) and (<i>E</i>)-3-(4-((dimethylamino)methyl)styryl)-1<i>H</i>-indazole-6-carbaldehyde (254 mg, 0.83 mmol) (75 °C, overnight). The crude mixture was concentrated, leaving a red gum that was treated with hot MeCN/MeOH, cooled to rt, and filtered. The filtrate was concentated to a gum that was purified by multiple prep TLCs (SiO<sub>2</sub>, 1 mm, 3% MeOH + 5% Et<sub>3</sub>N in DCM, eluted 2×, <i>R</i><sub>f</sub> major 0.4, minor 0.3), followed by prep HPLC to afford the title compound as a yellow solid (89 mg, 20%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.27 (d, <i>J</i> = 8.0 Hz, 1H), 7.88–7.91 (m, 2H), 7.82 (d, <i>J</i> = 8.3 Hz, 2H), 7.66 (d, <i>J</i> = 7.8 Hz, 1H), 7.63 (s, 2H), 7.57 (d, <i>J</i> = 8.8 Hz, 1H), 7.54 (d, <i>J</i> = 8.0 Hz, 2H), 7.25 (t, <i>J</i> = 7.8 Hz, 1H), 6.94 (d, <i>J</i> = 7.8 Hz, 1H), 6.88 (t, <i>J</i> = 7.8 Hz, 1H), 4.34 (s, 2H), 2.90 (s, 6H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>27</sub>H<sub>24</sub>N<sub>4</sub>O]<sup>+</sup> 421.2028, found 421.2029. HPLC A: 95A% at 214 nm.</div></div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Synthesis of (<i>E</i>)-3-((3-(4-((Dimethylamino)methyl)styryl)-1<i>H</i>-indazol-6-yl)-methylene)-5-methoxyindolin-2-one 2,2,2-trifluoroacetate (<b>48</b>)</h4><div id="sec4_2_23_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> 3-((3-(4-((Dimethylamino)methyl)styryl)-1-((2-(trimethylsilyl)ethoxy)-methyl)-1<i>H</i>-indazol-6-yl)methylene)-5-methoxyindolin-2-one</h5><div class="NLM_p last">Piperidine (0.01 mL, 0.1 mmol) was added to a solution of 5-methoxyoxindole (52 mg, 0.32 mmol) and (<i>E</i>)-3-(4-((dimethylamino)methyl)styryl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-indazole-6-carbaldehyde (95.5 mg, 0.22 mmol) in EtOH (5 mL). The reaction was then heated to 75 °C for 25 h. The solvent was evaporated in vacuo. Chromatography (5g silica SPE tube, Silicycle, 5–10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) gave the title compound as a brown oil (105 mg, contained product and TBAF by NMR). The residue was dissolved in EtOAc (100 mL) and washed with brine (3 × 15 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was evaporated in vacuo to give the title compound as a brown oil (110 mg, used without further purification).</div></div><div id="sec4_2_23_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> (<i>E</i>)-3-((3-(4-((Dimethylamino)methyl)styryl)-1<i>H</i>-indazol-6-yl)-methylene)-5-methoxyindolin-2-one 2,2,2-trifluoroacetate (<b>48</b>)</h5><div class="NLM_p last">According to the method of compound <b>41</b>, part 3, 3-((3-(4-((dimethylamino)methyl)styryl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-indazol-6-yl)-methylene)-5-methoxyindolin-2-one (19 mg, 0.033 mmol) was treated with boron trifluoride etherate, followed by 2 N HCl (water/EtOH) treatment. The solvents were removed in vacuo, and the residue was dissolved in MeOH/EtOAc and filtered to remove solid, then the solvent was evaporated in vacuo. Purification by prep HPLC gave compound <b>48</b> (<i>E</i> isomer, first eluting fraction, 95% by HPLC) as an orange solid (11 mg, 60%, TFA salt). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.26 (d, <i>J</i> = 8.5 Hz, 1H), 7.88 (d, <i>J</i> = 9.3 Hz, 2 H), 7.80 (d, <i>J</i> = 8.3 Hz, 2 H), 7.61 (s, 2 H), 7.51–7.58 (m, 3 H), 7.26 (s, 1 H), 6.84 (s, 2 H), 4.34 (s, 2 H), 3.63 (s, 3 H), 2.89 (s, 6 H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>28</sub>H<sub>26</sub>N<sub>4</sub>O<sub>2</sub> (M+) 450.2056, found 450.2053. HPLC A: 95A% at 214 nm.</div></div></div><div id="sec4_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Synthesis of (<i>E</i> and <i>Z</i>)-3-((3-((<i>E</i>)-2-(6-(4-Methylpiperazin-1-yl)pyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)methylene)-indolin-2-one (<b>49</b>)</h4><div id="sec4_2_24_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> 1-Methyl-4-(5-vinylpyridin-2-yl)piperazine</h5><div class="NLM_p last">A mixture of powdered KOH (0.9 g, 16 mmol) and 1,2-dibromoethane (0.58 mL, 6.7 mmol) in anhydrous THF (9 mL), degassed with Ar, was heated under microwave irradiation in a sealed vial at 95 °C for 70 min. The reaction mixture was then cooled to rt and treated with Pd(OAc)<sub>2</sub> (59 mg, 0.26 mmol), PPh<sub>3</sub> (138 mg, 0.53 mmol), and 1-methyl-4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazine (2.0 g, 6.6 mmol), and degassed MeOH (9 mL). The sealed reaction mixture, under Ar, was heated under microwave irradiation at 95 °C for 60 min. The crude mixture was diluted with EtOAc (250 mL), washed (H<sub>2</sub>O–brine 1:1, brine 2×), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. Purification by flash chromatography (SiO<sub>2</sub> 0–8% MeOH/DCM) provided the title compound as a pale-yellow gum (1.25 g, 93%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.07 (d, <i>J</i> = 2.3 Hz, 1 H), 7.73 (dd, <i>J</i> = 8.9, 2.4 Hz, 1 H), 6.82 (d, <i>J</i> = 9.0 Hz, 1 H), 6.62 (dd, <i>J</i> = 17.8, 11.0 Hz, 1 H), 5.63 (d, 1 H), 5.12 (d, <i>J</i> = 10.8 Hz, 4 H), 3.52–3.66 (m, 4 H), 2.50–2.61 (m, 4 H), 2.35 (s, 3 H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>12</sub>H<sub>17</sub>N<sub>3</sub> + H]<sup>+</sup> 204.1, found 204.0.</div></div><div id="sec4_2_24_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> (<i>E</i>)-3-(2-(6-(4-Methylpiperazin-1-yl)pyridin-3-yl)vinyl)-1-((2-(trimethylsilyl)-ethoxy)methyl)-1<i>H</i>-indazole-6-carbaldehyde</h5><div class="NLM_p last">The title compound was synthesized according to the method of compound <b>47</b>, part 1, utilizing 1-methyl-4-(5-vinylpyridin-2-yl)piperazine (65 mg, 0.32 mmol) and 3-iodo-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-indazole-6-carbaldehyde (100 mg, 0.25 mmol). The crude material was purified by prep TLC (SiO<sub>2</sub> 10% MeOH/DCM) to provide the title compound to as a pale-orange material (46 mg, 39%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 10.14 (s, 1H), 8.34 (d, <i>J</i> = 2.3 Hz, 1H), 8.24–8.28 (m, 2H), 8.00 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 7.80 (d, <i>J</i> = 8.8 Hz, 1H), 7.51 (d, <i>J</i> = 16.6 Hz, 1H), 7.36 (d, <i>J</i> = 16.6 Hz, 1H), 6.97 (d, <i>J</i> = 9.3 Hz, 1H), 5.85 (s, 2H), 3.77–3.87 (m, 4H), 3.63 (t, <i>J</i> = 7.9 Hz, 2H), 3.06–3.15 (m, 4H), 2.75 (s, 2H), 0.88 (t, <i>J</i> = 8.0 Hz, 2H), −0.09 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>26</sub>H<sub>35</sub>N<sub>5</sub>O<sub>2</sub>Si H]<sup>+</sup> 478.2, found 478.3.</div></div><div id="sec4_2_24_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> (<i>E</i>)-3-((3-((<i>E</i>)-2-(6-(4-Methylpiperazin-1-yl)pyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)methylene)-1-((2-(trimethylsilyl)ethoxy)methyl)indolin-2-one</h5><div class="NLM_p last">The title compound was synthesized according to the method of compound <b>41</b>, part 2, utilizing indolin-2-one (8.3 mg, 0.062 mmol) and the product from part 2 above (46 mg, 0.096 mmol). The crude mixture was concentrated under reduced pressure and purified by prep TLC (SiO<sub>2</sub> 10% MeOH/DCM) to provide the title compound as a (<i>E</i>:<i>Z</i>) mixture of isomers: a yellow solid (22.5 mg, 40%). MS (ESI) <i>m</i>/<i>z</i> 593.4 [M + H]<sup>+</sup>, calcd for [C<sub>34</sub>H<sub>40</sub>N<sub>6</sub>O<sub>2</sub>Si + H]<sup>+</sup> 593.8.</div></div><div id="sec4_2_24_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> (<i>E</i> and <i>Z</i>)-3-((3-((<i>E</i>)-2-(6-(4-Methylpiperazin-1-yl)pyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)methylene)-indolin-2-one Dihydrochloride (<b>49</b>)</h5><div class="NLM_p last">The title compound was prepared according to the method of compound <b>41</b>, part 3, utilizing (<i>E</i>)-3-((3-((<i>E</i>)-2-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)methylene)-1-((2-(trimethylsilyl)-ethoxy)methyl)indolin-2-one (22.5 mg, 0.038 mmol). The crude reaction mixture was stored at −20 °C overnight. The precipitate was collected by filtration and washed with MeCN to provide the title compound, a <i>E</i>/<i>Z</i> mixture of isomers (4:1), as a yellow solid (6.9 mg, 34%). For the <i>E</i> isomer: <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.56 (d, <i>J</i> = 9.5 Hz, 1H), 8.33 (s, 1H), 8.26 (d, <i>J</i> = 8.3 Hz, 1H), 7.85–7.91 (m, 2H), 7.65 (d, <i>J</i> = 7.8 Hz, 1H), 7.50–7.61 (m, 4H), 7.25 (t, <i>J</i> = 7.5 Hz, 1H), 6.94 (d, <i>J</i> = 7.5 Hz, 1H), 6.84–6.91 (m, 1H), 4.49 (bs, 2H), 3.73 (bs, 4H), 3.34–3.52 (m, 2H), 3.03 (s, 3H); the presence of the <i>Z</i> isomer was indicated by a signal at δ 9.0 (s, 1H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>28</sub>H<sub>26</sub>N<sub>6</sub>O + H]<sup>+</sup> 462.5, found 463.2. HPLC A: >95% at 325 nm</div></div></div><div id="sec4_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Synthesis of 5-Methoxy-(<i>E</i>)-3-((3-((<i>E</i>)-2-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)methylene)indolin-2-one (<b>50</b>)</h4><div id="sec4_2_25_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> 5-Methoxy-3-(<i>E</i>)-((3-((<i>E</i>)-2-(6-(4-methylpiperazin-1-yl)pyrid-3-yl)vinyl)-1-((2-(trimethyl-silyl)ethoxy)methyl)-1<i>H</i>-indazol-6-yl)methylene)indolin-2-one</h5><div class="NLM_p last">The title compound was synthesized according to the method of compound <b>41</b>, part 2, utilizing 5-methoxyindolin-2-one (14.7 mg, 0.090 mmol) and (<i>E</i>)-3-(2-(6-(4-methylpiperazin-1-yl)pyridine-3-yl)vinyl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-indazole-6-carbaldehyde (41 mg, 0.086 mmol). The crude mixture was concentrated under reduced pressure and purified by prep TLC (SiO<sub>2</sub> 5% MeOH/DCM) to afford a yellow solid (11.5 mg, 21%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.29 (d, <i>J</i> = 2.3 Hz, 1H), 8.22 (d, <i>J</i> = 8.0 Hz, 1H), 7.92–7.97 (m, 2H), 7.86 (s, 1H), 7.57 (d, <i>J</i> = 8.5 Hz, 1H), 7.50 (d, <i>J</i> = 16.6 Hz, 1H), 7.30 (d, <i>J</i> = 16.6 Hz, 1H), 7.20 (bs, 1H), 6.89 (d, <i>J</i> = 9.0 Hz, 1H), 6.84 (s, 2H), 5.77 (s, 2H), 3.58–3.67 (m, 9H), 2.55–2.62 (m, 4H), 2.37 (s, 3H), 0.88 (t, <i>J</i> = 8.2 Hz, 2H), −0.09 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>35</sub>H<sub>42</sub>N<sub>6</sub>O<sub>3</sub>Si–CH<sub>2</sub>CH<sub>2</sub>SiMe<sub>3</sub>]<sup>+</sup> 523.3, found 523.4.</div></div><div id="sec4_2_25_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> 5-Methoxy-(<i>E</i>)-3-((3-((<i>E</i>)-2-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)methylene)indolin-2-one Dihydrochloride (<b>50</b>)</h5><div class="NLM_p last">A solution of 5-methoxy-3-((3-((<i>E</i>)-2-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)methylene)-1-((2-(trimethylsilyl)ethoxy)methyl)indolin-2-one (11.5 mg, 0.018 mmol) in EtOH (4 mL) was treated with aq HCl (4 M, 0.5 mL) and the reaction was stirred, sealed under N<sub>2</sub>, in a heating block at 80 °C overnight. The reaction was cooled, diluted with MeCN, and stored at 5 °C overnight. The resulting solid was collected and washed with MeCN to provide the title compound as an orange powder (4.5 mg, 43%, HCl salt). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.87 (s, 1H), 8.50 (d, <i>J</i> = 9.0 Hz, 1H), 8.34 (s, 1H), 8.16 (d, <i>J</i> = 8.3 Hz, 1H), 8.01 (d, <i>J</i> = 8.3 Hz, 1H), 7.90 (s, 1H), 7.49–7.62 (m, 2H), 7.44 (d, <i>J</i> = 9.5 Hz, 1H), 7.32 (s, 1H), 6.84 (d, <i>J</i> = 6.5 Hz, 1H), 6.80 (d, <i>J</i> = 8.5 Hz, 1H), 4.41–4.59 (bs, 2H), 3.84 (s, 3H), 3.46–3.80 (bm, 6H), 3.02 (s, 3H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>29</sub>H<sub>28</sub>N<sub>6</sub>O<sub>2</sub>]<sup>+</sup> 492.2274, found 492.2268. HPLC A: 95A% at 254 nm.</div></div></div><div id="sec4_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Synthesis of 4-((<i>E</i>)-2-(6-((<i>E</i>)-(2-Oxoindolin-3-ylidene)methyl)-1<i>H</i>-indazol-3-yl)vinyl)benzoic Acid (<b>51</b>)</h4><div id="sec4_2_26_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> (<i>E</i>)-Methyl 4-(2-(6-Cyano-1<i>H</i>-indazol-3-yl)vinyl)benzoate</h5><div class="NLM_p last">A mixture of methyl 4-(bromomethyl)-benzoate (4.58 g, 20 mmol) and trimethyl phosphite (3.54 mL, 30 mmol) was refluxed (oil temp 125 °C) for 1 h under argon. After cooling to rt, the reaction mixture was diluted with DMF (50 mL) and cooled to 0 °C using ice bath. <sup><i>t</i></sup>BuOK (3.92 g, 35 mmol) was added slowly. After addition, the resulting dark-brown solution was stirred for 5 min at 0 °C before a solution of 3-formyl-1<i>H</i>-indazole-6-carbonitrile<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> (<b>34</b>, 2.0 g, 11.7 mmol) in DMF (15 mL) was added dropwise via a Pasteur pipet over 5 min. The reaction mixture was then stirred for 90 min at 0 °C; 2N HCl (25 mL) was added slowly over 2 min, followed by H<sub>2</sub>O (100 mL). The resulting suspension was stirred for 5 min at 0 °C. The precipitate, collected by suction filtration, was rinsed with H<sub>2</sub>O and dried to give crude (<i>E</i>)-methyl 4-(2-(6-cyano-1<i>H</i>-indazol-3-yl)vinyl)benzoate (3.70 g) as an orange solid. Trituration with 50 mL of ether, followed by sonication and suction filtration, gave the title compound as an orange solid (2.56 g, 72%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.83 (s, 1H), 8.43 (d, <i>J</i> = 8.8 Hz, 1H), 8.18 (s, 1H), 7.97 (d, <i>J</i> = 8.4 Hz, 2H), 7.87 (d, <i>J</i> = 8.4 Hz, 2H), 7.76 (d, <i>J</i> = 16.4 Hz, 1H), 7.63 (d, <i>J</i> = 16.8 Hz, 1H), 7.55 (d, <i>J</i> = 8.4 Hz, 1H), 3.86 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>18</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub> + H]<sup>+</sup> 304.1, found 304.1.</div></div><div id="sec4_2_26_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> (<i>E</i>)-Methyl 4-(2-(6-Formyl-1<i>H</i>-indazol-3-yl)vinyl)benzoate</h5><div class="NLM_p last">A mixture of (<i>E</i>)-methyl 4-(2-(6-cyano-1<i>H</i>-indazol-3-yl)vinyl)benzoate (606 mg, 2 mmol) in HOAc/pyridine/DMF (4 mL/8 mL/6 mL) was treated with a solution of NaH<sub>2</sub>PO<sub>2</sub> (704 mg, 8 mmol) in H<sub>2</sub>O (4 mL), followed by Raney-Nickel 2400 (slurry in H<sub>2</sub>O, 0.4 mL). The resulting mixture was heated for 1 h at 55 °C (oil temp). After cooling to rt, it was diluted with EtOAc (80 mL) and washed with H<sub>2</sub>O (30 mL). Aqueous layer was extracted with EtOAc (50 mL). Combined organic layers were washed with 2 N HCl (20 mL) and H<sub>2</sub>O (20 mL) and dried (Na<sub>2</sub>SO<sub>4</sub>). Evaporation of the solvent gave an orange solid, which was triturated with EtOAc (10 mL) followed by suction filtration, to yield the title compound (240 mg, 39%) as light-beige solid. The filtrate was concentrated, triturated with H<sub>2</sub>O, sonicated, and the resulting precipitates were collected by suction filtration and rinsed with H<sub>2</sub>O and dried to give additional title compound (151 mg, 25%) as orange solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.82 (s, 1H), 10.14 (s, 1H), 8.40 (d, <i>J</i> = 8.8 Hz, 1H), 8.18 (s, 1H), 7.97 (d, <i>J</i> = 8.0 Hz, 2H), 7.88 (d, <i>J</i> = 7.6 Hz, 2H), 7.77 (d, <i>J</i> = 16.8 Hz, 1H), 7.79 (d, <i>J</i> = 8.4 Hz, 1H), 7.64 (d, <i>J</i> = 15.6 Hz, 1H), 3.86 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>18</sub>H<sub>14</sub>N<sub>2</sub>O<sub>3</sub> + H]<sup>+</sup> 307.1, found 307.0.</div></div><div id="sec4_2_26_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> (<i>E</i>)-4-(2-(6-Formyl-1<i>H</i>-indazol-3-yl)vinyl)benzoic Acid</h5><div class="NLM_p last">A round-bottom flask containing (<i>E</i>)-methyl 4-(2-(6-cyano-1<i>H</i>-indazol-3-yl)vinyl)benzoate (606 mg, 2 mmol) was treated with 2 M NaOH (20 mL, 40 mmol), followed by THF (10 mL) and MeOH (10 mL). The resulting mixture was stirred O/N at rt. After removal of THF and MeOH via rotavap, the residue was cooled to 0 °C and treated with 2 M HCl (25 mL) and stirred for 2 min at that temp. The precipitates, collected by suction filtration, were rinsed with H<sub>2</sub>O to give crude (<i>E</i>)-4-(2-(6-cyano-1<i>H</i>-indazol-3-yl)vinyl)benzoic acid as brown–red solid. The solid was dissolved in AcOH/pyridine/DMF (4 mL/8 mL/6 mL) and a solution of NaH<sub>2</sub>PO<sub>2</sub> (704 mg, 8 mmol) in H<sub>2</sub>O (4 mL) was added, followed by Raney-Nickel 2400 (slurry in H<sub>2</sub>O, 0.4 mL). The resulting mixture was heated for 1 h at 55 °C (oil temp.). Aqueous workup, followed by trituration with H<sub>2</sub>O and drying, gave the title compound (332 mg, 54%) as a beige solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.81 (s, 1H), 12.90 (bs, 1H), 10.14 (s, 1H), 8.39 (d, J = 8.0 Hz, 1H), 8.19 (s, 1H), 7.96 (d, <i>J</i> = 8.0 Hz, 2H), 7.86 (d, <i>J</i> = 8.0 Hz, 2H), 7.76 (d, <i>J</i> = 16.8 Hz, 1H), 7.79 (d, <i>J</i> = 8.4 Hz, 1H), 7.64 (d, <i>J</i> = 16.4 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>17</sub>H<sub>12</sub>N<sub>2</sub>O<sub>3</sub> + H]<sup>+</sup> 293.1, found 293.0.</div></div><div id="sec4_2_26_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> 4-((<i>E</i>)-2-(6-((<i>E</i>)-(2-Oxoindolin-3-ylidene)methyl)-1<i>H</i>-indazol-3-yl)-vinyl)benzoic Acid (<b>51</b>)</h5><div class="NLM_p last">According to the method described for compound <b>38</b>, part 3 (oil temp 75 °C, reflux 90 min), using indolin-2-one (26.6 mg, 0.2 mmol) and (<i>E</i>)-4-(2-(6-formyl-1<i>H</i>-indazol-3-yl)vinyl)benzoic acid (58.4 mg, 0.2 mmol), the title compound (17 mg, 21%) was synthesized as an orange solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.49 (s, 1H), 12.90 (bs, 1H), 10.64 (s, 1H), 8.37 (d, <i>J</i> = 8.4 Hz, 2H), 7.97 (d, <i>J</i> = 8.4 Hz, 2H), 7.91 (s, 1H), 7.86 (d, <i>J</i> = 8.0 Hz, 2H), 7.80 (s, 1H), 7.74 (d, <i>J</i> = 16.8 Hz, 1H), 7.63 (d, <i>J</i> = 15.6 Hz, 1H partially overlapping with the singlet at 7.62), 7.62 (s, 1H partially overlapping with the doublet at 7.63), 7.24 (t, <i>J</i> = 7.4 Hz, 1H), 6.91–6.82 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>25</sub>H<sub>17</sub>N<sub>3</sub>O<sub>3</sub> + H]<sup>+</sup> 408.135, found 408.139. HPLC B: >99A% at 214 nm.</div></div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Biochemical Assays</h3><div class="NLM_p">Active PLK4 was purified from an <i>Escherichia coli</i> expression system as an amino terminal GST fusion of residues 1–391 of human PLK4. The protein was purified from clarified cell extracts after induction at 15 °C overnight using glutathione sepharose, gel permeation chromatography, and ion exchange (Resource Q). The resulting protein was dephosphorylated with lambda phosphatase (NEB cat. no. P0753) and resolved from the phosphatase using glutathione sepharose. The dephosphorylated GST-PLK4 was stored in aliquots at −80 °C until use.</div><div class="NLM_p">PLK4 activity was measured using an indirect ELISA detection system. Dephosphorylated GST-PLK4 (2 nM) was incubated in the presence of 15 μM ATP (Sigma cat. no. A7699), 50 mM HEPES-Na<sup>2+</sup>, pH 7.4, 1 mM EGTA, 10 mM MgCl<sub>2</sub>, and 0.01% Brij 35 (Sigma cat. no. P1254) in a 96-well microtiter plate precoated with MBP (Millipore cat. no. 30-011). The reaction was allowed to proceed for 30 min at 30 °C, followed by five washes of the plate with Wash Buffer (1× PBS pH 7.4 and 0.2% Tween 20) and incubation for 30 min with a 1:3000 dilution of phosphor-threonine antibody in 1% BSA/50 mM Tris, pH 7.5 (Cell Signaling cat. no. 9381). The plate was washed five times with wash buffer, incubated for 30 min in the presence of secondary antibody coupled to horse radish peroxidase (BioRad cat. no. 1721019, 1:3000 concentration), washed an additional five times with wash buffer, and incubated in the presence of TMB substrate (Sigma cat. no. T0440). The colorimetric reaction was allowed to continue for 5 min, followed by addition of stop solution (0.5 N H<sub>2</sub>SO<sub>4</sub>) and quantified by detection at 450 nm with either a monochromatic or filter-based plate reader (Molecular Devices M5 or Beckman DTX880, respectively).</div><div class="NLM_p">PLK1, PLK2, PLK3, Aurora A, Aurora B, FLT-3, and KDR compound inhibition were determined using FRET-based homogeneous assay kits from Invitrogen (Burlington, Ontario, Canada). The assays were performed according to the manufacturer’s specifications with ATP concentrations of 25, 60, and 80 μM, respectively for PLK1, PLK2, and PLK3 and ATP concentrations of 20, 128, 940, and 156 μM, respectively, for Aurora A, Aurora B, FLT3, and KDR.</div><div class="NLM_p">Compound inhibition was determined at either a fixed concentration (10 μM) or at a variable inhibitor concentration (typically 50–0.1 μM in a 10 point dose response titration). Compounds were mixed with enzyme prior to addition of ATP and the activity remaining quantified using the above-described activity assay. The % inhibition of a compound was determined using the following formula; % inhibition = 100(1 – (experimental value – background value)/(high activity control – background value)). The IC<sub>50</sub> value was determined using a nonlinear four-parameter logistic curve fit (XLfit4, IDBS, Guildford, Surrey, UK) with the formula: (<i>A</i> + (<i>B</i>/(1 + ((<i>x</i>/<i>C</i>)∧<i>D</i>)))), where <i>A</i> = background value, <i>B</i> = range, <i>C</i> = inflection point, <i>D</i> = curve fit parameter. Unless otherwise designated, the kinase IC<sub>50</sub> values given in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> are the results of a single determination. For values determined by averaging three replicates, the standard deviation is given in the PLK4 IC<sub>50</sub> column.</div><div class="NLM_p">The apparent <i>K</i><sub>i</sub> for compound <b>7</b> was estimated to be 0.7 μM by varying the ATP concentration in a series of PLK4 inhibition experiments at 0, 2.0, and 10 μM and applying nonlinear regression analysis. Similarly, the apparent <i>K</i><sub>i</sub> for compound <b>17</b> was determined to be 0.02 μM by varying the ATP concentration in a series of PLK4 inhibition experiments at 0, 0.12, 0.36, and 0.6 μM.</div><div class="NLM_p">The selectivity of inhibitor <b>50</b> against 274 protein kinases was assessed by Millipore (Dundee, Scotland) using a radiometric assay. Inhibition was determined at 1 μM inhibitor concentration with ATP at <i>K</i><sub>m</sub>; % inhibition was determined as stated in the preceding paragraph (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div><div class="NLM_p">Fluorogenic cytochrome P450 (CYP) inhibition studies were conducted at 37 °C in 96-well, round-bottom, white polystyrene plates. Supersome mixtures containing CYP protein, insect control Supersomes, substrate, and potassium phosphate buffer (pH 7.4) were prepared with the following final concentrations: CYP 3A4, 4 nM 3A4+OR+<i>b</i>5 Supersomes + 40 μM BFC in 160 mM buffer, CYP 3A4, 0.8 nM 3A4+OR+<i>b</i>5 Supersomes + 0.8 μM DBF in 160 mM buffer, CYP 2D6, 6 nM 2D6+OR Supersomes + 1.2 μM AMMC in 40 mM buffer, CYP 2C9, 4 nM CYP 2C9+OR+<i>b</i>5 + 8 μM MFC in 40 mM buffer, CYP 2C19, 4 nM CYP 2C19+OR+<i>b</i>5 + 20 μM CEC in 40 mM buffer, and CYP 1A2, 2 nM CYP 1A2+OR + 4 μM CEC in 40 mM buffer. Reaction times were verified to be within the limits of kinetic linearity (data not shown). All probe substrate concentrations selected for these determinations were approximately equal to the <i>K</i><sub>m</sub>. The final cofactor concentrations were 1.3 mM NADP, 3.3 mM glucose-6-phosphate, and 0.4 U/mL glucose-6-phosphate dehydrogenase for all enzymes. The final incubation volume was 0.2 mL. Buffer, cofactors, and inhibitor were added to the wells, and the plates prewarmed at 37 °C for 10 min. The solvent concentration was constant (≤0.2% DMSO for test articles, ≤ 2% CH<sub>3</sub>CN for positive control inhibitors) for all conditions within an experiment. Incubations were initiated by the addition of prewarmed enzyme/substrate mix. After the specified incubation times (10 min for CYP 3A4/DBF, 15 min for CYP 1A2/CEC, 30 min for CYP 2D6/AMMC, CYP 2C19/MFC and CYP 3A4/BFC, 45 min for CYP 2C9/MFC) reactions were stopped by the addition of 75 μL of 80% acetonitrile/20% 0.5 M Tris base, with the exception of 3A4/DBF, which was stopped by addition of 75 μL of 2N NaOH. At the final reaction times, fluorescence was determined using the following excitation/emission wavelengths: 3A4 (485/535 nm), 2D6 (390/465 nm), and 2C9 (409/535 nm).</div><div class="NLM_p last">The fluorescence signals within a dilution series were normalized to 0% and 100% inhibition, using the range defined by the positive and negative control inhibitors for each isoform/substrate. The % inhibition of a compound was determined using the following formula; % inhibition = 100(1 – (experimental value – background value)/(high activity control – background value)). The IC<sub>50</sub> value was determined using a nonlinear four-point logistic curve fit (XLfit4, IDBS) with the formula; (<i>A</i> + (<i>B</i>/(1 + ((<i>x</i>/<i>C</i>)∧<i>D</i>)))), where <i>A</i> = background value, <i>B</i> = range, <i>C</i> = inflection point, <i>D</i> = curve fit parameter.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Cell Assays</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Cell Lines</h4><div class="NLM_p last">All cell lines were obtained from American Type Culture Collection (ATCC, Manassas, VA) and maintained according to the supplier’s instructions. Short tandem repeat (STR) profiling was used to verify authenticity of the cell lines. Sixteen STR loci were simultaneously amplified in a multiplex PCR reaction (The Hospital for Sick Children, Toronto, Canada), and the ATCC database was used for comparison. Cell lines were routinely tested for mycoplasma and used at low passage numbers (<15). Primary cultures of normal human mammary epithelial cells (HMEC) were obtained from Lonza (Anaheim, CA) and maintained according to the supplier’s instructions. Cell doubling times as as follows: MCF-7 = 51 h, MDA-MB-231 = 25 h, MDA-MB-468 = 52 h, SKBr-3 = 56 h, HCC1954 = 46 h.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Cell Cycle Analysis</h4><div class="NLM_p last">Human MDA-MB-468 breast cancer cells in 6-well plates were treated with either DMSO or PLK4 inhibitor <b>41</b> at the indicated concentrations and cultured at 37 °C and 5% CO<sub>2</sub>. After 2 d, the cells were trypsinized, washed in phosphate-buffered saline, and centrifuged. Cell pellets were resuspended with propidium iodide in HEPES buffer, mixed, and incubated at room temperature in the dark. Samples were read in a FACSCalibur flow cytometer (Becton, Dickinson and Company) and data analyzed using FloJo software (Tree Star, Inc.).</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Cell Viability Assay (GI<sub>50</sub>)</h4><div class="NLM_p last">MCF-7, MDA-MB-468, MDA-MB-231, SKBr-3, and HCC1954 breast cancer cells were seeded into 96-well plates at 4000, 3000, 2500, 4000, and 4000 cells per 80 μL, respectively, 24 h before compound overlay, and cultured at 37 °C and 5% CO<sub>2</sub>. Compounds were prepared as 10 mM stocks in 100% DMSO. Each 10 mM stock was diluted with DMEM (Dulbecco’s Modified Eagle’s Medium) cell growth medium (Invitrogen, Burlington, ON, Canada) containing 10% FBS (fetal bovine serum) such that the final concentrations ranged from 50 nM to 250 μM. Aliquots (20 μL) from each concentration were overlaid to 80 μL of preseeded cells to achieve final concentrations of 10 nM to 50 μM. After 5 d, the cells were fixed in situ by gently removing the culture media and adding 50 μL of ice-cold 10% trichloroacetic acid (TCA) per well and incubation at 4 °C for 30 min. The plates were washed with water five times and allowed to air-dry for 5 min. Then 50 μL of 0.4% (w/v) sulforhodamine B (SRB) (Sigma, Oakville, ON, Canada) solution in 1% (v/v) acetic acid was added to each well followed by incubation for 30 min at rt. The plates were washed four times with 1% acetic acid to remove unbound SRB and air-dried for 5 min. The SRB was solubilized with 100 μL of 10 mM Tris pH 10.5 per well, and absorbance was read at 570 nm using a SpectraPlus microplate reader (Molecular Devices Corporation). The percentage (%) of relative inhibition of cell viability was calculated by comparing to DMSO treated only cells. GI<sub>50</sub>s were calculated using GraphPad PRISM software (GraphPad Software, Inc., San Diego, CA, USA).</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Reverse Transcription Polymerase Chain Reaction (RT-PCR) Analysis</h4><div class="NLM_p last">Total RNA (tRNA) was prepared using TRIzol Reagent (Invitrogen, Carlsbad, CA) according to manufacturer’s instructions. tRNA was DNase treated at room temperature for 15 min. Primers were designed to amplify short segments of target cDNA with a size range of 100–150 bp. RT-PCR reactions were performed using One Step SYBR QPCR Kit (Invitrogen, Carlsbad, CA) according to manufacturer’s instructions. Direct detection of the PCR product was monitored by measuring the increase in fluorescence caused by the binding of SYBR Green I dye to the double-stranded (ds) DNA product using the RealPlex4 System (Eppendorf, Westbury, NY). The conditions for the assay were 53 °C for 20 min, 95 °C for 5 min, followed by 42 cycles of 95 °C for 15 s, 60 °C for 30 s, and 72 °C for 30 s. All PCR efficiencies were above 95%. Relative quantification of gene expression was performed using the standard curve method comprising six serial dilution points (ranging from 0.32 to 1000 ng). Each tRNA sample was analyzed by calculating the average <i>C</i><sub>t</sub> values from triplicate PCR reactions. β-Actin gene expression was used for data normalization. Amplification primers for <i>PLK4</i> are 5′-GGTGGTAGAGGTTTTCCTCCTGC-3′ (forward) and 5′-CAGCACCAGGAGAATTCTCCATC-3′ (reverse), and β-<i>Actin</i> are 5′-GGCACTCTTCCAGCCTTCCTT-3′ (forward) and 5′-TCTCCTTCTGCATCCTGTCG-3′ (reverse). <i>PLK4</i> mRNA levels are expressed as a mean ± SD: MCF-7 = 0.0262 ± 0.0007, MDA-MB-231 = 0.022 ± 0.002, MDA-MB-468 = 0.0125 ± 0.0008, SKBr-3 = 0.014 ± 0.001, HCC1954 = 0.014 ± 0.002.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> PAMPA and PPB Assay</h3><div class="NLM_p last">Compound permeability was determined using a cosolvent double-sink parallel artificial membrane permeability assay (PAMPA) assay at pH 5.0 and 7.4; the values are given in direct permeability units (10<sup>–6</sup> cm/s). The assay was carried out at pION Inc., Woburn, MA, USA. Plasma protein binding (PPB) was measured by the equilibrium dialysis method at a test concentration of 10 mM for 4 h at 37 °C using HPLC-MS/MS detection and expressed as a % protein bound. The measurements were performed by Cerep, Redmond, WA, USA.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> Mouse Plasma Levels</h3><div class="NLM_p last">Adult female SCID mice (PMH Animal Facility) were used in the experiments. All animal experiments were approved by UHN IACUC. Nine mice were dosed at with compound <b>50</b> at 50 mg/kg (free base equivalents) via intraperitoneal injection (water with final pH adjusted to pH 4 with 1 M NaOH) using a volume of 200 μL. Saphenous vein blood was collected from three mice per time point over an 8 h period. The plasma samples were analyzed for drug and internal standard via LCMS/MS protocol using a Waters (Millford, MA, USA) UPLC coupled to either a Q-ToF Premier, or a XevoTQ mass spectrometer. The pharmacokinetic parameters were calculated using Microsoft Excel with pharmacokinetic add-in functions from Usansky et al.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Parameters were calculated using plasma concentration time data for composite averages.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> Xenograft Model</h3><div class="NLM_p last">MDA-MB-468 breast cancer cells (Basal, HER-2 negative) were purchased from ATCC (American Type Culture Collections) and cultured in DMEM (Dulbecco’s Modified Eagle Medium purchased from GIBCO) supplemented with 10% fetal calf serum. Five million cells were injected subcutaneously in the right flank of 6–8 week old female CB-17 SCID mice supplied by Charles River. When the mean tumor volume reached 80–120 mm<sup>3</sup>, mice were randomized into three groups (<i>n</i> = 8) and received either vehicle or compound at the doses indicated. Compound <b>50</b> was weighed and suspended in PEG400:water (30:70) and sonicated at rt for 30 min. The compound was dispensed in aliquots and stored at −20 C° for the duration of the study, and each aliquot was thawed at rt before each dose. The mice were dosed via intraperitoneal injection at 25 mg/kg daily for 21 d. Tumor volume and body weight were measured three times weekly. Efficacy data were graphically represented as the mean tumor volume. Tumor volume was calculated by the following formula: <i>x</i><sup>2</sup><i>y</i>/2. Percent tumor growth inhibition after initiation of treatment with compound was calculated by: TGI = 100 × (1 – (tumor volume<sub>final</sub> – tumor volume<sub>initial</sub> for compound treated group)/(tumor volume<sub>final</sub> – tumor volume<sub>initial</sub> for compound control group)).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84"><a href="/doi/suppl/10.1021/jm400380m">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28081" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28081" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Double reciprocal plots of PLK4 inhibition by compounds <b>7</b> and <b>17</b>; purity and MS data on screening hits; inhibition data of 274 member kinase panel by compound <b>50</b> at 1.0 μM.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400380m/suppl_file/jm400380m_si_001.pdf">jm400380m_si_001.pdf (174.62 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm400380m" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53300" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53300" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Henry W. Pauls</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#82eaf2e3f7eef1c2f7eaecf0e7f1e7e3f0e1eaace1e3"><span class="__cf_email__" data-cfemail="9ef6eeffebf2eddeebf6f0ecfbedfbffecfdf6b0fdff">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Radoslaw Laufer</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryan Forrest</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sze-Wan Li</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong Liu</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Sampson</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louise Edwards</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yunhui Lang</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald E. Awrey</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guodong Mao</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olga Plotnikova</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Genie Leung</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Hodgson</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irina Beletskaya</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacqueline M. Mason</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xunyi Luo</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Wei</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi Yao</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Miklos Feher</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fuqiang Ban</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Reza Kiarash</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erin Green</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tak W. Mak</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guohua Pan</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower, MaRS Centre, 101 College
Street, Toronto, Ontario MG5 1L7, Canada</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d318e6187-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i85">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40312" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40312" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Homer Pearce for helpful discussion during the course of the work and Dr. Timothy Burrows for performing the EXIDE NMR experiments. Amgen, the PMH Foundation, and the Canadian Foundation for Innovation are acknowledged for financial support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i86" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i86"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i87" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i87"> Abbreviations Used</h2><tr><td class="NLM_term"><i>A</i>%</td><td class="NLM_def"><p class="first last">area percent</p></td></tr><tr><td class="NLM_term">aq</td><td class="NLM_def"><p class="first last">aqueous</p></td></tr><tr><td class="NLM_term">anhyd</td><td class="NLM_def"><p class="first last">anhydrous</p></td></tr><tr><td class="NLM_term">Ar</td><td class="NLM_def"><p class="first last">argon</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine-5′-triphosphate</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">b</td><td class="NLM_def"><p class="first last">broad</p></td></tr><tr><td class="NLM_term">calcd</td><td class="NLM_def"><p class="first last">calculated</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">d</td><td class="NLM_def"><p class="first last">doublet</p></td></tr><tr><td class="NLM_term">DBU</td><td class="NLM_def"><p class="first last">1,8-diazabicycloundec-7-ene</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethyl-aminopyridine</p></td></tr><tr><td class="NLM_term">DME</td><td class="NLM_def"><p class="first last">dimethoxyethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">dppf</td><td class="NLM_def"><p class="first last">1,1′-bis(diphenylphosphino) ferrocene</p></td></tr><tr><td class="NLM_term">FLT3</td><td class="NLM_def"><p class="first last">fms-related tyrosine kinase 3</p></td></tr><tr><td class="NLM_term">GI<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal cell growth inhibitory concentration</p></td></tr><tr><td class="NLM_term">GST</td><td class="NLM_def"><p class="first last">glutathione <i>S</i>-transferase</p></td></tr><tr><td class="NLM_term">h</td><td class="NLM_def"><p class="first last">hour</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">HMBC</td><td class="NLM_def"><p class="first last">heteronuclear multiple-bond correlation spectroscopy</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectrometry</p></td></tr><tr><td class="NLM_term">IP</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">KDR</td><td class="NLM_def"><p class="first last">kinase insert domain receptor</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatography coupled to mass spectrometry</p></td></tr><tr><td class="NLM_term">MBP</td><td class="NLM_def"><p class="first last">myelin basic protein</p></td></tr><tr><td class="NLM_term">min</td><td class="NLM_def"><p class="first last">minute</p></td></tr><tr><td class="NLM_term">m</td><td class="NLM_def"><p class="first last">multiplet</p></td></tr><tr><td class="NLM_term">MS ESI</td><td class="NLM_def"><p class="first last">electrospray ionization mass spectrometry</p></td></tr><tr><td class="NLM_term">ND</td><td class="NLM_def"><p class="first last">not determined</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">NBS</td><td class="NLM_def"><p class="first last"><i>N</i>-bromosuccinimide</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeability assay</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">PCR</td><td class="NLM_def"><p class="first last">polymerase chain reaction</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">PEG400</td><td class="NLM_def"><p class="first last">polyethylene glycol 400</p></td></tr><tr><td class="NLM_term">pin</td><td class="NLM_def"><p class="first last">pinacol</p></td></tr><tr><td class="NLM_term">PMB</td><td class="NLM_def"><p class="first last"><i>p</i>-methoxybenzyl</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">prep</td><td class="NLM_def"><p class="first last">preparative</p></td></tr><tr><td class="NLM_term">QSAR</td><td class="NLM_def"><p class="first last">quantitative structure–activity relationship</p></td></tr><tr><td class="NLM_term">Ra-Ni</td><td class="NLM_def"><p class="first last">Raney nickel</p></td></tr><tr><td class="NLM_term">RBF</td><td class="NLM_def"><p class="first last">round bottomed flask</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">RP</td><td class="NLM_def"><p class="first last">reverse phase</p></td></tr><tr><td class="NLM_term">s</td><td class="NLM_def"><p class="first last">singlet</p></td></tr><tr><td class="NLM_term">satd</td><td class="NLM_def"><p class="first last">saturated</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">2-(trimethylsilyl)ethoxy]methyl</p></td></tr><tr><td class="NLM_term">siRNA</td><td class="NLM_def"><p class="first last">small interfering RNA</p></td></tr><tr><td class="NLM_term">SMs</td><td class="NLM_def"><p class="first last">starting materials</p></td></tr><tr><td class="NLM_term">t</td><td class="NLM_def"><p class="first last">triplet</p></td></tr><tr><td class="NLM_term">TBAB</td><td class="NLM_def"><p class="first last">tetra-<i>n</i>-butylammonium bromide</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetra-<i>n</i>-butylammonium fluoride</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">temp</td><td class="NLM_def"><p class="first last">temperature</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TGI</td><td class="NLM_def"><p class="first last">tumor growth inhibition</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">q</td><td class="NLM_def"><p class="first last">quartet</p></td></tr><tr><td class="NLM_term">UPLC</td><td class="NLM_def"><p class="first last">ultra performance liquid chromatography</p></td></tr><tr><td class="NLM_term">UHN IACUC</td><td class="NLM_def"><p class="first last">University Health Network Institutional Animal Care and Use Committee</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30303" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30303" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 56 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dar, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl S. Huang, P. S.</span><span> </span><span class="NLM_article-title">Targeted anti-mitotic therapies: can we improve on tubulin agents?</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1038%2Fnrc2049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=17251917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFOjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=107-117&author=J.+R.+Jacksonauthor=D.+R.+Patrickauthor=M.+M.+Darauthor=P.+S.+Pearl+S.+Huang&title=Targeted+anti-mitotic+therapies%3A+can+we+improve+on+tubulin+agents%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted anti-mitotic therapies: can we improve on tubulin agents?</span></div><div class="casAuthors">Jackson, Jeffrey R.; Patrick, Denis R.; Dar, Mohammed M.; Huang, Pearl S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-117</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The advent of molecularly targeted drug discovery has facilitated the identification of a new generation of anti-mitotic therapies that target proteins with specific functions in mitosis.  The exquisite selectivity for mitosis and the distinct ways in which these new agents interfere with mitosis provides the potential to not only overcome certain limitations of current tubulin-targeted anti-mitotic drugs, but to expand the scope of clin. efficacy that those drugs have established.  The development of these new anti-mitotic drugs as targeted therapies faces significant challenges; nevertheless, these potential therapies also serve as unique tools to dissect the mol. mechanisms of the mitotic-checkpoint response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTEI9t3GggVrVg90H21EOLACvtfcHk0lhR-ePTSrUj_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFOjtA%253D%253D&md5=67a94114629154b9be66428e697835bc</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc2049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2049%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DPatrick%26aufirst%3DD.%2BR.%26aulast%3DDar%26aufirst%3DM.%2BM.%26aulast%3DPearl%2BS.%2BHuang%26aufirst%3DP.%2BS.%26atitle%3DTargeted%2520anti-mitotic%2520therapies%253A%2520can%2520we%2520improve%2520on%2520tubulin%2520agents%253F%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D107%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span> </span><span class="NLM_article-title">Kinesin spindle protein inhibitors as anticancer agents</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1517</span><span class="NLM_x">–</span> <span class="NLM_lpage">1532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1517%2F13543776.16.11.1517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFems7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1517-1532&author=C.+Jiangauthor=Q.+Youauthor=Z.+Liauthor=Q.+Guo&title=Kinesin+spindle+protein+inhibitors+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Kinesin spindle protein inhibitors as anticancer agents</span></div><div class="casAuthors">Jiang, Cheng; You, Qidong; Li, Zhiyu; Guo, Qinglong</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1517-1532</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Kinesin spindle protein (KSP), or Hs Eg5, is a member of the kinesin superfamily of mol. motor proteins that utilize the energy generated from the hydrolysis of ATP to transport vesicles, organelles and microtubules.  KSP plays essential roles in mitotic spindle function and its inhibition prevents normal bipolar spindle formation, leading to mitotic arrest and subsequently to apoptosis of cells.  Therefore, KSP inhibitors have potential as novel anticancer therapeutics.  Since the discovery of monastrol in 1999, many types of KSP inhibitors were reported.  This review describes the mechanism of action and development of different types of KSP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqah-wXCZWf6bVg90H21EOLACvtfcHk0lhR-ePTSrUj_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFems7jK&md5=dd6d0bb463788d201533de28696f5554</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F13543776.16.11.1517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.16.11.1517%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DQ.%26atitle%3DKinesin%2520spindle%2520protein%2520inhibitors%2520as%2520anticancer%2520agents%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2006%26volume%3D16%26spage%3D1517%26epage%3D1532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastians, H.</span><span> </span><span class="NLM_article-title">Mitotic drug targets and the development of novel anti-mitotic anticancer drugs</span> <span class="citation_source-journal">Drug Res. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">162</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1016%2Fj.drup.2007.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=17669681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFWhs73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=162-181&author=M.+Schmidtauthor=H.+Bastians&title=Mitotic+drug+targets+and+the+development+of+novel+anti-mitotic+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic drug targets and the development of novel anti-mitotic anticancer drugs</span></div><div class="casAuthors">Schmidt, Mathias; Bastians, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">162-181</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Drugs that interfere with the normal progression of mitosis belong to the most successful chemotherapeutic compds. currently used for anti-cancer treatment.  Classically, these drugs are represented by microtubule binding drugs that inhibit the function of the mitotic spindle in order to halt the cell cycle in mitosis and to induce apoptosis in tumor cells.  However, these compds. act not only on proliferating tumor cells, but exhibit significant side effects on non-proliferating cells including neurons that are highly dependent on intracellular transport processes mediated by microtubules.  Therefore, there is a particular interest in developing novel anti-mitotic drugs that target non-microtubule structures.  In fact, recently several novel drugs that target mitotic kinesins or the Aurora and polo-like kinases have been developed and are currently tested in clin. trials.  In addn., approaches of cell cycle checkpoint abrogation during mitosis and at the G2/M transition inducing mitosis-assocd. tumor cell death are promising new strategies for anti-cancer therapy.  It is expected that this "next generation" of anti-mitotic drugs will be as successful as the classical anti-microtubule drugs, while avoiding some of the adverse side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiOJi9lDecBLVg90H21EOLACvtfcHk0ljS7XtahIMR4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFWhs73N&md5=b7262b3578e6daaad41412780d022937</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2007.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2007.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DBastians%26aufirst%3DH.%26atitle%3DMitotic%2520drug%2520targets%2520and%2520the%2520development%2520of%2520novel%2520anti-mitotic%2520anticancer%2520drugs%26jtitle%3DDrug%2520Res.%2520Updates%26date%3D2007%26volume%3D10%26spage%3D162%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Vermeulen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Bockstaele, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berneman, Z. N.</span><span> </span><span class="NLM_article-title">The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer</span> <span class="citation_source-journal">Cell Proliferation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1046%2Fj.1365-2184.2003.00266.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=12814430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtVOitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2003&pages=131-149&author=K.+Vermeulenauthor=D.+R.+Van+Bockstaeleauthor=Z.+N.+Berneman&title=The+cell+cycle%3A+a+review+of+regulation%2C+deregulation+and+therapeutic+targets+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer</span></div><div class="casAuthors">Vermeulen, Katrien; Van Bockstaele, Dirk R.; Berneman, Zwi N.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Proliferation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">131-149</span>CODEN:
                <span class="NLM_cas:coden">CPROEM</span>;
        ISSN:<span class="NLM_cas:issn">0960-7722</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The cell cycle is controlled by numerous mechanisms ensuring correct cell division.  This review will focus on these mechanisms, i.e. regulation of cyclin-dependent kinases (CDK) by cyclins, CDK inhibitors and phosphorylating events.  The quality checkpoints activated after DNA damage are also discussed.  The complexity of the regulation of the cell cycle is also reflected in the different alterations leading to aberrant cell proliferation and development of cancer.  Consequently, targeting the cell cycle in general and CDK in particular presents unique opportunities for drug discovery.  This review provides an overview of deregulation of the cell cycle in cancer.  Different families of known CDK inhibitors acting by ATP competition are also discussed.  Currently, at least three compds. with CDK inhibitory activity (flavopiridol, UCN-01, roscovitine) have entered clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWE0B9C2jWSbVg90H21EOLACvtfcHk0ljS7XtahIMR4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtVOitr4%253D&md5=295d73cbc7b74c6dede9c1e99bc87d30</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2184.2003.00266.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2184.2003.00266.x%26sid%3Dliteratum%253Aachs%26aulast%3DVermeulen%26aufirst%3DK.%26aulast%3DVan%2BBockstaele%26aufirst%3DD.%2BR.%26aulast%3DBerneman%26aufirst%3DZ.%2BN.%26atitle%3DThe%2520cell%2520cycle%253A%2520a%2520review%2520of%2520regulation%252C%2520deregulation%2520and%2520therapeutic%2520targets%2520in%2520cancer%26jtitle%3DCell%2520Proliferation%26date%3D2003%26volume%3D36%26spage%3D131%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Green, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolery, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahadevan, D.</span><span> </span><span class="NLM_article-title">Update on aurora kinase targeted therapeutics in oncology</span> <span class="citation_source-journal">Exp. Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1517%2F17460441.2011.555395" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=291-307&author=M.+R.+Greenauthor=J.+E.+Wooleryauthor=D.+Mahadevan&title=Update+on+aurora+kinase+targeted+therapeutics+in+oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F17460441.2011.555395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2011.555395%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DM.%2BR.%26aulast%3DWoolery%26aufirst%3DJ.%2BE.%26aulast%3DMahadevan%26aufirst%3DD.%26atitle%3DUpdate%2520on%2520aurora%2520kinase%2520targeted%2520therapeutics%2520in%2520oncology%26jtitle%3DExp.%2520Opin.%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D291%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Degenhardt, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampkin, T.</span><span> </span><span class="NLM_article-title">Targeting polo-like kinase in cancer therapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1158%2F1078-0432.CCR-09-1380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=20068088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktF2qsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=384-389&author=Y.+Degenhardtauthor=T.+Lampkin&title=Targeting+polo-like+kinase+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting polo-like kinase in cancer therapy</span></div><div class="casAuthors">Degenhardt, Yan; Lampkin, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">384-389</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Polo-like kinases (Plk) function in mitosis and maintaining DNA integrity.  There are four family members, of which Plk1 represents a target for anticancer therapy.  Plk1 is only expressed in dividing cells with peak expression during G2/M.  Plk1 functions in multiple steps of mitosis, and is overexpressed in many tumor types.  Mitotic arrest and inhibition of proliferation, apoptosis, and tumor growth inhibition have been obsd. in preclin. studies using small interfering RNAs (siRNA) or small mols. that inhibit Plk1.  Preclin. studies also show that Plk1 inhibitors may be active against tumors with RAS mutations and that tumor cells with mutations in TP53 are more sensitive to inhibition of Plk1.  Several Plk inhibitors are in phase I or II clin. studies.  As expected, hematol. toxicity is the primary dose-limiting toxicity.  Some patients have achieved clin. response, although in some studies only at doses above the max. tolerated dose defined in the study.  Further evaluation is necessary to discern the clin. utility of Plk1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp-WiWxvJiS7Vg90H21EOLACvtfcHk0ljePFwuHgXVIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktF2qsbw%253D&md5=94d00dd707dc1ca59ed9d58b0099ba89</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-1380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-1380%26sid%3Dliteratum%253Aachs%26aulast%3DDegenhardt%26aufirst%3DY.%26aulast%3DLampkin%26aufirst%3DT.%26atitle%3DTargeting%2520polo-like%2520kinase%2520in%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2010%26volume%3D16%26spage%3D384%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Coley, H. M.</span><span> </span><span class="NLM_article-title">Targeting the cell cycle as a strategy for treating cancer</span>. In  <span class="citation_source-book">Kenichi Trends in Cell Cycle Research</span>; <span class="NLM_contrib-group">Yoshida, K.</span>, Ed.; <span class="NLM_publisher-name">Research Signpost</span>: <span class="NLM_publisher-loc">Kerala, India</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">, </span>pp  <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=237-259&author=H.+M.+Coleyauthor=K.+Yoshida&title=Kenichi+Trends+in+Cell+Cycle+Research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DColey%26aufirst%3DH.%2BM.%26atitle%3DTargeting%2520the%2520cell%2520cycle%2520as%2520a%2520strategy%2520for%2520treating%2520cancer%26btitle%3DKenichi%2520Trends%2520in%2520Cell%2520Cycle%2520Research%26aulast%3DYoshida%26aufirst%3DK.%26pub%3DResearch%2520Signpost%26date%3D2008%26spage%3D237%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Dotan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, R. B.</span><span> </span><span class="NLM_article-title">The ongoing roll-out of aurora kinase inhibitors in cancer treatment</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">845</span><span class="NLM_x">–</span> <span class="NLM_lpage">858</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1358%2Fdof.2010.035.010.1529819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ejsL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=845-858&author=E.+Dotanauthor=R.+B.+Cohen&title=The+ongoing+roll-out+of+aurora+kinase+inhibitors+in+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The ongoing roll-out of aurora kinase inhibitors in cancer treatment</span></div><div class="casAuthors">Dotan, E.; Cohen, R. B.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">845-858</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The Aurora kinase family comprises three important regulatory proteins of mitosis: Aurora kinases A, B and C.  Their dysfunction is assocd. with abnormal cell division, aneuploidy and possibly tumorigenesis.  In addn., overexpression and/or amplification of Aurora kinase A or B has been demonstrated in various cancers.  These observations suggested that the Aurora kinases might be attractive therapeutic targets in oncol.  Drugs targeting the mitotic spindle such as taxanes and vinca alkaloids have been notably successful in cancer medicine.  The Aurora kinase inhibitors represent the latest entrants into this arena.  Inhibitors of Aurora kinases have shown promising results in preclin. studies, and are currently under evaluation in numerous clin. trials.  Considerable addnl. work will be required in order to optimize their use in the clinic, including identifying biomarkers for selection of sensitive tumors, refining the administration schedule of these agents and developing useful combinations of Aurora kinase inhibitors with existing cancer therapeutics.  This review article will summarize the function of each of the Aurora kinases, with emphasis on their role in tumorigenesis and interactions with other cellular pathways that govern tumor biol.  It also discusses those inhibitors that are in the clinic and summarizes the early clin. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovB0C-h4cVGrVg90H21EOLACvtfcHk0ljePFwuHgXVIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ejsL7L&md5=bae3d45b260f45c678ab863cceb5e292</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1358%2Fdof.2010.035.010.1529819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2010.035.010.1529819%26sid%3Dliteratum%253Aachs%26aulast%3DDotan%26aufirst%3DE.%26aulast%3DCohen%26aufirst%3DR.%2BB.%26atitle%3DThe%2520ongoing%2520roll-out%2520of%2520aurora%2520kinase%2520inhibitors%2520in%2520cancer%2520treatment%26jtitle%3DDrugs%2520Future%26date%3D2010%26volume%3D35%26spage%3D845%26epage%3D858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Archambault, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, D. M.</span><span> </span><span class="NLM_article-title">Polo-like kinases: conservation and divergence in their functions and regulation</span> <span class="citation_source-journal">Nature Rev., Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1038%2Fnrm2653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=19305416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVCqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=265-275&author=V.+Archambaultauthor=D.+M.+Glover&title=Polo-like+kinases%3A+conservation+and+divergence+in+their+functions+and+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinases: conservation and divergence in their functions and regulation</span></div><div class="casAuthors">Archambault, Vincent; Glover, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">265-275</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Polo-like kinases (Plks) are potent regulators of M-phase that are conserved from yeasts to humans.  Their roles in mitotic entry, spindle pole functions, and cytokinesis are broadly conserved despite phys. and mol. differences in these processes in disparate organisms.  Plks are characterized by their Polo-box domain, which mediates protein interactions.  They are addnl. controlled by phosphorylation, proteolysis, and transcription, depending on the biol. context.  Plks are now recognized to link cell division to developmental processes and to function in differentiated cells.  A comparison of Plk function and regulation between organisms offers insight into the rich variations of cell division.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMIkNbJzhkm7Vg90H21EOLACvtfcHk0ljM6NVn2aMJ7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVCqu7o%253D&md5=6f9339e80588d04f5f156f1900718193</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrm2653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2653%26sid%3Dliteratum%253Aachs%26aulast%3DArchambault%26aufirst%3DV.%26aulast%3DGlover%26aufirst%3DD.%2BM.%26atitle%3DPolo-like%2520kinases%253A%2520conservation%2520and%2520divergence%2520in%2520their%2520functions%2520and%2520regulation%26jtitle%3DNature%2520Rev.%252C%2520Mol.%2520Cell%2520Biol.%26date%3D2009%26volume%3D10%26spage%3D265%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Barr, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silljé, H. H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">Polo-like kinases and the orchestration of cell division</span> <span class="citation_source-journal">Nature Rev. Mod. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1038%2Fnrm1401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=15173822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVarsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=429-440&author=F.+A.+Barrauthor=H.+H.+W.+Sillj%C3%A9author=E.+A.+Nigg&title=Polo-like+kinases+and+the+orchestration+of+cell+division"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinases and the orchestration of cell division</span></div><div class="casAuthors">Barr, Francis A.; Sillje, Herman H. W.; Nigg, Erich A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">429-441</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Polo-like kinases (Plks) are increasingly recognized as key regulators of mitosis, meiosis and cytokinesis.  In agreement with a broad range of proposed functions during cell division, Plks are subject to complex temporal and spatial control.  Recent findings are uncovering the mechanisms of Plk regulation, notably their targeting to different cellular structures through interactions with phosphorylated docking proteins.  Moreover, information is emerging on the substrate specificity of Plks and the role of individual substrates in M-phase progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLN4E8Z5Hjq7Vg90H21EOLACvtfcHk0ljM6NVn2aMJ7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVarsLk%253D&md5=8c11ac86d8b157dfa74ab95841e9eba0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrm1401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1401%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DF.%2BA.%26aulast%3DSillj%25C3%25A9%26aufirst%3DH.%2BH.%2BW.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DPolo-like%2520kinases%2520and%2520the%2520orchestration%2520of%2520cell%2520division%26jtitle%3DNature%2520Rev.%2520Mod.%2520Cell%26date%3D2004%26volume%3D5%26spage%3D429%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Schoffski, P.</span><span> </span><span class="NLM_article-title">Polo-like kinase inhibitors in preclinical and early clinical development</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=559-570&author=P.+Schoffski&title=Polo-like+kinase+inhibitors+in+preclinical+and+early+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchoffski%26aufirst%3DP.%26atitle%3DPolo-like%2520kinase%2520inhibitors%2520in%2520preclinical%2520and%2520early%2520clinical%2520development%26jtitle%3DOncologist%26date%3D2009%26volume%3D14%26spage%3D559%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Sillibourne, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornens, M.</span><span> </span><span class="NLM_article-title">Polo-like kinase 4: the odd one out of the family</span> <span class="citation_source-journal">Cell Div.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1186%2F1747-1028-5-25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=20920249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A280%3ADC%252BC3cfovVygug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=25-34&author=J.+E.+Sillibourneauthor=M.+Bornens&title=Polo-like+kinase+4%3A+the+odd+one+out+of+the+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinase 4: the odd one out of the family</span></div><div class="casAuthors">Sillibourne James E; Bornens Michel</div><div class="citationInfo"><span class="NLM_cas:title">Cell division</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> Polo-like kinase 4 (PLK4) is a unique member of the Polo-like family of kinases that shares little homology with its siblings and has an essential role in centriole duplication.  The turn-over of this kinase must be strictly controlled to prevent centriole amplification.  This is achieved, in part, by an autoregulatory mechanism, whereby PLK4 autophosphorylates residues in a PEST sequence located carboxy-terminal to its catalytic domain.  Phosphorylated PLK4 is subsequently recognized by the SCF complex, ubiquitinylated and targeted to the proteasome for degradation.  Recent data have also shown that active PLK4 is restricted to the centrosome, a mechanism that could serve to prevent aberrant centriole assembly elsewhere in the cell.  While significant advances have been made in understanding how PLK4 is regulated it is certain that additional regulatory mechanisms exist to safeguard the fidelity of centriole duplication.  Here, we overview past and present data discussing the regulation and functions of PLK4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQklC7aPJn_9mhHGZei4OW9fW6udTcc2ebL5raA8KHlSLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfovVygug%253D%253D&md5=bfde20a11fdea2a94976f97ced04e63d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1186%2F1747-1028-5-25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1747-1028-5-25%26sid%3Dliteratum%253Aachs%26aulast%3DSillibourne%26aufirst%3DJ.%2BE.%26aulast%3DBornens%26aufirst%3DM.%26atitle%3DPolo-like%2520kinase%25204%253A%2520the%2520odd%2520one%2520out%2520of%2520the%2520family%26jtitle%3DCell%2520Div.%26date%3D2010%26volume%3D5%26spage%3D25%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Bettencourt-Dias, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues-Martins, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riparbelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatt, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balloux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, D. M.</span><span> </span><span class="NLM_article-title">SAK/PLK4 is required for centriole duplication and flagella development</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2199</span><span class="NLM_x">–</span> <span class="NLM_lpage">2207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1016%2Fj.cub.2005.11.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=16326102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlahu7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2199-2207&author=M.+Bettencourt-Diasauthor=A.+Rodrigues-Martinsauthor=L.+Carpenterauthor=M.+Riparbelliauthor=L.+Lehmannauthor=M.+K.+Gattauthor=N.+Carmoauthor=F.+Ballouxauthor=G.+Callainiauthor=D.+M.+Glover&title=SAK%2FPLK4+is+required+for+centriole+duplication+and+flagella+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">SAK/PLK4 Is Required for Centriole Duplication and Flagella Development</span></div><div class="casAuthors">Bettencourt-Dias, M.; Rodrigues-Martins, A.; Carpenter, L.; Riparbelli, M.; Lehmann, L.; Gatt, M. K.; Carmo, N.; Balloux, F.; Callaini, G.; Glover, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2199-2207</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">SAK/PLK4 is a distinct member of the polo-like kinase family.  SAK-/- mice die during embryogenesis, whereas SAK+/- mice develop liver and lung tumors and SAK+/- MEFs show mitotic abnormalities.  However, the mechanism underlying these phenotypes is still not known.  Here, the authors show that downregulation of SAK in Drosophila cells, by mutation or RNAi, leads to loss of centrioles, the core structures of centrosomes.  Such cells are able to undergo repeated rounds of cell division, but display broad disorganized mitotic spindle poles.  The authors also show that SAK mutants lose their centrioles during the mitotic divisions preceding male meiosis but still produce cysts of 16 primary spermatocytes as in the wild-type.  Math. modeling of the stereotyped cell divisions of spermatogenesis can account for such loss by defective centriole duplication.  The majority of spermatids in SAK mutants lack centrioles and so are unable to make sperm axonemes.  Finally, the authors show that depletion of SAK in human cells also prevents centriole duplication and gives rise to mitotic abnormalities.  SAK/PLK4 is necessary for centriole duplication both in Drosophila and human cells.  Drosophila cells tolerate the lack of centrioles and undertake mitosis but cannot form basal bodies and hence flagella.  Human cells depleted of SAK show error-prone mitosis, likely to underlie its tumor-suppressor role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFoGUh8x0B_7Vg90H21EOLACvtfcHk0ljPqgtNHhDFeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlahu7fP&md5=31069d55e1b8e6ecdaaababd791b72a7</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2005.11.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2005.11.042%26sid%3Dliteratum%253Aachs%26aulast%3DBettencourt-Dias%26aufirst%3DM.%26aulast%3DRodrigues-Martins%26aufirst%3DA.%26aulast%3DCarpenter%26aufirst%3DL.%26aulast%3DRiparbelli%26aufirst%3DM.%26aulast%3DLehmann%26aufirst%3DL.%26aulast%3DGatt%26aufirst%3DM.%2BK.%26aulast%3DCarmo%26aufirst%3DN.%26aulast%3DBalloux%26aufirst%3DF.%26aulast%3DCallaini%26aufirst%3DG.%26aulast%3DGlover%26aufirst%3DD.%2BM.%26atitle%3DSAK%252FPLK4%2520is%2520required%2520for%2520centriole%2520duplication%2520and%2520flagella%2520development%26jtitle%3DCurr.%2520Biol.%26date%3D2005%26volume%3D15%26spage%3D2199%26epage%3D2207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Habedanck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stierhof, Y.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">The Polo kinase PLK4 functions in centriole duplication</span> <span class="citation_source-journal">Nature Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1140</span><span class="NLM_x">–</span> <span class="NLM_lpage">1146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1038%2Fncb1335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=16244668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1WqtrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=1140-1146&author=R.+Habedanckauthor=Y.-D.+Stierhofauthor=C.+J.+Wilkinsonauthor=E.+A.+Nigg&title=The+Polo+kinase+PLK4+functions+in+centriole+duplication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The Polo kinase Plk4 functions in centriole duplication</span></div><div class="casAuthors">Habedanck, Robert; Stierhof, York-Dieter; Wilkinson, Christopher J.; Nigg, Erich A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1140-1146</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The human Polo-like kinase 1 (PLK1) and its functional homologs that are present in other eukaryotes have multiple, crucial roles in meiotic and mitotic cell division.  By contrast, the functions of other mammalian Polo family members remain largely unknown.  Plk4 is the most structurally divergent Polo family member; it is maximally expressed in actively dividing tissues and is essential for mouse embryonic development.  Here, we identify Plk4 as a key regulator of centriole duplication.  Both gain- and loss-of-function expts. demonstrate that Plk4 is required - in cooperation with Cdk2, CP110 and Hs-SAS6 - for the precise reprodn. of centrosomes during the cell cycle.  These findings provide an attractive explanation for the crucial function of Plk4 in cell proliferation and have implications for the role of Polo kinases in tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqCnuaYPx-YrVg90H21EOLACvtfcHk0ljPqgtNHhDFeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1WqtrjL&md5=dda15e878cf410e2de8796a4345aa405</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fncb1335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1335%26sid%3Dliteratum%253Aachs%26aulast%3DHabedanck%26aufirst%3DR.%26aulast%3DStierhof%26aufirst%3DY.-D.%26aulast%3DWilkinson%26aufirst%3DC.%2BJ.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DThe%2520Polo%2520kinase%2520PLK4%2520functions%2520in%2520centriole%2520duplication%26jtitle%3DNature%2520Cell%2520Biol.%26date%3D2005%26volume%3D7%26spage%3D1140%26epage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Kleylein-Sohn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westendorf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Clech, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habedanck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stierhof, Y.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">PLK4-induced centriole biogenesis in human cells</span> <span class="citation_source-journal">Dev. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=190-202&author=J.+Kleylein-Sohnauthor=J.+Westendorfauthor=M.+Le+Clechauthor=R.+Habedanckauthor=Y.-D.+Stierhofauthor=E.+A.+Nigg&title=PLK4-induced+centriole+biogenesis+in+human+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKleylein-Sohn%26aufirst%3DJ.%26aulast%3DWestendorf%26aufirst%3DJ.%26aulast%3DLe%2BClech%26aufirst%3DM.%26aulast%3DHabedanck%26aufirst%3DR.%26aulast%3DStierhof%26aufirst%3DY.-D.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DPLK4-induced%2520centriole%2520biogenesis%2520in%2520human%2520cells%26jtitle%3DDev.%2520Cell%26date%3D2007%26volume%3D13%26spage%3D190%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Peel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raff, J. W.</span><span> </span><span class="NLM_article-title">Overexpressing centriole-replication proteins in vivo induces centriole overduplication and de novo formation</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">834</span><span class="NLM_x">–</span> <span class="NLM_lpage">843</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1016%2Fj.cub.2007.04.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=17475495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1aht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=834-843&author=N.+Peelauthor=N.+R.+Stevensauthor=R.+Bastoauthor=J.+W.+Raff&title=Overexpressing+centriole-replication+proteins+in+vivo+induces+centriole+overduplication+and+de+novo+formation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpressing Centriole-Replication Proteins In Vivo Induces Centriole Overduplication and De Novo Formation</span></div><div class="casAuthors">Peel, Nina; Stevens, Naomi R.; Basto, Renata; Raff, Jordan W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">834-843</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Centrosomes have important roles in many aspects of cell organization, and aberrations in their no. and function are assocd. with various diseases, including cancer.  Centrosomes consist of a pair of centrioles surrounded by a pericentriolar matrix (PCM), and their replication is tightly regulated.  Here, we investigate the effects of overexpressing the 3 proteins known to be required for centriole replication in Drosophila: DSas-6, DSas-4, and Sak.  By directly observing centriole replication in living Drosophila embryos, we show that the overexpression of GFP-DSas-6 can drive extra rounds of centriole replication within a single cell cycle.  Extra centriole-like structures also accumulate in brain cells that overexpress either GFP-DSas-6 or GFP-Sak, but not DSas-4-GFP.  No extra centrioles accumulate in spermatocytes that overexpress any of these 3 proteins.  Most remarkably, the overexpression of any 1 of these 3 proteins results in the rapid de novo formation of many hundreds of centriole-like structures in unfertilized eggs, which normally do not contain centrioles.  Our data suggest that the levels of centriolar DSas-6 det. the no. of daughter centrioles formed during centriole replication.  Overexpression of either DSas-6 or Sak can induce the formation of extra centrioles in some tissues but not others, suggesting that centriole replication is regulated differently in different tissues.  The finding that the overexpression of DSas-4, DSas-6, or Sak can rapidly induce the de novo formation of centriole-like structures in Drosophila eggs suggests that this process results from the stabilization of centriole-precursors that are normally present in the egg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKnYNfvOO9UrVg90H21EOLACvtfcHk0lghnkell8amnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1aht78%253D&md5=87c8bdd099a367778687396dfc030e07</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2007.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2007.04.036%26sid%3Dliteratum%253Aachs%26aulast%3DPeel%26aufirst%3DN.%26aulast%3DStevens%26aufirst%3DN.%2BR.%26aulast%3DBasto%26aufirst%3DR.%26aulast%3DRaff%26aufirst%3DJ.%2BW.%26atitle%3DOverexpressing%2520centriole-replication%2520proteins%2520in%2520vivo%2520induces%2520centriole%2520overduplication%2520and%2520de%2520novo%2520formation%26jtitle%3DCurr.%2520Biol.%26date%3D2007%26volume%3D17%26spage%3D834%26epage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Hudson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozarova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macmillan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swallow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, J. W.</span><span> </span><span class="NLM_article-title">Late mitotic failure in mice lacking Sak, a polo-like kinase</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1016%2FS0960-9822%2801%2900117-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=11301255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXis1Sjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=441-446&author=J.+W.+Hudsonauthor=A.+Kozarovaauthor=P.+Cheungauthor=J.+C.+Macmillanauthor=C.+J.+Swallowauthor=J.+C.+Crossauthor=J.+W.+Dennis&title=Late+mitotic+failure+in+mice+lacking+Sak%2C+a+polo-like+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Late mitotic failure in mice lacking Sak, a polo-like kinase</span></div><div class="casAuthors">Hudson, J. W.; Kozarova, A.; Cheung, P.; Macmillan, J. C.; Swallow, C. J.; Cross, J. C.; Dennis, J. W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">441-446</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Polo-like kinases in yeast, flies, and mammals regulate key events in mitosis.  Such events include spindle formation at G2/M, the anaphase-promoting complex (APC) at the exit from mitosis, the cleavage structure at cytokinesis, and DNA damage checkpoints in G2/M.  Polo-like kinases are distinguished by two C-terminal polo box (pb) motifs, which localize the enzymes to mitotic structures.  We previously identified Sak, a novel polo-like kinase found in Drosophila and mammals.  Here, we demonstrate that the Sak kinase has a functional pb domain that localizes the enzyme to the nucleolus during G2, to the centrosomes in G2/M, and to the cleavage furrow during cytokinesis.  To study the role of Sak in embryo development, we generated a Sak null allele, the first polo-like kinase to be mutated in mice.  Sak-/- embryos arrested after gastrulation at E7.5, with a marked increase in mitotic and apoptotic cells.  Sak-/- embryos displayed cells in late anaphase or telophase that continued to express cyclin B1 and phosphorylated histone H3.  Our results suggest that Sak is required for the APC-dependent destruction of cyclin B1 and for exit from mitosis in the postgastrulation embryo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNr2bwHbpvC7Vg90H21EOLACvtfcHk0lhl-Epe7BvVRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXis1Sjtrc%253D&md5=c38f41a06857914e256fe2388c0d7623</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0960-9822%2801%2900117-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-9822%252801%252900117-8%26sid%3Dliteratum%253Aachs%26aulast%3DHudson%26aufirst%3DJ.%2BW.%26aulast%3DKozarova%26aufirst%3DA.%26aulast%3DCheung%26aufirst%3DP.%26aulast%3DMacmillan%26aufirst%3DJ.%2BC.%26aulast%3DSwallow%26aufirst%3DC.%2BJ.%26aulast%3DCross%26aufirst%3DJ.%2BC.%26aulast%3DDennis%26aufirst%3DJ.%2BW.%26atitle%3DLate%2520mitotic%2520failure%2520in%2520mice%2520lacking%2520Sak%252C%2520a%2520polo-like%2520kinase%26jtitle%3DCurr.%2520Biol.%26date%3D2001%26volume%3D11%26spage%3D441%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Cunha-Ferreira, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues-Martins, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bento, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riparbelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laue, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettencourt-Dias, M.</span><span> </span><span class="NLM_article-title">The SCF/Slimb ubiquitin ligase limits centrosome amplification through degradation of SAK/PLK4</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1016%2Fj.cub.2008.11.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=19084407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVamtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=43-49&author=I.+Cunha-Ferreiraauthor=A.+Rodrigues-Martinsauthor=I.+Bentoauthor=M.+Riparbelliauthor=W.+Zhangauthor=E.+Laueauthor=G.+Callainiauthor=D.+M.+Gloverauthor=M.+Bettencourt-Dias&title=The+SCF%2FSlimb+ubiquitin+ligase+limits+centrosome+amplification+through+degradation+of+SAK%2FPLK4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The SCF/Slimb Ubiquitin Ligase Limits Centrosome Amplification through Degradation of SAK/PLK4</span></div><div class="casAuthors">Cunha-Ferreira, Ines; Rodrigues-Martins, Ana; Bento, Ines; Riparbelli, Maria; Zhang, Wei; Laue, Ernest; Callaini, Giuliano; Glover, David M.; Bettencourt-Dias, Monica</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-49</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Centrioles are essential for the formation of microtubule-derived structures, including cilia and centrosomes.  Abnormalities in centrosome no. and structure occur in many cancers and are assocd. with genomic instability.  In most dividing animal cells, centriole formation is coordinated with DNA replication and is highly regulated such that only one daughter centriole forms close to each mother centriole.  Centriole formation is triggered and dependent on a conserved kinase, SAK/PLK4.  Downregulation and overexpression of SAK/PLK4 is assocd. with cancer in humans, mice, and flies.  Here we show that centrosome amplification is normally inhibited by degrdn. of SAK/PLK4, mediated by the SCF/Slimb ubiquitin ligase.  This complex phys. interacts with SAK/PLK4, and in its absence, SAK/PLK4 accumulates, leading to the striking formation of multiple daughter centrioles surrounding each mother.  This interaction is mediated via a conserved Slimb binding motif in SAK/PLK4, mutations of which leads to centrosome amplification.  This regulation is likely to be conserved, because knockout of the ortholog of Slimb, β-Trcp1 in mice, also leads to centrosome amplification.  Because the SCF/β-Trcp complex plays an important role in cell-cycle progression, our results lead to new understanding of the control of centrosome no. and how it may go awry in human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowKTYy51boqrVg90H21EOLACvtfcHk0lhl-Epe7BvVRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVamtQ%253D%253D&md5=c838ab567d3d77767ed9979862649404</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2008.11.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2008.11.037%26sid%3Dliteratum%253Aachs%26aulast%3DCunha-Ferreira%26aufirst%3DI.%26aulast%3DRodrigues-Martins%26aufirst%3DA.%26aulast%3DBento%26aufirst%3DI.%26aulast%3DRiparbelli%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLaue%26aufirst%3DE.%26aulast%3DCallaini%26aufirst%3DG.%26aulast%3DGlover%26aufirst%3DD.%2BM.%26aulast%3DBettencourt-Dias%26aufirst%3DM.%26atitle%3DThe%2520SCF%252FSlimb%2520ubiquitin%2520ligase%2520limits%2520centrosome%2520amplification%2520through%2520degradation%2520of%2520SAK%252FPLK4%26jtitle%3DCurr.%2520Biol.%26date%3D2009%26volume%3D19%26spage%3D43%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Rogers, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusan, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peifer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, S. L.</span><span> </span><span class="NLM_article-title">The SCF/Slimb ubiquitin ligase regulates PLK4/Sak levels to block centriole reduplication</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">184</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2009&pages=225-238&author=G.+C.+Rogersauthor=N.+M.+Rusanauthor=D.+M.+Robertsauthor=M.+Peiferauthor=S.+L.+Rogers&title=The+SCF%2FSlimb+ubiquitin+ligase+regulates+PLK4%2FSak+levels+to+block+centriole+reduplication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DG.%2BC.%26aulast%3DRusan%26aufirst%3DN.%2BM.%26aulast%3DRoberts%26aufirst%3DD.%2BM.%26aulast%3DPeifer%26aufirst%3DM.%26aulast%3DRogers%26aufirst%3DS.%2BL.%26atitle%3DThe%2520SCF%252FSlimb%2520ubiquitin%2520ligase%2520regulates%2520PLK4%252FSak%2520levels%2520to%2520block%2520centriole%2520reduplication%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2009%26volume%3D184%26spage%3D225%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Guderian, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westendorf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uldschmid, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">PLK4 trans-autophosphorylation regulates centriole number by controlling betaTrCP-mediated degradation</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">2163</span><span class="NLM_x">–</span> <span class="NLM_lpage">2169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1242%2Fjcs.068502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=20516151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVWlsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2010&pages=2163-2169&author=G.+Guderianauthor=J.+Westendorfauthor=A.+Uldschmidauthor=E.+A.+Nigg&title=PLK4+trans-autophosphorylation+regulates+centriole+number+by+controlling+betaTrCP-mediated+degradation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Plk4 trans-autophosphorylation regulates centriole number by controlling βTrCP-mediated degradation</span></div><div class="casAuthors">Guderian, Gernot; Westendorf, Jens; Uldschmid, Andreas; Nigg, Erich A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2163-2169</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Centrioles are the main constituents of the mammalian centrosome and act as basal bodies for ciliogenesis.  Centrosomes organize the cytoplasmic microtubule network during interphase and the mitotic spindle during mitosis, and aberrations in centrosome no. have been implicated in chromosomal instability and tumor formation.  The centriolar protein Polo-like kinase 4 (Plk4) is a key regulator of centriole biogenesis and is crucial for maintaining const. centriole no., but the mechanisms regulating its activity and expression are only beginning to emerge.  Here, we show that human Plk4 is subject to βTrCP-dependent proteasomal degrdn., indicating that this pathway is conserved from Drosophila to human.  Unexpectedly, we found that stable overexpression of kinase-dead Plk4 leads to centriole overduplication.  This phenotype depends on the presence of endogenous wild-type Plk4.  Our data indicate that centriole overduplication results from disruption of Plk4 trans-autophosphorylation by kinase-dead Plk4, which then shields endogenous Plk4 from recognition by βTrCP.  We conclude that active Plk4 promotes its own degrdn. by catalyzing βTrCP binding through trans-autophosphorylation (phosphorylation by the other kinase in the dimer) within homodimers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2g342LYsoobVg90H21EOLACvtfcHk0lj2eoQ_gNP3oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVWlsLrL&md5=3354d6f7e9e4f9664fafa9e9cdf15209</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1242%2Fjcs.068502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.068502%26sid%3Dliteratum%253Aachs%26aulast%3DGuderian%26aufirst%3DG.%26aulast%3DWestendorf%26aufirst%3DJ.%26aulast%3DUldschmid%26aufirst%3DA.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DPLK4%2520trans-autophosphorylation%2520regulates%2520centriole%2520number%2520by%2520controlling%2520betaTrCP-mediated%2520degradation%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2010%26volume%3D123%26spage%3D2163%26epage%3D2169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Holland, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niessen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoover, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleveland, D. W.</span><span> </span><span class="NLM_article-title">Polo-like kinase 4 kinase activity limits centrosome overduplication by autoregulating its own stability</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">188</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2010&pages=191-198&author=A.+J.+Hollandauthor=W.+Lanauthor=S.+Niessenauthor=H.+Hooverauthor=D.+W.+Cleveland&title=Polo-like+kinase+4+kinase+activity+limits+centrosome+overduplication+by+autoregulating+its+own+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolland%26aufirst%3DA.%2BJ.%26aulast%3DLan%26aufirst%3DW.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DHoover%26aufirst%3DH.%26aulast%3DCleveland%26aufirst%3DD.%2BW.%26atitle%3DPolo-like%2520kinase%25204%2520kinase%2520activity%2520limits%2520centrosome%2520overduplication%2520by%2520autoregulating%2520its%2520own%2520stability%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2010%26volume%3D188%26spage%3D191%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Brownlee, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebba, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buster, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G. C.</span><span> </span><span class="NLM_article-title">The protein phosphatase 2A regulatory subunit Twins stabilizes PLK4 to induce centriole amplification</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2011&pages=231-243&author=C.+W.+Brownleeauthor=J.+E.+Klebbaauthor=D.+W.+Busterauthor=G.+C.+Rogers&title=The+protein+phosphatase+2A+regulatory+subunit+Twins+stabilizes+PLK4+to+induce+centriole+amplification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrownlee%26aufirst%3DC.%2BW.%26aulast%3DKlebba%26aufirst%3DJ.%2BE.%26aulast%3DBuster%26aufirst%3DD.%2BW.%26aulast%3DRogers%26aufirst%3DG.%2BC.%26atitle%3DThe%2520protein%2520phosphatase%25202A%2520regulatory%2520subunit%2520Twins%2520stabilizes%2520PLK4%2520to%2520induce%2520centriole%2520amplification%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2011%26volume%3D195%26spage%3D231%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Ganem, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godinho, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellman, D.</span><span> </span><span class="NLM_article-title">A mechanism linking extra centrosomes to chromosomal instability</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">460</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=460&publication_year=2009&pages=278-282&author=N.+J.+Ganemauthor=S.+A.+Godinhoauthor=D.+Pellman&title=A+mechanism+linking+extra+centrosomes+to+chromosomal+instability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGanem%26aufirst%3DN.%2BJ.%26aulast%3DGodinho%26aufirst%3DS.%2BA.%26aulast%3DPellman%26aufirst%3DD.%26atitle%3DA%2520mechanism%2520linking%2520extra%2520centrosomes%2520to%2520chromosomal%2520instability%26jtitle%3DNature%26date%3D2009%26volume%3D460%26spage%3D278%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Mason, J.; Wei, S.; Luo, S.; Nadeem, V.; Kiarash, R.; Huang, P.; Awrey, A.; Leung, G.; Beletskaya, I.; Feher, M.; Forrest, B.; Laufer, R.; Sampson, P.; Li, S.-W.; Liu, Y.; Lang, Y.; Pauls, H. W.; Mak, T. W.; Pan, J. G.</span><span> </span><span class="NLM_article-title">Inhibition of Polo-like kinase 4 as an anti-cancer strategy</span>. In Book of Abstracts, <span class="NLM_conf-name">AACR 102nd Annual Meeting</span>, <span class="NLM_conf-loc">Orlando, FL</span>, <span class="NLM_conf-date">April 2-6, 2011</span>,  <span class="NLM_fpage">LB-215</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mason%2C+J.%3B+Wei%2C+S.%3B+Luo%2C+S.%3B+Nadeem%2C+V.%3B+Kiarash%2C+R.%3B+Huang%2C+P.%3B+Awrey%2C+A.%3B+Leung%2C+G.%3B+Beletskaya%2C+I.%3B+Feher%2C+M.%3B+Forrest%2C+B.%3B+Laufer%2C+R.%3B+Sampson%2C+P.%3B+Li%2C+S.-W.%3B+Liu%2C+Y.%3B+Lang%2C+Y.%3B+Pauls%2C+H.+W.%3B+Mak%2C+T.+W.%3B+Pan%2C+J.+G.+Inhibition+of+Polo-like+kinase+4+as+an+anti-cancer+strategy.+In+Book+of+Abstracts%2C+AACR+102nd+Annual+Meeting%2C+Orlando%2C+FL%2C+April+2-6%2C+2011%2C+LB-215."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520Polo-like%2520kinase%25204%2520as%2520an%2520anti-cancer%2520strategy%26jtitle%3DBook%2520of%2520Abstracts%26spage%3DLB-215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Targeting the Cell Cycle in Cancer: TTK (MPS1) and PLK4 as Novel Mitotic Targets</span>. In Book of Abstracts, <span class="NLM_conf-name">AACR 103rd Annual Meeting</span>, <span class="NLM_conf-loc">Chicago, IL</span>, <span class="NLM_conf-date">April 1–5, 2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mak%2C+T.+W.+Targeting+the+Cell+Cycle+in+Cancer%3A+TTK+%28MPS1%29+and+PLK4+as+Novel+Mitotic+Targets.+In+Book+of+Abstracts%2C+AACR+103rd+Annual+Meeting%2C+Chicago%2C+IL%2C+April+1%E2%80%935%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DTargeting%2520the%2520Cell%2520Cycle%2520in%2520Cancer%253A%2520TTK%2520%2528MPS1%2529%2520and%2520PLK4%2520as%2520Novel%2520Mitotic%2520Targets%26jtitle%3DBook%2520of%2520Abstracts" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marron, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qaqish, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livasy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dressler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nobel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewend, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tretiakova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orrico, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palazzo, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perreard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olopade, O. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perou, C. M.</span><span> </span><span class="NLM_article-title">The molecular portraits of breast tumors are conserved across microarray platforms</span> <span class="citation_source-journal">BMC Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=96-108&author=Z.+Huauthor=C.+Fanauthor=D.+S.+Ohauthor=J.+S.+Marronauthor=X.+Heauthor=B.+F.+Qaqishauthor=C.+Livasyauthor=L.+A.+Careyauthor=E.+Reynoldsauthor=L.+Dresslerauthor=A.+Nobelauthor=J.+Parkerauthor=M.+G.+Ewendauthor=L.+R.+Sawyerauthor=J.+Wuauthor=Y.+Liuauthor=R.+Nandaauthor=M.+Tretiakovaauthor=A.+R.+Orricoauthor=D.+Dreherauthor=J.+P.+Palazzoauthor=L.+Perreardauthor=E.+Nelsonauthor=M.+Moneauthor=H.+Hansenauthor=M.+Mullinsauthor=J.+F.+Quackenbushauthor=M.+J.+Ellisauthor=O.+I.+Olopadeauthor=P.+S.+Bernardauthor=C.+M.+Perou&title=The+molecular+portraits+of+breast+tumors+are+conserved+across+microarray+platforms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DOh%26aufirst%3DD.%2BS.%26aulast%3DMarron%26aufirst%3DJ.%2BS.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DQaqish%26aufirst%3DB.%2BF.%26aulast%3DLivasy%26aufirst%3DC.%26aulast%3DCarey%26aufirst%3DL.%2BA.%26aulast%3DReynolds%26aufirst%3DE.%26aulast%3DDressler%26aufirst%3DL.%26aulast%3DNobel%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DJ.%26aulast%3DEwend%26aufirst%3DM.%2BG.%26aulast%3DSawyer%26aufirst%3DL.%2BR.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DNanda%26aufirst%3DR.%26aulast%3DTretiakova%26aufirst%3DM.%26aulast%3DOrrico%26aufirst%3DA.%2BR.%26aulast%3DDreher%26aufirst%3DD.%26aulast%3DPalazzo%26aufirst%3DJ.%2BP.%26aulast%3DPerreard%26aufirst%3DL.%26aulast%3DNelson%26aufirst%3DE.%26aulast%3DMone%26aufirst%3DM.%26aulast%3DHansen%26aufirst%3DH.%26aulast%3DMullins%26aufirst%3DM.%26aulast%3DQuackenbush%26aufirst%3DJ.%2BF.%26aulast%3DEllis%26aufirst%3DM.%2BJ.%26aulast%3DOlopade%26aufirst%3DO.%2BI.%26aulast%3DBernard%26aufirst%3DP.%2BS.%26aulast%3DPerou%26aufirst%3DC.%2BM.%26atitle%3DThe%2520molecular%2520portraits%2520of%2520breast%2520tumors%2520are%2520conserved%2520across%2520microarray%2520platforms%26jtitle%3DBMC%2520Genomics%26date%3D2006%26volume%3D7%26spage%3D96%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">van di Vijver, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van ’t Veer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voskuil, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterse, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atsma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witteveen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delahaye, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Velde, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartelink, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodenhuis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutgers, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friend, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernards, R.</span><span> </span><span class="NLM_article-title">A gene-expression signature as a predictor of survival in breast cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">1999</span><span class="NLM_x">–</span> <span class="NLM_lpage">2009</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1056%2FNEJMoa021967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=12490681" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2002&pages=1999-2009&author=M.+J.+van+di+Vijverauthor=Y.+D.+Heauthor=L.+van+%E2%80%99t+Veerauthor=H.+Daiauthor=A.+A.+M.+Hartauthor=D.+W.+Voskuilauthor=G.+J.+Schreiberauthor=J.+L.+Peterseauthor=C.+Robertsauthor=M.+J.+Martonauthor=M.+Parrishauthor=D.+Atsmaauthor=A.+Witteveenauthor=A.+Glasauthor=L.+Delahayeauthor=T.+van+der+Veldeauthor=H.+Bartelinkauthor=S.+Rodenhuisauthor=E.+T.+Rutgersauthor=S.+H.+Friendauthor=R.+Bernards&title=A+gene-expression+signature+as+a+predictor+of+survival+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa021967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa021967%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bdi%2BVijver%26aufirst%3DM.%2BJ.%26aulast%3DHe%26aufirst%3DY.%2BD.%26aulast%3Dvan%2B%25E2%2580%2599t%2BVeer%26aufirst%3DL.%26aulast%3DDai%26aufirst%3DH.%26aulast%3DHart%26aufirst%3DA.%2BA.%2BM.%26aulast%3DVoskuil%26aufirst%3DD.%2BW.%26aulast%3DSchreiber%26aufirst%3DG.%2BJ.%26aulast%3DPeterse%26aufirst%3DJ.%2BL.%26aulast%3DRoberts%26aufirst%3DC.%26aulast%3DMarton%26aufirst%3DM.%2BJ.%26aulast%3DParrish%26aufirst%3DM.%26aulast%3DAtsma%26aufirst%3DD.%26aulast%3DWitteveen%26aufirst%3DA.%26aulast%3DGlas%26aufirst%3DA.%26aulast%3DDelahaye%26aufirst%3DL.%26aulast%3Dvan%2Bder%2BVelde%26aufirst%3DT.%26aulast%3DBartelink%26aufirst%3DH.%26aulast%3DRodenhuis%26aufirst%3DS.%26aulast%3DRutgers%26aufirst%3DE.%2BT.%26aulast%3DFriend%26aufirst%3DS.%2BH.%26aulast%3DBernards%26aufirst%3DR.%26atitle%3DA%2520gene-expression%2520signature%2520as%2520a%2520predictor%2520of%2520survival%2520in%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D347%26spage%3D1999%26epage%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Miller, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeds, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergara, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ploner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawitan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, J.</span><span> </span><span class="NLM_article-title">An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">13550</span><span class="NLM_x">–</span> <span class="NLM_lpage">13555</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=13550-13555&author=L.+D.+Millerauthor=J.+Smedsauthor=J.+Georgeauthor=V.+B.+Vegaauthor=L.+Vergaraauthor=A.+Plonerauthor=Y.+Pawitanauthor=P.+Hallauthor=S.+Klaarauthor=E.+T.+Liuauthor=J.+Bergh&title=An+expression+signature+for+p53+status+in+human+breast+cancer+predicts+mutation+status%2C+transcriptional+effects%2C+and+patient+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DL.%2BD.%26aulast%3DSmeds%26aufirst%3DJ.%26aulast%3DGeorge%26aufirst%3DJ.%26aulast%3DVega%26aufirst%3DV.%2BB.%26aulast%3DVergara%26aufirst%3DL.%26aulast%3DPloner%26aufirst%3DA.%26aulast%3DPawitan%26aufirst%3DY.%26aulast%3DHall%26aufirst%3DP.%26aulast%3DKlaar%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DE.%2BT.%26aulast%3DBergh%26aufirst%3DJ.%26atitle%3DAn%2520expression%2520signature%2520for%2520p53%2520status%2520in%2520human%2520breast%2520cancer%2520predicts%2520mutation%2520status%252C%2520transcriptional%2520effects%252C%2520and%2520patient%2520survival%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D13550%26epage%3D13555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giranda, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span> </span><span class="NLM_article-title">Pharmacological and Functional Comparison of the Polo-Like Kinase Family: Insight into Inhibitor and Substrate Specificity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">9551</span><span class="NLM_x">–</span> <span class="NLM_lpage">9563</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi7008745" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=9551-9563&author=E.+F.+Johnsonauthor=K.+D.+Stewartauthor=K.+W.+Woodsauthor=V.+L.+Girandaauthor=Y.+Luo&title=Pharmacological+and+Functional+Comparison+of+the+Polo-Like+Kinase+Family%3A+Insight+into+Inhibitor+and+Substrate+Specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fbi7008745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7008745%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DWoods%26aufirst%3DK.%2BW.%26aulast%3DGiranda%26aufirst%3DV.%2BL.%26aulast%3DLuo%26aufirst%3DY.%26atitle%3DPharmacological%2520and%2520Functional%2520Comparison%2520of%2520the%2520Polo-Like%2520Kinase%2520Family%253A%2520Insight%2520into%2520Inhibitor%2520and%2520Substrate%2520Specificity%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D9551%26epage%3D9563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolinsky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heimbrook, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span> </span><span class="NLM_article-title">Small-molecule inducer of cancer cell polyploidy promotes apoptosis or senescence: implications for therapy</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">3364</span><span class="NLM_x">–</span> <span class="NLM_lpage">3375</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=3364-3375&author=C.+Tovarauthor=B.+Higginsauthor=D.+Deoauthor=K.+Kolinskyauthor=J.-J.+Liuauthor=D.+C.+Heimbrookauthor=L.+T.+Vassilev&title=Small-molecule+inducer+of+cancer+cell+polyploidy+promotes+apoptosis+or+senescence%3A+implications+for+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DDeo%26aufirst%3DD.%26aulast%3DKolinsky%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DJ.-J.%26aulast%3DHeimbrook%26aufirst%3DD.%2BC.%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26atitle%3DSmall-molecule%2520inducer%2520of%2520cancer%2520cell%2520polyploidy%2520promotes%2520apoptosis%2520or%2520senescence%253A%2520implications%2520for%2520therapy%26jtitle%3DCell%2520Cycle%26date%3D2010%26volume%3D9%26spage%3D3364%26epage%3D3375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Diels, G. S. M.; Ten Holte, P.; Freyne, E. J. E.; Grand-Perret, T. A. R.; Van Emelen, K.; Embrechts, W. C. J.; Bonnet, P. G. A.</span><span> </span><span class="NLM_article-title">Pyrrolopyrimidines</span>. PCT Int. Appl. WO 2009016132,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=G.+S.+M.+Diels&author=P.+Ten+Holte&author=E.+J.+E.+Freyne&author=T.+A.+R.+Grand-Perret&author=K.+Van+Emelen&author=W.+C.+J.+Embrechts&author=P.+G.+A.+Bonnet&title=Pyrrolopyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDiels%26aufirst%3DG.%2BS.%2BM.%26atitle%3DPyrrolopyrimidines%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Buijnsters, P. J. J. A.; Verdonck, M. G. C.; Van Emelen, K.; Bonnet, P. G. A.</span><span> </span><span class="NLM_article-title">4-Aryl-2-anilino-pyrimidines as PLK kinase inhibitors</span>. PCT Int. Appl. WO 2009112439,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=P.+J.+J.+A.+Buijnsters&author=M.+G.+C.+Verdonck&author=K.+Van+Emelen&author=P.+G.+A.+Bonnet&title=4-Aryl-2-anilino-pyrimidines+as+PLK+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBuijnsters%26aufirst%3DP.%2BJ.%2BJ.%2BA.%26atitle%3D4-Aryl-2-anilino-pyrimidines%2520as%2520PLK%2520kinase%2520inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">PLK4 Inhibitors of Novel Structure as Potent Anti-proliferative Agents</span>. Book of Abstracts, <span class="NLM_conf-name">241st ACS National Meeting</span>, <span class="NLM_conf-loc">Anaheim, CA</span>, <span class="NLM_conf-date">March 27–31, 2011</span>,  <span class="NLM_fpage">MEDI 189</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Pauls%2C+H.+W.+PLK4+Inhibitors+of+Novel+Structure+as+Potent+Anti-proliferative+Agents.+Book+of+Abstracts%2C+241st+ACS+National+Meeting%2C+Anaheim%2C+CA%2C+March+27%E2%80%9331%2C+2011%2C+MEDI+189."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DPLK4%2520Inhibitors%2520of%2520Novel%2520Structure%2520as%2520Potent%2520Anti-proliferative%2520Agents%26jtitle%3DBook%2520of%2520Abstracts%26spage%3DMEDI%2520189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Baber, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirley, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feher, M.</span><span> </span><span class="NLM_article-title">The Use of Consensus Scanning in Ligand-Based Virtual Screening</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci050296y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKltrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=277-288&author=C.+Baberauthor=W.+Shirleyauthor=Y.+Gaoauthor=M.+Feher&title=The+Use+of+Consensus+Scanning+in+Ligand-Based+Virtual+Screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The use of consensus scoring in ligand-based virtual screening</span></div><div class="casAuthors">Baber, J. Christian; Shirley, William A.; Gao, Yinghong; Feher, Miklos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">277-288</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new consensus approach has been developed for ligand-based virtual screening.  It involves combining highly disparate properties in order to improve performance in virtual screening.  The properties include structural, 2D pharmacophore and property-based fingerprints, scores derived using BCUT descriptors, and 3D pharmacophore approaches.  Different approaches for the combination of all or some of these methods have been tested.  Logistic regression and sum ranks were found to be the most advantageous in different pharmaceutical applications.  The three major reasons consensus scoring appears to enrich data sets better than single scoring functions are (1) using multiple scoring functions is similar to repeated samplings, in which case the mean is closer to the true value than any single value, (2) due to the better clustering of actives, multiple sampling will recover more actives than inactives, and (3) different methods seem to agree more on the ranking of the actives than on the inactives.  Furthermore, consensus results are not only better but are also more consistent across receptor systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGM-4XLoNCUbVg90H21EOLACvtfcHk0lgZ7DmpP_rAwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKltrzM&md5=712a51193b4a98a02b668832f6ff7b20</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fci050296y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci050296y%26sid%3Dliteratum%253Aachs%26aulast%3DBaber%26aufirst%3DC.%26aulast%3DShirley%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DFeher%26aufirst%3DM.%26atitle%3DThe%2520Use%2520of%2520Consensus%2520Scanning%2520in%2520Ligand-Based%2520Virtual%2520Screening%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2006%26volume%3D46%26spage%3D277%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Feher, V. A.; Lawson, D. J.</span><span> </span><span class="NLM_article-title">Approaches to kinase homology modeling: successes and consideration for the structural kinome</span>. In  <span class="citation_source-book">Kinase Inhibitor Drugs</span>; <span class="NLM_contrib-group">Li, R.; Stafford, J. A.</span>, Eds.; <span class="NLM_publisher-name">John Wiley & Sons Inc.</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Chapter 17, pp  <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1002%2F9780470524961.ch17" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=433-460&author=V.+A.+Feher&author=D.+J.+Lawsonauthor=R.+Li&author=J.+A.+Stafford&title=Kinase+Inhibitor+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2F9780470524961.ch17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9780470524961.ch17%26sid%3Dliteratum%253Aachs%26aulast%3DFeher%26aufirst%3DV.%2BA.%26atitle%3DApproaches%2520to%2520kinase%2520homology%2520modeling%253A%2520successes%2520and%2520consideration%2520for%2520the%2520structural%2520kinome%26btitle%3DKinase%2520Inhibitor%2520Drugs%26aulast%3DLi%26aufirst%3DR.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%2520Inc%26date%3D2009%26spage%3D433%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span>GOLD, <span class="NLM_edition">version 3.2</span>; <span class="NLM_publisher-name">Cambridge Crystallographic Database</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GOLD%2C+version+3.2%3B+Cambridge+Crystallographic+Database%3A+Cambridge%2C+U.K.%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGOLD%26pub%3DCambridge%2520Crystallographic%2520Database%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span>Glide, <span class="NLM_edition">version 2007</span>; <span class="NLM_publisher-name">Schrodinger Inc.</span>: <span class="NLM_publisher-loc">Portland, OR</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+2007%3B+Schrodinger+Inc.%3A+Portland%2C+OR%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGlide%26pub%3DSchrodinger%2520Inc%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Lackey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O. Bradley McDonald, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNutt, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peel, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutkowske, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, E. R.</span><span> </span><span class="NLM_article-title">The Discovery of Potent cRaf1 Kinase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=223-226&author=K.+Lackeyauthor=M.+Coryauthor=R.+Davisauthor=S.+V.+Fryeauthor=P.+A.+Harrisauthor=R.+N.+Hunterauthor=D.+K.+Jungauthor=O.+B.+O.+Bradley+McDonaldauthor=R.+W.+McNuttauthor=M.+R.+Peelauthor=R.+D.+Rutkowskeauthor=J.+M.+Vealauthor=E.+R.+Wood&title=The+Discovery+of+Potent+cRaf1+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLackey%26aufirst%3DK.%26aulast%3DCory%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DHunter%26aufirst%3DR.%2BN.%26aulast%3DJung%26aufirst%3DD.%2BK.%26aulast%3DO.%2BBradley%2BMcDonald%26aufirst%3DO.%2BB.%26aulast%3DMcNutt%26aufirst%3DR.%2BW.%26aulast%3DPeel%26aufirst%3DM.%2BR.%26aulast%3DRutkowske%26aufirst%3DR.%2BD.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DWood%26aufirst%3DE.%2BR.%26atitle%3DThe%2520Discovery%2520of%2520Potent%2520cRaf1%2520Kinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D223%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Braud, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duflos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nourrisson, M.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonnerre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Baut, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, G.</span><span> </span><span class="NLM_article-title">Potential Inhibitors of Angiogenesis, Part I: 3-(Imidazole-4(5)-ylmethylene)indoin-2-ones</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1080%2F1475636031000106575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=14506915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlt1GhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=243-252&author=E.+Braudauthor=M.+Duflosauthor=M.-R.+Nourrissonauthor=A.+Tonnerreauthor=C.+Picotauthor=G.+Le+Bautauthor=P.+Renardauthor=B.+Pfeifferauthor=G.+Tucker&title=Potential+Inhibitors+of+Angiogenesis%2C+Part+I%3A+3-%28Imidazole-4%285%29-ylmethylene%29indoin-2-ones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Potential Inhibitors of Angiogenesis. Part I: 3-(Imidazol-4(5)-ylmethylene)indolin-2-ones</span></div><div class="casAuthors">Braud, Emmanuelle; Duflos, Muriel; Nourrisson, Marie-Renee; Tonnerre, Alain; Picot, Carine; Le Baut, Guillaume; Renard, Pierre; Pfeiffer, Bruno; Tucker, Gordon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">243-252</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The synthesis and pharmacol. evaluation of new 3-(imidazol-4(5)-ylmethylene)indolin-2-ones, analogs of SU-5416, are reported.  The final compds. 20-51 were obtained by Knoevenagel coupling between the substituted indolin-2-ones 1-15 and either the formylimidazole derivs. 16-18 or 2-formyl-3,5-dimethylpyrrole 19.  Methylation at the nitrogen atom of the indolin-2-one and/or imidazole moieties was carried out in the presence of the couple NaH/DMF.  A Mannich reaction afforded the 1-dimethylaminomethyl derivs. 43 and 48.  The antiangiogenic activity of these compds. was evaluated in a three dimensional in vitro rat aortic ring assay.  In this test, compd. 20 induced a decrease of angiogenesis comparable to that obsd. with SU-5416; the vascular d. indexes at 1 μM were 30±18 and 22±4 % of control, resp.  The compds. were also evaluated, in an independent manner, as inhibitors of the human EGF-receptor tyrosine kinase activity.  As expected, only minor activities were obsd. with four compds., out of thirty-one, exerting inhibitory effects in the range of 40-55 % at 10 μM concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-ry4RtIrkrrVg90H21EOLACvtfcHk0lhclsDZ3cB1OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlt1GhtbY%253D&md5=0d2657ea2a41d61bbd366834c0a328b1</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1080%2F1475636031000106575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F1475636031000106575%26sid%3Dliteratum%253Aachs%26aulast%3DBraud%26aufirst%3DE.%26aulast%3DDuflos%26aufirst%3DM.%26aulast%3DNourrisson%26aufirst%3DM.-R.%26aulast%3DTonnerre%26aufirst%3DA.%26aulast%3DPicot%26aufirst%3DC.%26aulast%3DLe%2BBaut%26aufirst%3DG.%26aulast%3DRenard%26aufirst%3DP.%26aulast%3DPfeiffer%26aufirst%3DB.%26aulast%3DTucker%26aufirst%3DG.%26atitle%3DPotential%2520Inhibitors%2520of%2520Angiogenesis%252C%2520Part%2520I%253A%25203-%2528Imidazole-4%25285%2529-ylmethylene%2529indoin-2-ones%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2003%26volume%3D18%26spage%3D243%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Krishnamurthy, V. V.</span><span> </span><span class="NLM_article-title">Excitation-Sculptured Indirect-Detection Experiment (EXSIDE) for Long-Range CH Coupling-Constant Measurement</span> <span class="citation_source-journal">J. Magn. Reson.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=1996&pages=33-41&author=V.+V.+Krishnamurthy&title=Excitation-Sculptured+Indirect-Detection+Experiment+%28EXSIDE%29+for+Long-Range+CH+Coupling-Constant+Measurement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnamurthy%26aufirst%3DV.%2BV.%26atitle%3DExcitation-Sculptured%2520Indirect-Detection%2520Experiment%2520%2528EXSIDE%2529%2520for%2520Long-Range%2520CH%2520Coupling-Constant%2520Measurement%26jtitle%3DJ.%2520Magn.%2520Reson.%26date%3D1996%26volume%3D121%26spage%3D33%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">App, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2588</span><span class="NLM_x">–</span> <span class="NLM_lpage">2603</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2588-2603&author=S.+Liauthor=H.+Tranauthor=F.+Tangauthor=H.+Appauthor=P.+Hirthauthor=G.+McMahonauthor=C.+Tang&title=Synthesis+and+biological+evaluations+of+3-substituted+indolin-2-ones%3A+a+novel+class+of+tyrosine+kinase+inhibitors+that+exhibit+selectivity+toward+particular+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.%26aulast%3DTran%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DApp%26aufirst%3DH.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluations%2520of%25203-substituted%2520indolin-2-ones%253A%2520a%2520novel%2520class%2520of%2520tyrosine%2520kinase%2520inhibitors%2520that%2520exhibit%2520selectivity%2520toward%2520particular%2520receptor%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2588%26epage%3D2603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Höttecke, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebeck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubenel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span> </span><span class="NLM_article-title">Inhibition of c-secretase by the CK1 inhibitor IC261 does not depend on CK1δ</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2958</span><span class="NLM_x">–</span> <span class="NLM_lpage">2963</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2958-2963&author=N.+H%C3%B6tteckeauthor=M.+Liebeckauthor=K.+Baumannauthor=R.+Schubenelauthor=E.+Winklerauthor=H.+Steinerauthor=B.+Schmidt&title=Inhibition+of+c-secretase+by+the+CK1+inhibitor+IC261+does+not+depend+on+CK1%CE%B4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25B6ttecke%26aufirst%3DN.%26aulast%3DLiebeck%26aufirst%3DM.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DSchubenel%26aufirst%3DR.%26aulast%3DWinkler%26aufirst%3DE.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520c-secretase%2520by%2520the%2520CK1%2520inhibitor%2520IC261%2520does%2520not%2520depend%2520on%2520CK1%25CE%25B4%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2958%26epage%3D2963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Walsby, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepper, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, K.</span><span> </span><span class="NLM_article-title">Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts</span> <span class="citation_source-journal">Haematologica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">662</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2008&pages=662-669&author=E.+Walsbyauthor=V.+Walshauthor=C.+Pepperauthor=A.+Burnettauthor=K.+Mills&title=Effects+of+the+aurora+kinase+inhibitors+AZD1152-HQPA+and+ZM447439+on+growth+arrest+and+polyploidy+in+acute+myeloid+leukemia+cell+lines+and+primary+blasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalsby%26aufirst%3DE.%26aulast%3DWalsh%26aufirst%3DV.%26aulast%3DPepper%26aufirst%3DC.%26aulast%3DBurnett%26aufirst%3DA.%26aulast%3DMills%26aufirst%3DK.%26atitle%3DEffects%2520of%2520the%2520aurora%2520kinase%2520inhibitors%2520AZD1152-HQPA%2520and%2520ZM447439%2520on%2520growth%2520arrest%2520and%2520polyploidy%2520in%2520acute%2520myeloid%2520leukemia%2520cell%2520lines%2520and%2520primary%2520blasts%26jtitle%3DHaematologica%26date%3D2008%26volume%3D93%26spage%3D662%26epage%3D669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span>MOE (Molecular Operating Environment), <span class="NLM_edition">version 2005.06</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">1010 Sherbrooke St. West, Suite 910, Montreal, Quebec H3A 2R7, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MOE+%28Molecular+Operating+Environment%29%2C+version+2005.06%3B+Chemical+Computing+Group+Inc.%3A+1010+Sherbrooke+St.+West%2C+Suite+910%2C+Montreal%2C+Quebec+H3A+2R7%2C+Canada%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMOE%2520%2528Molecular%2520Operating%2520Environment%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Ewing, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baber, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feher, M.</span><span> </span><span class="NLM_article-title">Novel 2D Fingerprints for Ligand-Based Virtual Screening</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2423</span><span class="NLM_x">–</span> <span class="NLM_lpage">2431</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci060155b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsF2hsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=2423-2431&author=T.+Ewingauthor=J.+C.+Baberauthor=M.+Feher&title=Novel+2D+Fingerprints+for+Ligand-Based+Virtual+Screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 2D Fingerprints for Ligand-Based Virtual Screening</span></div><div class="casAuthors">Ewing, Todd; Baber, J. Christian; Feher, Miklos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2423-2431</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes the development of a set of new 2D fingerprints for the purposes of virtual screening in a pharmaceutical environment.  The new fingerprints are based on established ones: the changes in their design included the introduction of overlapping pharmacophore feature types, feature counts for pharmacophore and structural fingerprints, as well as changes in the resoln. in property description for property fingerprints.  The effects of each of these changes on virtual screening performance were monitored using two types of training sets, emulating different stages in the drug discovery process.  The results demonstrate that these changes all lead to an improvement in virtual screening performance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUwDfGYUmJrrVg90H21EOLACvtfcHk0lh-SeMxeBrSNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsF2hsLc%253D&md5=623e7efe2668bef2fdbbce5b4fe5381b</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fci060155b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci060155b%26sid%3Dliteratum%253Aachs%26aulast%3DEwing%26aufirst%3DT.%26aulast%3DBaber%26aufirst%3DJ.%2BC.%26aulast%3DFeher%26aufirst%3DM.%26atitle%3DNovel%25202D%2520Fingerprints%2520for%2520Ligand-Based%2520Virtual%2520Screening%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2006%26volume%3D46%26spage%3D2423%26epage%3D2431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span>Wombat 2007.01; <span class="NLM_publisher-name">Sunset Molecular Discovery LLC</span>: <span class="NLM_publisher-loc">Santa Fe, NM, 87505</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Wombat+2007.01%3B+Sunset+Molecular+Discovery+LLC%3A+Santa+Fe%2C+NM%2C+87505%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DWombat%25202007.01%26pub%3DSunset%2520Molecular%2520Discovery%2520LLC%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Olah, M.; Mracec, M.; Ostopovici, L.; Rad, R.; Bora, A.; Hadaruga, N.; Olah, I.; Banda, M.; Simon, Z.; Mracec, M.; Oprea, T. I.</span><span> </span><span class="NLM_article-title">WOMBAT: World of Molecular Bioactivity</span>. In  <span class="citation_source-book">Chemoinformatics in Drug Discovery</span>; <span class="NLM_contrib-group">Oprea, T. I.</span>, Ed; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=223-239&author=M.+Olah&author=M.+Mracec&author=L.+Ostopovici&author=R.+Rad&author=A.+Bora&author=N.+Hadaruga&author=I.+Olah&author=M.+Banda&author=Z.+Simon&author=M.+Mracec&author=T.+I.+Opreaauthor=T.+I.+Oprea&title=Chemoinformatics+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DOlah%26aufirst%3DM.%26atitle%3DWOMBAT%253A%2520World%2520of%2520Molecular%2520Bioactivity%26btitle%3DChemoinformatics%2520in%2520Drug%2520Discovery%26aulast%3DOprea%26aufirst%3DT.%2BI.%26pub%3DWiley-VCH%26date%3D2004%26spage%3D223%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Fancelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bindi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappella, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpinelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catana, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgini, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantegani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsiglio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pittalà, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roletto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soncini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storici, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianello, P.</span><span> </span><span class="NLM_article-title">Potent and selective Aurora inhibitors identified by the expansion of a novel scaffold for protein kinase inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3080</span><span class="NLM_x">–</span> <span class="NLM_lpage">3084</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049076m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3080-3084&author=D.+Fancelliauthor=D.+Bertaauthor=S.+Bindiauthor=A.+Cameronauthor=P.+Cappellaauthor=P.+Carpinelliauthor=C.+Catanaauthor=B.+Forteauthor=P.+Giordanoauthor=M.+L.+Giorginiauthor=S.+Manteganiauthor=A.+Marsiglioauthor=M.+Meroniauthor=J.+Mollauthor=V.+Pittal%C3%A0author=F.+Rolettoauthor=D.+Severinoauthor=C.+Sonciniauthor=P.+Storiciauthor=R.+Tonaniauthor=M.+Varasiauthor=A.+Vulpettiauthor=P.+Vianello&title=Potent+and+selective+Aurora+inhibitors+identified+by+the+expansion+of+a+novel+scaffold+for+protein+kinase+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm049076m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049076m%26sid%3Dliteratum%253Aachs%26aulast%3DFancelli%26aufirst%3DD.%26aulast%3DBerta%26aufirst%3DD.%26aulast%3DBindi%26aufirst%3DS.%26aulast%3DCameron%26aufirst%3DA.%26aulast%3DCappella%26aufirst%3DP.%26aulast%3DCarpinelli%26aufirst%3DP.%26aulast%3DCatana%26aufirst%3DC.%26aulast%3DForte%26aufirst%3DB.%26aulast%3DGiordano%26aufirst%3DP.%26aulast%3DGiorgini%26aufirst%3DM.%2BL.%26aulast%3DMantegani%26aufirst%3DS.%26aulast%3DMarsiglio%26aufirst%3DA.%26aulast%3DMeroni%26aufirst%3DM.%26aulast%3DMoll%26aufirst%3DJ.%26aulast%3DPittal%25C3%25A0%26aufirst%3DV.%26aulast%3DRoletto%26aufirst%3DF.%26aulast%3DSeverino%26aufirst%3DD.%26aulast%3DSoncini%26aufirst%3DC.%26aulast%3DStorici%26aufirst%3DP.%26aulast%3DTonani%26aufirst%3DR.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DVianello%26aufirst%3DP.%26atitle%3DPotent%2520and%2520selective%2520Aurora%2520inhibitors%2520identified%2520by%2520the%2520expansion%2520of%2520a%2520novel%2520scaffold%2520for%2520protein%2520kinase%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3080%26epage%3D3084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span>Corina, <span class="NLM_edition">version 3.2</span>; <span class="NLM_publisher-name">Molecular Networks GmbH</span>: <span class="NLM_publisher-loc">Erlangen, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Corina%2C+version+3.2%3B+Molecular+Networks+GmbH%3A+Erlangen%2C+Germany%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DCorina%26pub%3DMolecular%2520Networks%2520GmbH%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><div class="note"><p class="first last">Analyse/visualise H bonds for database with DBV Browser, SVL exchange,</p></div><a href="http://svl.chemcomp.com" class="extLink">http://svl.chemcomp.com</a><div class="note"><p class="first last">(accessed April 12, 2012)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Analyse%2Fvisualise+H+bonds+for+database+with+DBV+Browser%2C+SVL+exchange%2Chttp%3A%2F%2Fsvl.chemcomp.com%28accessed+April+12%2C+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Dubinina, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chupryna, O. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platonov, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borisko, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrovska, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachov, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shtil, A. A.</span><span> </span><span class="NLM_article-title">In silico design of protein kinase inhibitors: successes and failures</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=171-188&author=G.+G.+Dubininaauthor=O.+O.+Chuprynaauthor=M.+O.+Platonovauthor=P.+O.+Boriskoauthor=G.+V.+Ostrovskaauthor=A.+O.+Tolmachovauthor=A.+A.+Shtil&title=In+silico+design+of+protein+kinase+inhibitors%3A+successes+and+failures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDubinina%26aufirst%3DG.%2BG.%26aulast%3DChupryna%26aufirst%3DO.%2BO.%26aulast%3DPlatonov%26aufirst%3DM.%2BO.%26aulast%3DBorisko%26aufirst%3DP.%2BO.%26aulast%3DOstrovska%26aufirst%3DG.%2BV.%26aulast%3DTolmachov%26aufirst%3DA.%2BO.%26aulast%3DShtil%26aufirst%3DA.%2BA.%26atitle%3DIn%2520silico%2520design%2520of%2520protein%2520kinase%2520inhibitors%253A%2520successes%2520and%2520failures%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D171%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewing, T.</span><span> </span><span class="NLM_article-title">Global or local QSAR: Is there a way out?</span> <span class="citation_source-journal">QSAR Comb. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">850</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=850-855&author=M.+Feherauthor=T.+Ewing&title=Global+or+local+QSAR%3A+Is+there+a+way+out%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DEwing%26aufirst%3DT.%26atitle%3DGlobal%2520or%2520local%2520QSAR%253A%2520Is%2520there%2520a%2520way%2520out%253F%26jtitle%3DQSAR%2520Comb.%2520Sci.%26date%3D2009%26volume%3D28%26spage%3D850%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span>ADMET Predictor, <span class="NLM_edition">v5.0</span>;  <span class="NLM_publisher-name">Simulations Plus</span>: <span class="NLM_publisher-loc">Lancaster, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ADMET+Predictor%2C+v5.0%3B+Simulations+Plus%3A+Lancaster%2C+CA%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DADMET%2520Predictor%26pub%3DSimulations%2520Plus%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Su, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naughton, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arfsten, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCowan, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakubowski, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruterbories, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sall, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, R. M.</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">4308</span><span class="NLM_x">–</span> <span class="NLM_lpage">4318</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9704863" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Su%2C+T.%3B+Naughton%2C+M.+A.%3B+Smyth%2C+M.+S.%3B+Rose%2C+J.+W.%3B+Arfsten%2C+A.+E.%3B+McCowan%2C+J.+R.%3B+Jakubowski%2C+J.+A.%3B+Wyss%2C+V.+L.%3B+Ruterbories%2C+K.+J.%3B+Sall%2C+D.+J.%3B+Scarborough%2C+R.+M.J.+Med.+Chem.+1997%2C+40%2C+4308%E2%80%934318"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm9704863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9704863%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DT.%26aulast%3DNaughton%26aufirst%3DM.%2BA.%26aulast%3DSmyth%26aufirst%3DM.%2BS.%26aulast%3DRose%26aufirst%3DJ.%2BW.%26aulast%3DArfsten%26aufirst%3DA.%2BE.%26aulast%3DMcCowan%26aufirst%3DJ.%2BR.%26aulast%3DJakubowski%26aufirst%3DJ.%2BA.%26aulast%3DWyss%26aufirst%3DV.%2BL.%26aulast%3DRuterbories%26aufirst%3DK.%2BJ.%26aulast%3DSall%26aufirst%3DD.%2BJ.%26aulast%3DScarborough%26aufirst%3DR.%2BM.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D4308%26epage%3D4318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Usansky, J. I.; Desai, A.; Tang-Liu, D.</span>PK Functions for Microsoft Excel; <a href="http://www.boomer.org/pkin/soft.html" class="extLink">http://www.boomer.org/pkin/soft.html</a><div class="note"><p class="first last">(accessed November, 2008)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Usansky%2C+J.+I.%3B+Desai%2C+A.%3B+Tang-Liu%2C+D.PK+Functions+for+Microsoft+Excel%3B+http%3A%2F%2Fwww.boomer.org%2Fpkin%2Fsoft.html%28accessed+November%2C+2008%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DUsansky%26aufirst%3DJ.%2BI.%26jtitle%3DPK%2520Functions%2520for%2520Microsoft%2520Excel" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span>ACD/Structure Designer, <span class="NLM_edition">version 12.01</span>; <span class="NLM_publisher-name">Advanced Chemistry Development, Inc.</span>: <span class="NLM_publisher-loc">Toronto, ON, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ACD%2FStructure+Designer%2C+version+12.01%3B+Advanced+Chemistry+Development%2C+Inc.%3A+Toronto%2C+ON%2C+Canada%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DACD%252FStructure%2520Designer%26pub%3DAdvanced%2520Chemistry%2520Development%252C%2520Inc%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 41 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tanaji T.  Talele</span>  . </span><span class="cited-content_cbyCitation_article-title">The “Cyclopropyl Fragment” is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 8712-8756. <a href="https://doi.org/10.1021/acs.jmedchem.6b00472" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00472%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252B%2525E2%252580%25259CCyclopropyl%252BFragment%2525E2%252580%25259D%252Bis%252Ba%252BVersatile%252BPlayer%252Bthat%252BFrequently%252BAppears%252Bin%252BPreclinical%25252FClinical%252BDrug%252BMolecules%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D30032016%26date%3D30062016%26date%3D13102016%26date%3D14062016%26volume%3D59%26issue%3D19%26spage%3D8712%26epage%3D8756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Hai  Zhai</span>, <span class="hlFld-ContribAuthor ">Li-Hong  Guo</span>, <span class="hlFld-ContribAuthor ">Yang-Hui  Luo</span>, <span class="hlFld-ContribAuthor ">Yang  Ling</span>, and <span class="hlFld-ContribAuthor ">Bai-Wang  Sun</span>  . </span><span class="cited-content_cbyCitation_article-title">Effective Laboratory-Scale Preparation of Axitinib by Two CuI-Catalyzed Coupling Reactions. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2015,</strong> <em>19 </em>
                                    (7)
                                     , 849-857. <a href="https://doi.org/10.1021/acs.oprd.5b00123" title="DOI URL">https://doi.org/10.1021/acs.oprd.5b00123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.5b00123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.5b00123%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DEffective%252BLaboratory-Scale%252BPreparation%252Bof%252BAxitinib%252Bby%252BTwo%252BCuI-Catalyzed%252BCoupling%252BReactions%26aulast%3DZhai%26aufirst%3DLi-Hai%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D15042015%26date%3D29062015%26date%3D17072015%26date%3D11062015%26volume%3D19%26issue%3D7%26spage%3D849%26epage%3D857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Yunhui  Lang</span>, <span class="hlFld-ContribAuthor ">Narendra Kumar  Patel</span>, <span class="hlFld-ContribAuthor ">Grace  Ng</span>, <span class="hlFld-ContribAuthor ">Radoslaw  Laufer</span>, <span class="hlFld-ContribAuthor ">Sze-Wan  Li</span>, <span class="hlFld-ContribAuthor ">Louise  Edwards</span>, <span class="hlFld-ContribAuthor ">Bryan  Forrest</span>, <span class="hlFld-ContribAuthor ">Peter B.  Sampson</span>, <span class="hlFld-ContribAuthor ">Miklos  Feher</span>, <span class="hlFld-ContribAuthor ">Fuqiang  Ban</span>, <span class="hlFld-ContribAuthor ">Donald E.  Awrey</span>, <span class="hlFld-ContribAuthor ">Irina  Beletskaya</span>, <span class="hlFld-ContribAuthor ">Guodong  Mao</span>, <span class="hlFld-ContribAuthor ">Richard  Hodgson</span>, <span class="hlFld-ContribAuthor ">Olga  Plotnikova</span>, <span class="hlFld-ContribAuthor ">Wei  Qiu</span>, <span class="hlFld-ContribAuthor ">Nickolay Y.  Chirgadze</span>, <span class="hlFld-ContribAuthor ">Jacqueline M.  Mason</span>, <span class="hlFld-ContribAuthor ">Xin  Wei</span>, <span class="hlFld-ContribAuthor ">Dan Chi-Chia  Lin</span>, <span class="hlFld-ContribAuthor ">Yi  Che</span>, <span class="hlFld-ContribAuthor ">Reza  Kiarash</span>, <span class="hlFld-ContribAuthor ">Brian  Madeira</span>, <span class="hlFld-ContribAuthor ">Graham C.  Fletcher</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>, <span class="hlFld-ContribAuthor ">Mark R.  Bray</span>, and <span class="hlFld-ContribAuthor ">Henry W.  Pauls</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of Orally Bioavailable Tyrosine Threonine Kinase (TTK) Inhibitors: 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides as Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (8)
                                     , 3366-3392. <a href="https://doi.org/10.1021/jm501740a" title="DOI URL">https://doi.org/10.1021/jm501740a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501740a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501740a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252BOrally%252BBioavailable%252BTyrosine%252BThreonine%252BKinase%252B%252528TTK%252529%252BInhibitors%25253A%252B3-%2525284-%252528heterocyclyl%252529phenyl%252529-1H-indazole-5-carboxamides%252Bas%252BAnticancer%252BAgents%26aulast%3DLiu%26aufirst%3DYong%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D10112014%26date%3D03042015%26date%3D23042015%26date%3D12032015%26volume%3D58%26issue%3D8%26spage%3D3366%26epage%3D3392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel Weiliang  Tay</span>, <span class="hlFld-ContribAuthor ">Howard  Jong</span>, <span class="hlFld-ContribAuthor ">Yee Hwee  Lim</span>, <span class="hlFld-ContribAuthor ">Wenqin  Wu</span>, <span class="hlFld-ContribAuthor ">Xinying  Chew</span>, <span class="hlFld-ContribAuthor ">Edward G.  Robins</span>, and <span class="hlFld-ContribAuthor ">Charles W.  Johannes</span>  . </span><span class="cited-content_cbyCitation_article-title">Palladium-meta-Terarylphosphine Catalyst for the Mizoroki–Heck Reaction of (Hetero)Aryl Bromides and Functional Olefins. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (8)
                                     , 4054-4063. <a href="https://doi.org/10.1021/acs.joc.5b00386" title="DOI URL">https://doi.org/10.1021/acs.joc.5b00386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b00386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b00386%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPalladium-meta-Terarylphosphine%252BCatalyst%252Bfor%252Bthe%252BMizoroki%2525E2%252580%252593Heck%252BReaction%252Bof%252B%252528Hetero%252529Aryl%252BBromides%252Band%252BFunctional%252BOlefins%26aulast%3DTay%26aufirst%3DDaniel%2BWeiliang%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D17022015%26date%3D27032015%26date%3D17042015%26date%3D13032015%26volume%3D80%26issue%3D8%26spage%3D4054%26epage%3D4063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>, <span class="hlFld-ContribAuthor ">Arturo  Aliaga</span>, <span class="hlFld-ContribAuthor ">Antonio  Aliaga</span>, <span class="hlFld-ContribAuthor ">Mehdi  Boudjemeline</span>, <span class="hlFld-ContribAuthor ">Robert  Hopewell</span>, <span class="hlFld-ContribAuthor ">Alexey  Kostikov</span>, <span class="hlFld-ContribAuthor ">Pedro  Rosa-Neto</span>, <span class="hlFld-ContribAuthor ">Alexander  Thiel</span>, and <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>  . </span><span class="cited-content_cbyCitation_article-title">Syntheses and Evaluation of Carbon-11- and Fluorine-18-Radiolabeled pan-Tropomyosin Receptor Kinase (Trk) Inhibitors: Exploration of the 4-Aza-2-oxindole Scaffold as Trk PET Imaging Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2015,</strong> <em>6 </em>
                                    (2)
                                     , 260-276. <a href="https://doi.org/10.1021/cn500193f" title="DOI URL">https://doi.org/10.1021/cn500193f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn500193f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn500193f%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DSyntheses%252Band%252BEvaluation%252Bof%252BCarbon-11-%252Band%252BFluorine-18-Radiolabeled%252Bpan-Tropomyosin%252BReceptor%252BKinase%252B%252528Trk%252529%252BInhibitors%25253A%252BExploration%252Bof%252Bthe%252B4-Aza-2-oxindole%252BScaffold%252Bas%252BTrk%252BPET%252BImaging%252BAgents%26aulast%3DBernard-Gauthier%26aufirst%3DVadim%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D25082014%26date%3D28102014%26date%3D10112014%26date%3D18022015%26date%3D28102014%26volume%3D6%26issue%3D2%26spage%3D260%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter B.  Sampson</span>, <span class="hlFld-ContribAuthor ">Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Bryan  Forrest</span>, <span class="hlFld-ContribAuthor ">Graham  Cumming</span>, <span class="hlFld-ContribAuthor ">Sze-Wan  Li</span>, <span class="hlFld-ContribAuthor ">Narendra Kumar  Patel</span>, <span class="hlFld-ContribAuthor ">Louise  Edwards</span>, <span class="hlFld-ContribAuthor ">Radoslaw  Laufer</span>, <span class="hlFld-ContribAuthor ">Miklos  Feher</span>, <span class="hlFld-ContribAuthor ">Fuqiang  Ban</span>, <span class="hlFld-ContribAuthor ">Donald E.  Awrey</span>, <span class="hlFld-ContribAuthor ">Guodong  Mao</span>, <span class="hlFld-ContribAuthor ">Olga  Plotnikova</span>, <span class="hlFld-ContribAuthor ">Richard  Hodgson</span>, <span class="hlFld-ContribAuthor ">Irina  Beletskaya</span>, <span class="hlFld-ContribAuthor ">Jacqueline M.  Mason</span>, <span class="hlFld-ContribAuthor ">Xunyi  Luo</span>, <span class="hlFld-ContribAuthor ">Vincent  Nadeem</span>, <span class="hlFld-ContribAuthor ">Xin  Wei</span>, <span class="hlFld-ContribAuthor ">Reza  Kiarash</span>, <span class="hlFld-ContribAuthor ">Brian  Madeira</span>, <span class="hlFld-ContribAuthor ">Ping  Huang</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>, <span class="hlFld-ContribAuthor ">Guohua  Pan</span>, and <span class="hlFld-ContribAuthor ">Henry W.  Pauls</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of Polo-Like Kinase 4 Inhibitors: Identification of (1R,2S)-2-(3-((E)-4-(((cis)-2,6-Dimethylmorpholino)methyl)styryl)-1H-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (CFI-400945) as a Potent, Orally Active Antitumor Agent. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 147-169. <a href="https://doi.org/10.1021/jm5005336" title="DOI URL">https://doi.org/10.1021/jm5005336</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5005336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5005336%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252BPolo-Like%252BKinase%252B4%252BInhibitors%25253A%252BIdentification%252Bof%252B%2525281R%25252C2S%252529-2-%2525283-%252528%252528E%252529-4-%252528%252528%252528cis%252529-2%25252C6-Dimethylmorpholino%252529methyl%252529styryl%252529-1H-indazol-6-yl%252529-5%2525E2%252580%2525B2-methoxyspiro%25255Bcyclopropane-1%25252C3%2525E2%252580%2525B2-indolin%25255D-2%2525E2%252580%2525B2-one%252B%252528CFI-400945%252529%252Bas%252Ba%252BPotent%25252C%252BOrally%252BActive%252BAntitumor%252BAgent%26aulast%3DSampson%26aufirst%3DPeter%2BB.%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D03042014%26date%3D24062014%26date%3D08012015%26date%3D27052014%26volume%3D58%26issue%3D1%26spage%3D147%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter B.  Sampson</span>, <span class="hlFld-ContribAuthor ">Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Narendra Kumar  Patel</span>, <span class="hlFld-ContribAuthor ">Miklos  Feher</span>, <span class="hlFld-ContribAuthor ">Bryan  Forrest</span>, <span class="hlFld-ContribAuthor ">Sze-Wan  Li</span>, <span class="hlFld-ContribAuthor ">Louise  Edwards</span>, <span class="hlFld-ContribAuthor ">Radoslaw  Laufer</span>, <span class="hlFld-ContribAuthor ">Yunhui  Lang</span>, <span class="hlFld-ContribAuthor ">Fuqiang  Ban</span>, <span class="hlFld-ContribAuthor ">Donald E.  Awrey</span>, <span class="hlFld-ContribAuthor ">Guodong  Mao</span>, <span class="hlFld-ContribAuthor ">Olga  Plotnikova</span>, <span class="hlFld-ContribAuthor ">Genie  Leung</span>, <span class="hlFld-ContribAuthor ">Richard  Hodgson</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Mason</span>, <span class="hlFld-ContribAuthor ">Xin  Wei</span>, <span class="hlFld-ContribAuthor ">Reza  Kiarash</span>, <span class="hlFld-ContribAuthor ">Erin  Green</span>, <span class="hlFld-ContribAuthor ">Wei  Qiu</span>, <span class="hlFld-ContribAuthor ">Nickolay Y.  Chirgadze</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>, <span class="hlFld-ContribAuthor ">Guohua  Pan</span>, and <span class="hlFld-ContribAuthor ">Henry W.  Pauls</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of Polo-Like Kinase 4 Inhibitors: Design and Optimization of Spiro[cyclopropane-1,3′[3H]indol]-2′(1′H)-ones as Orally Bioavailable Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 130-146. <a href="https://doi.org/10.1021/jm500537u" title="DOI URL">https://doi.org/10.1021/jm500537u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500537u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500537u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252BPolo-Like%252BKinase%252B4%252BInhibitors%25253A%252BDesign%252Band%252BOptimization%252Bof%252BSpiro%25255Bcyclopropane-1%25252C3%2525E2%252580%2525B2%25255B3H%25255Dindol%25255D-2%2525E2%252580%2525B2%2525281%2525E2%252580%2525B2H%252529-ones%252Bas%252BOrally%252BBioavailable%252BAntitumor%252BAgents%26aulast%3DSampson%26aufirst%3DPeter%2BB.%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D04042014%26date%3D24062014%26date%3D08012015%26date%3D27052014%26volume%3D58%26issue%3D1%26spage%3D130%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaolan  Xing</span>, <span class="hlFld-ContribAuthor ">Peng  Guan</span>, <span class="hlFld-ContribAuthor ">Shubin  Song</span>, <span class="hlFld-ContribAuthor ">Guirong  You</span>, <span class="hlFld-ContribAuthor ">Chengcai  Xia</span>, <span class="hlFld-ContribAuthor ">Tingting  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in agents targeting polo-like kinases: Promising therapeutic strategies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>217 </em>, 113314. <a href="https://doi.org/10.1016/j.ejmech.2021.113314" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113314</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113314%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bprogress%252Bin%252Bagents%252Btargeting%252Bpolo-like%252Bkinases%25253A%252BPromising%252Btherapeutic%252Bstrategies%26aulast%3DZhang%26aufirst%3DZheng%26date%3D2021%26volume%3D217%26spage%3D113314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Wei</span>, <span class="hlFld-ContribAuthor ">Zhihao  Liu</span>, <span class="hlFld-ContribAuthor ">Xiuli  Wu</span>, <span class="hlFld-ContribAuthor ">Cailing  Gan</span>, <span class="hlFld-ContribAuthor ">Xingping  Su</span>, <span class="hlFld-ContribAuthor ">Hongyao  Liu</span>, <span class="hlFld-ContribAuthor ">Hanyun  Que</span>, <span class="hlFld-ContribAuthor ">Qianyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiang  Xue</span>, <span class="hlFld-ContribAuthor ">Lin  Yue</span>, <span class="hlFld-ContribAuthor ">Luoting  Yu</span>, <span class="hlFld-ContribAuthor ">Tinghong  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of indazole derivatives as anti-cancer agents. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (26)
                                     , 15675-15687. <a href="https://doi.org/10.1039/D1RA01147B" title="DOI URL">https://doi.org/10.1039/D1RA01147B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1RA01147B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1RA01147B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bindazole%252Bderivatives%252Bas%252Banti-cancer%252Bagents%26aulast%3DWei%26aufirst%3DWei%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D26%26spage%3D15675%26epage%3D15687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prajwal  Dhokne</span>, <span class="hlFld-ContribAuthor ">Akash P.  Sakla</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>. </span><span class="cited-content_cbyCitation_article-title">Structural insights of oxindole based kinase inhibitors as anticancer agents: Recent advances. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>216 </em>, 113334. <a href="https://doi.org/10.1016/j.ejmech.2021.113334" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113334</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113334%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252Binsights%252Bof%252Boxindole%252Bbased%252Bkinase%252Binhibitors%252Bas%252Banticancer%252Bagents%25253A%252BRecent%252Badvances%26aulast%3DDhokne%26aufirst%3DPrajwal%26date%3D2021%26volume%3D216%26spage%3D113334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyang  Zhang</span>, <span class="hlFld-ContribAuthor ">Cheng  Wei</span>, <span class="hlFld-ContribAuthor ">Hao  Liang</span>, <span class="hlFld-ContribAuthor ">Lei  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Polo-Like Kinase 4’s Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fonc.2021.587554" title="DOI URL">https://doi.org/10.3389/fonc.2021.587554</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2021.587554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2021.587554%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DPolo-Like%252BKinase%252B4%2525E2%252580%252599s%252BCritical%252BRole%252Bin%252BCancer%252BDevelopment%252Band%252BStrategies%252Bfor%252BPlk4-Targeted%252BTherapy%26aulast%3DZhang%26aufirst%3DXiaoyang%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yaquan  Cao</span>, <span class="hlFld-ContribAuthor ">Chunying  Luo</span>, <span class="hlFld-ContribAuthor ">Pu  Yang</span>, <span class="hlFld-ContribAuthor ">Pan  Li</span>, <span class="hlFld-ContribAuthor ">Chunli  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Indazole scaffold: a generalist for marketed and clinical drugs. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (3)
                                     , 501-518. <a href="https://doi.org/10.1007/s00044-020-02665-7" title="DOI URL">https://doi.org/10.1007/s00044-020-02665-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02665-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02665-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DIndazole%252Bscaffold%25253A%252Ba%252Bgeneralist%252Bfor%252Bmarketed%252Band%252Bclinical%252Bdrugs%26aulast%3DCao%26aufirst%3DYaquan%26date%3D2021%26date%3D2020%26volume%3D30%26issue%3D3%26spage%3D501%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sonal  Jaiswal</span>, <span class="hlFld-ContribAuthor ">Priyanka  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Centrosome dysfunction in human diseases. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cell & Developmental Biology</span><span> <strong>2021,</strong> <em>110 </em>, 113-122. <a href="https://doi.org/10.1016/j.semcdb.2020.04.019" title="DOI URL">https://doi.org/10.1016/j.semcdb.2020.04.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcdb.2020.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcdb.2020.04.019%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cell%2520%2526%2520Developmental%2520Biology%26atitle%3DCentrosome%252Bdysfunction%252Bin%252Bhuman%252Bdiseases%26aulast%3DJaiswal%26aufirst%3DSonal%26date%3D2021%26volume%3D110%26spage%3D113%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wagdy M.  Eldehna</span>, <span class="hlFld-ContribAuthor ">Sara T.  Al-Rashood</span>, <span class="hlFld-ContribAuthor ">Tarfah  Al-Warhi</span>, <span class="hlFld-ContribAuthor ">Razan O.  Eskandrani</span>, <span class="hlFld-ContribAuthor ">Amal  Alharbi</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  El Kerdawy</span>. </span><span class="cited-content_cbyCitation_article-title">Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and
              in silico
              studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>
                                    (1)
                                     , 270-285. <a href="https://doi.org/10.1080/14756366.2020.1862101" title="DOI URL">https://doi.org/10.1080/14756366.2020.1862101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1862101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1862101%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Boxindole%25252Fbenzofuran%252Bhybrids%252Bas%252Bpotential%252Bdual%252BCDK2%25252FGSK-3%2525CE%2525B2%252Binhibitors%252Btargeting%252Bbreast%252Bcancer%25253A%252Bdesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Band%252Bin%252Bsilico%252Bstudies%26aulast%3DEldehna%26aufirst%3DWagdy%2BM.%26date%3D2021%26date%3D2020%26volume%3D36%26issue%3D1%26spage%3D270%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tarfah  Al-Warhi</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  El Kerdawy</span>, <span class="hlFld-ContribAuthor ">Nada  Aljaeed</span>, <span class="hlFld-ContribAuthor ">Omnia E.  Ismael</span>, <span class="hlFld-ContribAuthor ">Rezk R.  Ayyad</span>, <span class="hlFld-ContribAuthor ">Wagdy M.  Eldehna</span>, <span class="hlFld-ContribAuthor ">Hatem A.  Abdel-Aziz</span>, <span class="hlFld-ContribAuthor ">Ghada H.  Al-Ansary</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole–Indole Conjugates as Anticancer CDK Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (9)
                                     , 2031. <a href="https://doi.org/10.3390/molecules25092031" title="DOI URL">https://doi.org/10.3390/molecules25092031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25092031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25092031%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%25252C%252BBiological%252BEvaluation%252Band%252BIn%252BSilico%252BStudies%252Bof%252BCertain%252BOxindole%2525E2%252580%252593Indole%252BConjugates%252Bas%252BAnticancer%252BCDK%252BInhibitors%26aulast%3DAl-Warhi%26aufirst%3DTarfah%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D9%26spage%3D2031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael F.  Press</span>, <span class="hlFld-ContribAuthor ">Bin  Xie</span>, <span class="hlFld-ContribAuthor ">Simon  Davenport</span>, <span class="hlFld-ContribAuthor ">Yu  Zhou</span>, <span class="hlFld-ContribAuthor ">Roberta  Guzman</span>, <span class="hlFld-ContribAuthor ">Garry P.  Nolan</span>, <span class="hlFld-ContribAuthor ">Neil  O’Brien</span>, <span class="hlFld-ContribAuthor ">Michael  Palazzolo</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>, <span class="hlFld-ContribAuthor ">Joan S.  Brugge</span>, <span class="hlFld-ContribAuthor ">Dennis J.  Slamon</span>. </span><span class="cited-content_cbyCitation_article-title">Role for polo-like kinase 4 in mediation of cytokinesis. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2019,</strong> <em>116 </em>
                                    (23)
                                     , 11309-11318. <a href="https://doi.org/10.1073/pnas.1818820116" title="DOI URL">https://doi.org/10.1073/pnas.1818820116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1818820116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1818820116%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DRole%252Bfor%252Bpolo-like%252Bkinase%252B4%252Bin%252Bmediation%252Bof%252Bcytokinesis%26aulast%3DPress%26aufirst%3DMichael%2BF.%26date%3D2019%26date%3D2019%26volume%3D116%26issue%3D23%26spage%3D11309%26epage%3D11318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amreena  Suri</span>, <span class="hlFld-ContribAuthor ">Anders W.  Bailey</span>, <span class="hlFld-ContribAuthor ">Maurício T.  Tavares</span>, <span class="hlFld-ContribAuthor ">Hendra  Gunosewoyo</span>, <span class="hlFld-ContribAuthor ">Connor P.  Dyer</span>, <span class="hlFld-ContribAuthor ">Alex T.  Grupenmacher</span>, <span class="hlFld-ContribAuthor ">David R.  Piper</span>, <span class="hlFld-ContribAuthor ">Robert A.  Horton</span>, <span class="hlFld-ContribAuthor ">Tadanori  Tomita</span>, <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>, <span class="hlFld-ContribAuthor ">Saktimayee M.  Roy</span>, <span class="hlFld-ContribAuthor ">Simone T.  Sredni</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (9)
                                     , 2112. <a href="https://doi.org/10.3390/ijms20092112" title="DOI URL">https://doi.org/10.3390/ijms20092112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20092112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20092112%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DEvaluation%252Bof%252BProtein%252BKinase%252BInhibitors%252Bwith%252BPLK4%252BCross-Over%252BPotential%252Bin%252Ba%252BPre-Clinical%252BModel%252Bof%252BCancer%26aulast%3DSuri%26aufirst%3DAmreena%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D9%26spage%3D2112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Babita  Aneja</span>, <span class="hlFld-ContribAuthor ">Nashrah Sharif  Khan</span>, <span class="hlFld-ContribAuthor ">Parvez  Khan</span>, <span class="hlFld-ContribAuthor ">Aarfa  Queen</span>, <span class="hlFld-ContribAuthor ">Afzal  Hussain</span>, <span class="hlFld-ContribAuthor ">Md. Tabish  Rehman</span>, <span class="hlFld-ContribAuthor ">Mohamed F.  Alajmi</span>, <span class="hlFld-ContribAuthor ">Hesham R.  El-Seedi</span>, <span class="hlFld-ContribAuthor ">Sher  Ali</span>, <span class="hlFld-ContribAuthor ">Md. Imtaiyaz  Hassan</span>, <span class="hlFld-ContribAuthor ">Mohammad  Abid</span>. </span><span class="cited-content_cbyCitation_article-title">Design and development of Isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>163 </em>, 840-852. <a href="https://doi.org/10.1016/j.ejmech.2018.12.026" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.026%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bdevelopment%252Bof%252BIsatin-triazole%252Bhydrazones%252Bas%252Bpotential%252Binhibitors%252Bof%252Bmicrotubule%252Baffinity-regulating%252Bkinase%252B4%252Bfor%252Bthe%252Btherapeutic%252Bmanagement%252Bof%252Bcell%252Bproliferation%252Band%252Bmetastasis%26aulast%3DAneja%26aufirst%3DBabita%26date%3D2019%26volume%3D163%26spage%3D840%26epage%3D852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qian  Lei</span>, <span class="hlFld-ContribAuthor ">Lu  Xiong</span>, <span class="hlFld-ContribAuthor ">Yong  Xia</span>, <span class="hlFld-ContribAuthor ">Zhanzhan  Feng</span>, <span class="hlFld-ContribAuthor ">Tiantao  Gao</span>, <span class="hlFld-ContribAuthor ">Wei  Wei</span>, <span class="hlFld-ContribAuthor ">Xuejiao  Song</span>, <span class="hlFld-ContribAuthor ">Tinghong  Ye</span>, <span class="hlFld-ContribAuthor ">Ningyu  Wang</span>, <span class="hlFld-ContribAuthor ">Cuiting  Peng</span>, <span class="hlFld-ContribAuthor ">Zhongping  Li</span>, <span class="hlFld-ContribAuthor ">Zhihao  Liu</span>, <span class="hlFld-ContribAuthor ">Luoting  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defect. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Disease</span><span> <strong>2018,</strong> <em>9 </em>
                                    (11)
                                     <a href="https://doi.org/10.1038/s41419-018-1071-2" title="DOI URL">https://doi.org/10.1038/s41419-018-1071-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41419-018-1071-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41419-018-1071-2%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Disease%26atitle%3DYLT-11%25252C%252Ba%252Bnovel%252BPLK4%252Binhibitor%25252C%252Binhibits%252Bhuman%252Bbreast%252Bcancer%252Bgrowth%252Bvia%252Binducing%252Bmaladjusted%252Bcentriole%252Bduplication%252Band%252Bmitotic%252Bdefect%26aulast%3DLei%26aufirst%3DQian%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinyun  Dong</span>, <span class="hlFld-ContribAuthor ">Qijing  Zhang</span>, <span class="hlFld-ContribAuthor ">Zengtao  Wang</span>, <span class="hlFld-ContribAuthor ">Guang  Huang</span>, <span class="hlFld-ContribAuthor ">Shaoshun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Development of Indazole-based Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (15)
                                     , 1490-1507. <a href="https://doi.org/10.1002/cmdc.201800253" title="DOI URL">https://doi.org/10.1002/cmdc.201800253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800253%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BDevelopment%252Bof%252BIndazole-based%252BAnticancer%252BAgents%26aulast%3DDong%26aufirst%3DJinyun%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D15%26spage%3D1490%26epage%3D1507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Radhika Radha  Maniswami</span>, <span class="hlFld-ContribAuthor ">Seema  Prashanth</span>, <span class="hlFld-ContribAuthor ">Archana Venkataramana  Karanth</span>, <span class="hlFld-ContribAuthor ">Sindhu  Koushik</span>, <span class="hlFld-ContribAuthor ">Hemalatha  Govindaraj</span>, <span class="hlFld-ContribAuthor ">Ramesh  Mullangi</span>, <span class="hlFld-ContribAuthor ">Sriram  Rajagopal</span>, <span class="hlFld-ContribAuthor ">Sooriya Kumar  Jegatheesan</span>. </span><span class="cited-content_cbyCitation_article-title">PLK4: a link between centriole biogenesis and cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2018,</strong> <em>22 </em>
                                    (1)
                                     , 59-73. <a href="https://doi.org/10.1080/14728222.2018.1410140" title="DOI URL">https://doi.org/10.1080/14728222.2018.1410140</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2018.1410140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2018.1410140%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DPLK4%25253A%252Ba%252Blink%252Bbetween%252Bcentriole%252Bbiogenesis%252Band%252Bcancer%26aulast%3DManiswami%26aufirst%3DRadhika%2BRadha%26date%3D2018%26date%3D2017%26volume%3D22%26issue%3D1%26spage%3D59%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arnaud  Chevalier</span>, <span class="hlFld-ContribAuthor ">Abdelaaziz  Ouahrouch</span>, <span class="hlFld-ContribAuthor ">Alexandre  Arnaud</span>, <span class="hlFld-ContribAuthor ">Thibault  Gallavardin</span>, <span class="hlFld-ContribAuthor ">Xavier  Franck</span>. </span><span class="cited-content_cbyCitation_article-title">An optimized procedure for direct access to 1
              H
              -indazole-3-carboxaldehyde derivatives by nitrosation of indoles. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (24)
                                     , 13121-13128. <a href="https://doi.org/10.1039/C8RA01546E" title="DOI URL">https://doi.org/10.1039/C8RA01546E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA01546E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA01546E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DAn%252Boptimized%252Bprocedure%252Bfor%252Bdirect%252Baccess%252Bto%252B1%252BH%252B-indazole-3-carboxaldehyde%252Bderivatives%252Bby%252Bnitrosation%252Bof%252Bindoles%26aulast%3DChevalier%26aufirst%3DArnaud%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D24%26spage%3D13121%26epage%3D13128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingbo  Yu</span>, <span class="hlFld-ContribAuthor ">Zikun  Hong</span>, <span class="hlFld-ContribAuthor ">Xinjie  Yang</span>, <span class="hlFld-ContribAuthor ">Yu  Jiang</span>, <span class="hlFld-ContribAuthor ">Zhijiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Weike  Su</span>. </span><span class="cited-content_cbyCitation_article-title">Bromide-assisted chemoselective Heck reaction of 3-bromoindazoles under high-speed ball-milling conditions: synthesis of axitinib. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>14 </em>, 786-795. <a href="https://doi.org/10.3762/bjoc.14.66" title="DOI URL">https://doi.org/10.3762/bjoc.14.66</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.14.66&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.14.66%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DBromide-assisted%252Bchemoselective%252BHeck%252Breaction%252Bof%252B3-bromoindazoles%252Bunder%252Bhigh-speed%252Bball-milling%252Bconditions%25253A%252Bsynthesis%252Bof%252Baxitinib%26aulast%3DYu%26aufirst%3DJingbo%26date%3D2018%26date%3D2018%26volume%3D14%26spage%3D786%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.M.  Tice</span>, <span class="hlFld-ContribAuthor ">Y.  Zheng</span>, <span class="hlFld-ContribAuthor ">S.B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic Scaffolds in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 211-263. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12291-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12291-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12291-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12291-7%26sid%3Dliteratum%253Aachs%26atitle%3DSpirocyclic%252BScaffolds%252Bin%252BDrug%252BDiscovery%26aulast%3DTice%26aufirst%3DC.M.%26date%3D2017%26spage%3D211%26epage%3D263%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H.  Tsui</span>, <span class="hlFld-ContribAuthor ">Q.  Zeng</span>, <span class="hlFld-ContribAuthor ">K.  Chen</span>, <span class="hlFld-ContribAuthor ">X.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibiting Kinases in the CNS. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 408-446. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13815-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13815-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13815-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13815-6%26sid%3Dliteratum%253Aachs%26atitle%3DInhibiting%252BKinases%252Bin%252Bthe%252BCNS%26aulast%3DTsui%26aufirst%3DH.%26date%3D2017%26spage%3D408%26epage%3D446%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhihao  Liu</span>, <span class="hlFld-ContribAuthor ">Qian  Lei</span>, <span class="hlFld-ContribAuthor ">Wei  Wei</span>, <span class="hlFld-ContribAuthor ">Lu  Xiong</span>, <span class="hlFld-ContribAuthor ">Yaojie  Shi</span>, <span class="hlFld-ContribAuthor ">Guoyi  Yan</span>, <span class="hlFld-ContribAuthor ">Chao  Gao</span>, <span class="hlFld-ContribAuthor ">Tinghong  Ye</span>, <span class="hlFld-ContribAuthor ">Ningyu  Wang</span>, <span class="hlFld-ContribAuthor ">Luoting  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of (E)-4-(3-arylvinyl-1H-indazol-6-yl)pyrimidin-2-amine derivatives as PLK4 inhibitors for the treatment of breast cancer. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (44)
                                     , 27737-27746. <a href="https://doi.org/10.1039/C7RA02518A" title="DOI URL">https://doi.org/10.1039/C7RA02518A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7RA02518A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7RA02518A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B%252528E%252529-4-%2525283-arylvinyl-1H-indazol-6-yl%252529pyrimidin-2-amine%252Bderivatives%252Bas%252BPLK4%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bbreast%252Bcancer%26aulast%3DLiu%26aufirst%3DZhihao%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D44%26spage%3D27737%26epage%3D27746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michele  Graciotti</span>, <span class="hlFld-ContribAuthor ">Zhou  Fang</span>, <span class="hlFld-ContribAuthor ">Kai  Johnsson</span>, <span class="hlFld-ContribAuthor ">Pierre  Gönczy</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Genetic Screen Identifies Natural Products that Modulate Centriole Number. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2016,</strong> <em>17 </em>
                                    (21)
                                     , 2063-2074. <a href="https://doi.org/10.1002/cbic.201600327" title="DOI URL">https://doi.org/10.1002/cbic.201600327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.201600327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.201600327%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DChemical%252BGenetic%252BScreen%252BIdentifies%252BNatural%252BProducts%252Bthat%252BModulate%252BCentriole%252BNumber%26aulast%3DGraciotti%26aufirst%3DMichele%26date%3D2016%26date%3D2016%26volume%3D17%26issue%3D21%26spage%3D2063%26epage%3D2074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fereshteh  Shiri</span>, <span class="hlFld-ContribAuthor ">Somayeh  Rakhshani-morad</span>, <span class="hlFld-ContribAuthor ">Alireza  Samzadeh-kermani</span>, <span class="hlFld-ContribAuthor ">Poya  Karimi</span>. </span><span class="cited-content_cbyCitation_article-title">Computer-aided molecular design of some indolinone derivatives of PLK4 inhibitors as novel anti-proliferative agents. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2016,</strong> <em>25 </em>
                                    (11)
                                     , 2643-2665. <a href="https://doi.org/10.1007/s00044-016-1638-3" title="DOI URL">https://doi.org/10.1007/s00044-016-1638-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-016-1638-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-016-1638-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DComputer-aided%252Bmolecular%252Bdesign%252Bof%252Bsome%252Bindolinone%252Bderivatives%252Bof%252BPLK4%252Binhibitors%252Bas%252Bnovel%252Banti-proliferative%252Bagents%26aulast%3DShiri%26aufirst%3DFereshteh%26date%3D2016%26date%3D2016%26volume%3D25%26issue%3D11%26spage%3D2643%26epage%3D2665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sze-Wan  Li</span>, <span class="hlFld-ContribAuthor ">Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Peter B.  Sampson</span>, <span class="hlFld-ContribAuthor ">Narendra Kumar  Patel</span>, <span class="hlFld-ContribAuthor ">Bryan T.  Forrest</span>, <span class="hlFld-ContribAuthor ">Louise  Edwards</span>, <span class="hlFld-ContribAuthor ">Radoslaw  Laufer</span>, <span class="hlFld-ContribAuthor ">Miklos  Feher</span>, <span class="hlFld-ContribAuthor ">Fuqiang  Ban</span>, <span class="hlFld-ContribAuthor ">Donald E.  Awrey</span>, <span class="hlFld-ContribAuthor ">Richard  Hodgson</span>, <span class="hlFld-ContribAuthor ">Irina  Beletskaya</span>, <span class="hlFld-ContribAuthor ">Guodong  Mao</span>, <span class="hlFld-ContribAuthor ">Jacqueline M.  Mason</span>, <span class="hlFld-ContribAuthor ">Xin  Wei</span>, <span class="hlFld-ContribAuthor ">Xunyi  Luo</span>, <span class="hlFld-ContribAuthor ">Reza  Kiarash</span>, <span class="hlFld-ContribAuthor ">Erin  Green</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>, <span class="hlFld-ContribAuthor ">Guohua  Pan</span>, <span class="hlFld-ContribAuthor ">Henry W.  Pauls</span>. </span><span class="cited-content_cbyCitation_article-title">Design and optimization of (3-aryl-1 H -indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones as potent PLK4 inhibitors with oral antitumor efficacy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (19)
                                     , 4625-4630. <a href="https://doi.org/10.1016/j.bmcl.2016.08.063" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.08.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.08.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.08.063%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Boptimization%252Bof%252B%2525283-aryl-1%252BH%252B-indazol-6-yl%252529spiro%25255Bcyclopropane-1%25252C3%2525E2%252580%2525B2-indolin%25255D-2%2525E2%252580%2525B2-ones%252Bas%252Bpotent%252BPLK4%252Binhibitors%252Bwith%252Boral%252Bantitumor%252Befficacy%26aulast%3DLi%26aufirst%3DSze-Wan%26date%3D2016%26volume%3D26%26issue%3D19%26spage%3D4625%26epage%3D4630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Loana  Musso</span>, <span class="hlFld-ContribAuthor ">Raffaella  Cincinelli</span>, <span class="hlFld-ContribAuthor ">Valentina  Zuco</span>, <span class="hlFld-ContribAuthor ">Michelandrea  De Cesare</span>, <span class="hlFld-ContribAuthor ">Franco  Zunino</span>, <span class="hlFld-ContribAuthor ">Anna Lucia  Fallacara</span>, <span class="hlFld-ContribAuthor ">Maurizio  Botta</span>, <span class="hlFld-ContribAuthor ">Sabrina  Dallavalle</span>. </span><span class="cited-content_cbyCitation_article-title">3-Arylidene-
              N
              -hydroxyoxindoles: A New Class of Compounds Endowed with Antitumor Activity. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (16)
                                     , 1700-1704. <a href="https://doi.org/10.1002/cmdc.201600225" title="DOI URL">https://doi.org/10.1002/cmdc.201600225</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201600225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201600225%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3D3-Arylidene-%252BN%252B-hydroxyoxindoles%25253A%252BA%252BNew%252BClass%252Bof%252BCompounds%252BEndowed%252Bwith%252BAntitumor%252BActivity%26aulast%3DMusso%26aufirst%3DLoana%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D16%26spage%3D1700%26epage%3D1704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kishna Ram  Senwar</span>, <span class="hlFld-ContribAuthor ">T. Srinivasa  Reddy</span>, <span class="hlFld-ContribAuthor ">Dinesh  Thummuri</span>, <span class="hlFld-ContribAuthor ">Pankaj  Sharma</span>, <span class="hlFld-ContribAuthor ">Suresh K.  Bharghava</span>, <span class="hlFld-ContribAuthor ">V.G.M.  Naidu</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of 4′-O-alkylamino-tethered-benzylideneindolin-2-ones as potent cytotoxic and apoptosis inducing agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (16)
                                     , 4061-4069. <a href="https://doi.org/10.1016/j.bmcl.2016.06.077" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.06.077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.06.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.06.077%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252B4%2525E2%252580%2525B2-O-alkylamino-tethered-benzylideneindolin-2-ones%252Bas%252Bpotent%252Bcytotoxic%252Band%252Bapoptosis%252Binducing%252Bagents%26aulast%3DSenwar%26aufirst%3DKishna%2BRam%26date%3D2016%26volume%3D26%26issue%3D16%26spage%3D4061%26epage%3D4069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tak  Mak</span>. </span><span class="cited-content_cbyCitation_article-title">A Journey in Science: “Not Lost in Translation”. </span><span class="cited-content_cbyCitation_journal-name">Molecular Medicine</span><span> <strong>2016,</strong> <em>22 </em>
                                    (1)
                                     , 675-679. <a href="https://doi.org/10.2119/molmed.2016.00176" title="DOI URL">https://doi.org/10.2119/molmed.2016.00176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2119/molmed.2016.00176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2119%2Fmolmed.2016.00176%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Medicine%26atitle%3DA%252BJourney%252Bin%252BScience%25253A%252B%2525E2%252580%25259CNot%252BLost%252Bin%252BTranslation%2525E2%252580%25259D%26aulast%3DMak%26aufirst%3DTak%26date%3D2016%26date%3D2016%26volume%3D22%26issue%3D1%26spage%3D675%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tyler C.  Moyer</span>, <span class="hlFld-ContribAuthor ">Kevin M.  Clutario</span>, <span class="hlFld-ContribAuthor ">Bramwell G.  Lambrus</span>, <span class="hlFld-ContribAuthor ">Vikas  Daggubati</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Holland</span>. </span><span class="cited-content_cbyCitation_article-title">Binding of STIL to Plk4 activates kinase activity to promote centriole assembly. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cell Biology</span><span> <strong>2015,</strong> <em>209 </em>
                                    (6)
                                     , 863-878. <a href="https://doi.org/10.1083/jcb.201502088" title="DOI URL">https://doi.org/10.1083/jcb.201502088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1083/jcb.201502088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1083%2Fjcb.201502088%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cell%2520Biology%26atitle%3DBinding%252Bof%252BSTIL%252Bto%252BPlk4%252Bactivates%252Bkinase%252Bactivity%252Bto%252Bpromote%252Bcentriole%252Bassembly%26aulast%3DMoyer%26aufirst%3DTyler%2BC.%26date%3D2015%26date%3D2015%26volume%3D209%26issue%3D6%26spage%3D863%26epage%3D878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoqi  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Translational Oncology</span><span> <strong>2015,</strong> <em>8 </em>
                                    (3)
                                     , 185-195. <a href="https://doi.org/10.1016/j.tranon.2015.03.010" title="DOI URL">https://doi.org/10.1016/j.tranon.2015.03.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tranon.2015.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tranon.2015.03.010%26sid%3Dliteratum%253Aachs%26jtitle%3DTranslational%2520Oncology%26atitle%3DTargeting%252BPolo-Like%252BKinases%25253A%252BA%252BPromising%252BTherapeutic%252BApproach%252Bfor%252BCancer%252BTreatment%26aulast%3DLiu%26aufirst%3DXiaoqi%26date%3D2015%26volume%3D8%26issue%3D3%26spage%3D185%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C O  Rosario</span>, <span class="hlFld-ContribAuthor ">K  Kazazian</span>, <span class="hlFld-ContribAuthor ">F S W  Zih</span>, <span class="hlFld-ContribAuthor ">O  Brashavitskaya</span>, <span class="hlFld-ContribAuthor ">Y  Haffani</span>, <span class="hlFld-ContribAuthor ">R S Z  Xu</span>, <span class="hlFld-ContribAuthor ">A  George</span>, <span class="hlFld-ContribAuthor ">J W  Dennis</span>, <span class="hlFld-ContribAuthor ">C J  Swallow</span>. </span><span class="cited-content_cbyCitation_article-title">A novel role for Plk4 in regulating cell spreading and motility. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2015,</strong> <em>34 </em>
                                    (26)
                                     , 3441-3451. <a href="https://doi.org/10.1038/onc.2014.275" title="DOI URL">https://doi.org/10.1038/onc.2014.275</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/onc.2014.275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fonc.2014.275%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DA%252Bnovel%252Brole%252Bfor%252BPlk4%252Bin%252Bregulating%252Bcell%252Bspreading%252Band%252Bmotility%26aulast%3DRosario%26aufirst%3DC%2BO%26date%3D2015%26date%3D2014%26volume%3D34%26issue%3D26%26spage%3D3441%26epage%3D3451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Yu</span>, <span class="hlFld-ContribAuthor ">Ping-Ping  Qi</span>, <span class="hlFld-ContribAuthor ">De-Quan  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of orally active anticancer candidate CFI-400945 derived from biologically promising spirooxindoles: Success and challenges. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>95 </em>, 35-40. <a href="https://doi.org/10.1016/j.ejmech.2015.03.020" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.03.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.03.020%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Borally%252Bactive%252Banticancer%252Bcandidate%252BCFI-400945%252Bderived%252Bfrom%252Bbiologically%252Bpromising%252Bspirooxindoles%25253A%252BSuccess%252Band%252Bchallenges%26aulast%3DYu%26aufirst%3DBin%26date%3D2015%26volume%3D95%26spage%3D35%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rita  Meleddu</span>, <span class="hlFld-ContribAuthor ">Simona  Distinto</span>, <span class="hlFld-ContribAuthor ">Angela  Corona</span>, <span class="hlFld-ContribAuthor ">Giulia  Bianco</span>, <span class="hlFld-ContribAuthor ">Valeria  Cannas</span>, <span class="hlFld-ContribAuthor ">Francesca  Esposito</span>, <span class="hlFld-ContribAuthor ">Anna  Artese</span>, <span class="hlFld-ContribAuthor ">Stefano  Alcaro</span>, <span class="hlFld-ContribAuthor ">Peter  Matyus</span>, <span class="hlFld-ContribAuthor ">Dora  Bogdan</span>, <span class="hlFld-ContribAuthor ">Filippo  Cottiglia</span>, <span class="hlFld-ContribAuthor ">Enzo  Tramontano</span>, <span class="hlFld-ContribAuthor ">Elias  Maccioni</span>. </span><span class="cited-content_cbyCitation_article-title">(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>93 </em>, 452-460. <a href="https://doi.org/10.1016/j.ejmech.2015.02.032" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.02.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.02.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.02.032%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%2525283Z%252529-3-%2525282-%25255B4-%252528aryl%252529-1%25252C3-thiazol-2-yl%25255Dhydrazin-1-ylidene%252529-2%25252C3-dihydro-1H-indol-2-one%252Bderivatives%252Bas%252Bdual%252Binhibitors%252Bof%252BHIV-1%252Breverse%252Btranscriptase%26aulast%3DMeleddu%26aufirst%3DRita%26date%3D2015%26volume%3D93%26spage%3D452%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wagdy M.  Eldehna</span>, <span class="hlFld-ContribAuthor ">Ayman  Altoukhy</span>, <span class="hlFld-ContribAuthor ">Hoda  Mahrous</span>, <span class="hlFld-ContribAuthor ">Hatem A.  Abdel-Aziz</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>90 </em>, 684-694. <a href="https://doi.org/10.1016/j.ejmech.2014.12.010" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.12.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.12.010%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252BQSAR%252Bstudy%252Bof%252Bcertain%252Bisatin-pyridine%252Bhybrids%252Bas%252Bpotential%252Banti-proliferative%252Bagents%26aulast%3DEldehna%26aufirst%3DWagdy%2BM.%26date%3D2015%26volume%3D90%26spage%3D684%26epage%3D694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Radoslaw  Laufer</span>, <span class="hlFld-ContribAuthor ">Grace  Ng</span>, <span class="hlFld-ContribAuthor ">Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Narendra Kumar B.  Patel</span>, <span class="hlFld-ContribAuthor ">Louise G.  Edwards</span>, <span class="hlFld-ContribAuthor ">Yunhui  Lang</span>, <span class="hlFld-ContribAuthor ">Sze-Wan  Li</span>, <span class="hlFld-ContribAuthor ">Miklos  Feher</span>, <span class="hlFld-ContribAuthor ">Don E.  Awrey</span>, <span class="hlFld-ContribAuthor ">Genie  Leung</span>, <span class="hlFld-ContribAuthor ">Irina  Beletskaya</span>, <span class="hlFld-ContribAuthor ">Olga  Plotnikova</span>, <span class="hlFld-ContribAuthor ">Jacqueline M.  Mason</span>, <span class="hlFld-ContribAuthor ">Richard  Hodgson</span>, <span class="hlFld-ContribAuthor ">Xin  Wei</span>, <span class="hlFld-ContribAuthor ">Guodong  Mao</span>, <span class="hlFld-ContribAuthor ">Xunyi  Luo</span>, <span class="hlFld-ContribAuthor ">Ping  Huang</span>, <span class="hlFld-ContribAuthor ">Erin  Green</span>, <span class="hlFld-ContribAuthor ">Reza  Kiarash</span>, <span class="hlFld-ContribAuthor ">Dan Chi-Chia  Lin</span>, <span class="hlFld-ContribAuthor ">Marees  Harris-Brandts</span>, <span class="hlFld-ContribAuthor ">Fuqiang  Ban</span>, <span class="hlFld-ContribAuthor ">Vincent  Nadeem</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>, <span class="hlFld-ContribAuthor ">Guohua J.  Pan</span>, <span class="hlFld-ContribAuthor ">Wei  Qiu</span>, <span class="hlFld-ContribAuthor ">Nickolay Y.  Chirgadze</span>, <span class="hlFld-ContribAuthor ">Henry W.  Pauls</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (17)
                                     , 4968-4997. <a href="https://doi.org/10.1016/j.bmc.2014.06.027" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.06.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.06.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Binhibitors%252Bof%252Bthe%252Bmitotic%252Bkinase%252BTTK%252Bbased%252Bon%252BN-%2525283-%2525283-sulfamoylphenyl%252529-1H-indazol-5-yl%252529-acetamides%252Band%252Bcarboxamides%26aulast%3DLaufer%26aufirst%3DRadoslaw%26date%3D2014%26volume%3D22%26issue%3D17%26spage%3D4968%26epage%3D4997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandra N  Craig</span>, <span class="hlFld-ContribAuthor ">Michael D  Wyatt</span>, <span class="hlFld-ContribAuthor ">Campbell  McInnes</span>. </span><span class="cited-content_cbyCitation_article-title">Current assessment of polo-like kinases as anti-tumor drug targets. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2014,</strong> <em>9 </em>
                                    (7)
                                     , 773-789. <a href="https://doi.org/10.1517/17460441.2014.918100" title="DOI URL">https://doi.org/10.1517/17460441.2014.918100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2014.918100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2014.918100%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DCurrent%252Bassessment%252Bof%252Bpolo-like%252Bkinases%252Bas%252Banti-tumor%252Bdrug%252Btargets%26aulast%3DCraig%26aufirst%3DSandra%2BN%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D7%26spage%3D773%26epage%3D789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Inês  Cunha-Ferreira</span>, <span class="hlFld-ContribAuthor ">Inês  Bento</span>, <span class="hlFld-ContribAuthor ">Ana  Pimenta-Marques</span>, <span class="hlFld-ContribAuthor ">Swadhin Chandra  Jana</span>, <span class="hlFld-ContribAuthor ">Mariana  Lince-Faria</span>, <span class="hlFld-ContribAuthor ">Paulo  Duarte</span>, <span class="hlFld-ContribAuthor ">Joana  Borrego-Pinto</span>, <span class="hlFld-ContribAuthor ">Samuel  Gilberto</span>, <span class="hlFld-ContribAuthor ">Tiago  Amado</span>, <span class="hlFld-ContribAuthor ">Daniela  Brito</span>, <span class="hlFld-ContribAuthor ">Ana  Rodrigues-Martins</span>, <span class="hlFld-ContribAuthor ">Janusz  Debski</span>, <span class="hlFld-ContribAuthor ">Nikola  Dzhindzhev</span>, <span class="hlFld-ContribAuthor ">Mónica  Bettencourt-Dias</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation of Autophosphorylation Controls PLK4 Self-Destruction and Centriole Number. </span><span class="cited-content_cbyCitation_journal-name">Current Biology</span><span> <strong>2013,</strong> <em>23 </em>
                                    (22)
                                     , 2245-2254. <a href="https://doi.org/10.1016/j.cub.2013.09.037" title="DOI URL">https://doi.org/10.1016/j.cub.2013.09.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cub.2013.09.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cub.2013.09.037%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Biology%26atitle%3DRegulation%252Bof%252BAutophosphorylation%252BControls%252BPLK4%252BSelf-Destruction%252Band%252BCentriole%252BNumber%26aulast%3DCunha-Ferreira%26aufirst%3DIn%25C3%25AAs%26date%3D2013%26volume%3D23%26issue%3D22%26spage%3D2245%26epage%3D2254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0016.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Reported PLK4 Activity of Known Kinase Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (left panel) Overlay of the highest scoring binding modes of compounds <b>11</b> (green) and <b>15</b> (gray) in the PLK4 homology (generated from Aurora-A structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BMC">2BMC</a>). H-bonds to hinge region shown as dashed lines. (right panel) Bioisosteric replacement of phenol with benzotriazole and indazoles.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of (1<i>H</i>-Indazol-6-yl)methylene)indolin-2-ones</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Approach to Substituted (1<i>H</i>-Indazol-6-yl)methylene)indolin-2-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Me<sub>3</sub>SiCH<sub>2</sub>CH<sub>2</sub>OCH<sub>2</sub>Cl, DCM, H<sub>2</sub>O, KOH, TBAB; (b) Pd(OAc)<sub>2</sub>, P(<i>o</i>-tol)<sub>3</sub>, DIPEA, DMF, 100 °C, vinylarene; (c) piperidine, MeOH, Δ; (d) TBAF, THF, Δ or BF<sub>3</sub>OEt<sub>2</sub>, DCM; 2 M aq HCl, EtOH, Δ; (e) dialkyl arylmethylphosphonate, <i>t</i>-BuOK, DMF; (f) Ra-Ni, Na<sub>2</sub>PO<sub>2</sub>H<sub>2</sub>, Δ; (g) NaOH, H<sub>2</sub>O, THF, MeOH.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding modes of (<i>E</i>)-3-((1<i>H</i>-indazol-6-yl)methylene)indolin-2-one, compound <b>17</b>, in PLK4 homology model (generated from Aurora-A structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BMC">2BMC</a>). (left panel) Mode 1 with H-bonds from indolinone moiety to hinge region and H-bond to Leu18. (right panel) Mode 2 with H-bonds from indazole moiety to the hinge region and H-bonds to Lys41 and Asp154.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding modes of PLK4 inhibitors in the modified <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK">3COK</a> PLK4 structure. (left panel) Compound <b>37</b> with H-bonds to hinge region and Asp154; hydrophobic interaction between the side chain of Leu18 and pyridyl ring shown by a dotted line. (right panel) Compound <b>44</b> with a surface on PLK4 active site; pyridyl nitrogen sits at enzyme/solvent interface and the OMe moiety nestles in a groove bounded by the protein backbone and the side chains of Leu143 and Glu96.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cell Cycle analysis of in MDA-MB-468 cells treated with PLK4 inhibitor <b>41</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Correlation of pGI<sub>50</sub> measured with pGI<sub>50</sub> calculated for PLK4 inhibitors in the MDA-MB-468 cell line. QSAR analysis established that three independent variables are sufficient to describe pGI<sub>50</sub> calcd, namely pIC<sub>50</sub>PLK4, molecular volume, and log <i>P</i> with <i>R</i><sup>2</sup> of 0.52 and RMSE of 0.62 (<i>n</i> = 181).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Heat map showing % inhibition of 274 human kinases at a screening concentration of 1 μM for compound <b>50</b> in comparison to Axitinib and Sunitinib. Compounds were individually sorted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/medium/jm-2013-00380m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Average tumor volume (TV) and average weight (Wt) vs days of treatment with compound <b>50</b> (25 mg/kg IP) and VX680 (50 mg/kg IP) in an MDA-MB-468 mouse xenograft model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400380m/production/images/large/jm-2013-00380m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400380m&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i88">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45881" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45881" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 56 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dar, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl S. Huang, P. S.</span><span> </span><span class="NLM_article-title">Targeted anti-mitotic therapies: can we improve on tubulin agents?</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1038%2Fnrc2049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=17251917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFOjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=107-117&author=J.+R.+Jacksonauthor=D.+R.+Patrickauthor=M.+M.+Darauthor=P.+S.+Pearl+S.+Huang&title=Targeted+anti-mitotic+therapies%3A+can+we+improve+on+tubulin+agents%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted anti-mitotic therapies: can we improve on tubulin agents?</span></div><div class="casAuthors">Jackson, Jeffrey R.; Patrick, Denis R.; Dar, Mohammed M.; Huang, Pearl S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-117</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The advent of molecularly targeted drug discovery has facilitated the identification of a new generation of anti-mitotic therapies that target proteins with specific functions in mitosis.  The exquisite selectivity for mitosis and the distinct ways in which these new agents interfere with mitosis provides the potential to not only overcome certain limitations of current tubulin-targeted anti-mitotic drugs, but to expand the scope of clin. efficacy that those drugs have established.  The development of these new anti-mitotic drugs as targeted therapies faces significant challenges; nevertheless, these potential therapies also serve as unique tools to dissect the mol. mechanisms of the mitotic-checkpoint response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTEI9t3GggVrVg90H21EOLACvtfcHk0ljvHp-Gl7a2ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFOjtA%253D%253D&md5=67a94114629154b9be66428e697835bc</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc2049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2049%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DPatrick%26aufirst%3DD.%2BR.%26aulast%3DDar%26aufirst%3DM.%2BM.%26aulast%3DPearl%2BS.%2BHuang%26aufirst%3DP.%2BS.%26atitle%3DTargeted%2520anti-mitotic%2520therapies%253A%2520can%2520we%2520improve%2520on%2520tubulin%2520agents%253F%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D107%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span> </span><span class="NLM_article-title">Kinesin spindle protein inhibitors as anticancer agents</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1517</span><span class="NLM_x">–</span> <span class="NLM_lpage">1532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1517%2F13543776.16.11.1517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFems7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1517-1532&author=C.+Jiangauthor=Q.+Youauthor=Z.+Liauthor=Q.+Guo&title=Kinesin+spindle+protein+inhibitors+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Kinesin spindle protein inhibitors as anticancer agents</span></div><div class="casAuthors">Jiang, Cheng; You, Qidong; Li, Zhiyu; Guo, Qinglong</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1517-1532</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Kinesin spindle protein (KSP), or Hs Eg5, is a member of the kinesin superfamily of mol. motor proteins that utilize the energy generated from the hydrolysis of ATP to transport vesicles, organelles and microtubules.  KSP plays essential roles in mitotic spindle function and its inhibition prevents normal bipolar spindle formation, leading to mitotic arrest and subsequently to apoptosis of cells.  Therefore, KSP inhibitors have potential as novel anticancer therapeutics.  Since the discovery of monastrol in 1999, many types of KSP inhibitors were reported.  This review describes the mechanism of action and development of different types of KSP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqah-wXCZWf6bVg90H21EOLACvtfcHk0ljvHp-Gl7a2ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFems7jK&md5=dd6d0bb463788d201533de28696f5554</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F13543776.16.11.1517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.16.11.1517%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DQ.%26atitle%3DKinesin%2520spindle%2520protein%2520inhibitors%2520as%2520anticancer%2520agents%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2006%26volume%3D16%26spage%3D1517%26epage%3D1532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastians, H.</span><span> </span><span class="NLM_article-title">Mitotic drug targets and the development of novel anti-mitotic anticancer drugs</span> <span class="citation_source-journal">Drug Res. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">162</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1016%2Fj.drup.2007.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=17669681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFWhs73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=162-181&author=M.+Schmidtauthor=H.+Bastians&title=Mitotic+drug+targets+and+the+development+of+novel+anti-mitotic+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic drug targets and the development of novel anti-mitotic anticancer drugs</span></div><div class="casAuthors">Schmidt, Mathias; Bastians, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">162-181</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Drugs that interfere with the normal progression of mitosis belong to the most successful chemotherapeutic compds. currently used for anti-cancer treatment.  Classically, these drugs are represented by microtubule binding drugs that inhibit the function of the mitotic spindle in order to halt the cell cycle in mitosis and to induce apoptosis in tumor cells.  However, these compds. act not only on proliferating tumor cells, but exhibit significant side effects on non-proliferating cells including neurons that are highly dependent on intracellular transport processes mediated by microtubules.  Therefore, there is a particular interest in developing novel anti-mitotic drugs that target non-microtubule structures.  In fact, recently several novel drugs that target mitotic kinesins or the Aurora and polo-like kinases have been developed and are currently tested in clin. trials.  In addn., approaches of cell cycle checkpoint abrogation during mitosis and at the G2/M transition inducing mitosis-assocd. tumor cell death are promising new strategies for anti-cancer therapy.  It is expected that this "next generation" of anti-mitotic drugs will be as successful as the classical anti-microtubule drugs, while avoiding some of the adverse side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiOJi9lDecBLVg90H21EOLACvtfcHk0ljvHp-Gl7a2ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFWhs73N&md5=b7262b3578e6daaad41412780d022937</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2007.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2007.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DBastians%26aufirst%3DH.%26atitle%3DMitotic%2520drug%2520targets%2520and%2520the%2520development%2520of%2520novel%2520anti-mitotic%2520anticancer%2520drugs%26jtitle%3DDrug%2520Res.%2520Updates%26date%3D2007%26volume%3D10%26spage%3D162%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Vermeulen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Bockstaele, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berneman, Z. N.</span><span> </span><span class="NLM_article-title">The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer</span> <span class="citation_source-journal">Cell Proliferation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1046%2Fj.1365-2184.2003.00266.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=12814430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtVOitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2003&pages=131-149&author=K.+Vermeulenauthor=D.+R.+Van+Bockstaeleauthor=Z.+N.+Berneman&title=The+cell+cycle%3A+a+review+of+regulation%2C+deregulation+and+therapeutic+targets+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer</span></div><div class="casAuthors">Vermeulen, Katrien; Van Bockstaele, Dirk R.; Berneman, Zwi N.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Proliferation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">131-149</span>CODEN:
                <span class="NLM_cas:coden">CPROEM</span>;
        ISSN:<span class="NLM_cas:issn">0960-7722</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The cell cycle is controlled by numerous mechanisms ensuring correct cell division.  This review will focus on these mechanisms, i.e. regulation of cyclin-dependent kinases (CDK) by cyclins, CDK inhibitors and phosphorylating events.  The quality checkpoints activated after DNA damage are also discussed.  The complexity of the regulation of the cell cycle is also reflected in the different alterations leading to aberrant cell proliferation and development of cancer.  Consequently, targeting the cell cycle in general and CDK in particular presents unique opportunities for drug discovery.  This review provides an overview of deregulation of the cell cycle in cancer.  Different families of known CDK inhibitors acting by ATP competition are also discussed.  Currently, at least three compds. with CDK inhibitory activity (flavopiridol, UCN-01, roscovitine) have entered clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWE0B9C2jWSbVg90H21EOLACvtfcHk0lh2mkJIxpBvcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtVOitr4%253D&md5=295d73cbc7b74c6dede9c1e99bc87d30</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2184.2003.00266.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2184.2003.00266.x%26sid%3Dliteratum%253Aachs%26aulast%3DVermeulen%26aufirst%3DK.%26aulast%3DVan%2BBockstaele%26aufirst%3DD.%2BR.%26aulast%3DBerneman%26aufirst%3DZ.%2BN.%26atitle%3DThe%2520cell%2520cycle%253A%2520a%2520review%2520of%2520regulation%252C%2520deregulation%2520and%2520therapeutic%2520targets%2520in%2520cancer%26jtitle%3DCell%2520Proliferation%26date%3D2003%26volume%3D36%26spage%3D131%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Green, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolery, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahadevan, D.</span><span> </span><span class="NLM_article-title">Update on aurora kinase targeted therapeutics in oncology</span> <span class="citation_source-journal">Exp. Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1517%2F17460441.2011.555395" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=291-307&author=M.+R.+Greenauthor=J.+E.+Wooleryauthor=D.+Mahadevan&title=Update+on+aurora+kinase+targeted+therapeutics+in+oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F17460441.2011.555395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2011.555395%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DM.%2BR.%26aulast%3DWoolery%26aufirst%3DJ.%2BE.%26aulast%3DMahadevan%26aufirst%3DD.%26atitle%3DUpdate%2520on%2520aurora%2520kinase%2520targeted%2520therapeutics%2520in%2520oncology%26jtitle%3DExp.%2520Opin.%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D291%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Degenhardt, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampkin, T.</span><span> </span><span class="NLM_article-title">Targeting polo-like kinase in cancer therapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1158%2F1078-0432.CCR-09-1380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=20068088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktF2qsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=384-389&author=Y.+Degenhardtauthor=T.+Lampkin&title=Targeting+polo-like+kinase+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting polo-like kinase in cancer therapy</span></div><div class="casAuthors">Degenhardt, Yan; Lampkin, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">384-389</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Polo-like kinases (Plk) function in mitosis and maintaining DNA integrity.  There are four family members, of which Plk1 represents a target for anticancer therapy.  Plk1 is only expressed in dividing cells with peak expression during G2/M.  Plk1 functions in multiple steps of mitosis, and is overexpressed in many tumor types.  Mitotic arrest and inhibition of proliferation, apoptosis, and tumor growth inhibition have been obsd. in preclin. studies using small interfering RNAs (siRNA) or small mols. that inhibit Plk1.  Preclin. studies also show that Plk1 inhibitors may be active against tumors with RAS mutations and that tumor cells with mutations in TP53 are more sensitive to inhibition of Plk1.  Several Plk inhibitors are in phase I or II clin. studies.  As expected, hematol. toxicity is the primary dose-limiting toxicity.  Some patients have achieved clin. response, although in some studies only at doses above the max. tolerated dose defined in the study.  Further evaluation is necessary to discern the clin. utility of Plk1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp-WiWxvJiS7Vg90H21EOLACvtfcHk0lh2mkJIxpBvcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktF2qsbw%253D&md5=94d00dd707dc1ca59ed9d58b0099ba89</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-1380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-1380%26sid%3Dliteratum%253Aachs%26aulast%3DDegenhardt%26aufirst%3DY.%26aulast%3DLampkin%26aufirst%3DT.%26atitle%3DTargeting%2520polo-like%2520kinase%2520in%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2010%26volume%3D16%26spage%3D384%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Coley, H. M.</span><span> </span><span class="NLM_article-title">Targeting the cell cycle as a strategy for treating cancer</span>. In  <span class="citation_source-book">Kenichi Trends in Cell Cycle Research</span>; <span class="NLM_contrib-group">Yoshida, K.</span>, Ed.; <span class="NLM_publisher-name">Research Signpost</span>: <span class="NLM_publisher-loc">Kerala, India</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">, </span>pp  <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=237-259&author=H.+M.+Coleyauthor=K.+Yoshida&title=Kenichi+Trends+in+Cell+Cycle+Research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DColey%26aufirst%3DH.%2BM.%26atitle%3DTargeting%2520the%2520cell%2520cycle%2520as%2520a%2520strategy%2520for%2520treating%2520cancer%26btitle%3DKenichi%2520Trends%2520in%2520Cell%2520Cycle%2520Research%26aulast%3DYoshida%26aufirst%3DK.%26pub%3DResearch%2520Signpost%26date%3D2008%26spage%3D237%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Dotan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, R. B.</span><span> </span><span class="NLM_article-title">The ongoing roll-out of aurora kinase inhibitors in cancer treatment</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">845</span><span class="NLM_x">–</span> <span class="NLM_lpage">858</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1358%2Fdof.2010.035.010.1529819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ejsL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=845-858&author=E.+Dotanauthor=R.+B.+Cohen&title=The+ongoing+roll-out+of+aurora+kinase+inhibitors+in+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The ongoing roll-out of aurora kinase inhibitors in cancer treatment</span></div><div class="casAuthors">Dotan, E.; Cohen, R. B.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">845-858</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The Aurora kinase family comprises three important regulatory proteins of mitosis: Aurora kinases A, B and C.  Their dysfunction is assocd. with abnormal cell division, aneuploidy and possibly tumorigenesis.  In addn., overexpression and/or amplification of Aurora kinase A or B has been demonstrated in various cancers.  These observations suggested that the Aurora kinases might be attractive therapeutic targets in oncol.  Drugs targeting the mitotic spindle such as taxanes and vinca alkaloids have been notably successful in cancer medicine.  The Aurora kinase inhibitors represent the latest entrants into this arena.  Inhibitors of Aurora kinases have shown promising results in preclin. studies, and are currently under evaluation in numerous clin. trials.  Considerable addnl. work will be required in order to optimize their use in the clinic, including identifying biomarkers for selection of sensitive tumors, refining the administration schedule of these agents and developing useful combinations of Aurora kinase inhibitors with existing cancer therapeutics.  This review article will summarize the function of each of the Aurora kinases, with emphasis on their role in tumorigenesis and interactions with other cellular pathways that govern tumor biol.  It also discusses those inhibitors that are in the clinic and summarizes the early clin. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovB0C-h4cVGrVg90H21EOLACvtfcHk0lhfx0vWbf4AiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ejsL7L&md5=bae3d45b260f45c678ab863cceb5e292</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1358%2Fdof.2010.035.010.1529819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2010.035.010.1529819%26sid%3Dliteratum%253Aachs%26aulast%3DDotan%26aufirst%3DE.%26aulast%3DCohen%26aufirst%3DR.%2BB.%26atitle%3DThe%2520ongoing%2520roll-out%2520of%2520aurora%2520kinase%2520inhibitors%2520in%2520cancer%2520treatment%26jtitle%3DDrugs%2520Future%26date%3D2010%26volume%3D35%26spage%3D845%26epage%3D858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Archambault, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, D. M.</span><span> </span><span class="NLM_article-title">Polo-like kinases: conservation and divergence in their functions and regulation</span> <span class="citation_source-journal">Nature Rev., Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1038%2Fnrm2653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=19305416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVCqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=265-275&author=V.+Archambaultauthor=D.+M.+Glover&title=Polo-like+kinases%3A+conservation+and+divergence+in+their+functions+and+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinases: conservation and divergence in their functions and regulation</span></div><div class="casAuthors">Archambault, Vincent; Glover, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">265-275</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Polo-like kinases (Plks) are potent regulators of M-phase that are conserved from yeasts to humans.  Their roles in mitotic entry, spindle pole functions, and cytokinesis are broadly conserved despite phys. and mol. differences in these processes in disparate organisms.  Plks are characterized by their Polo-box domain, which mediates protein interactions.  They are addnl. controlled by phosphorylation, proteolysis, and transcription, depending on the biol. context.  Plks are now recognized to link cell division to developmental processes and to function in differentiated cells.  A comparison of Plk function and regulation between organisms offers insight into the rich variations of cell division.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMIkNbJzhkm7Vg90H21EOLACvtfcHk0lhfx0vWbf4AiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVCqu7o%253D&md5=6f9339e80588d04f5f156f1900718193</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrm2653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2653%26sid%3Dliteratum%253Aachs%26aulast%3DArchambault%26aufirst%3DV.%26aulast%3DGlover%26aufirst%3DD.%2BM.%26atitle%3DPolo-like%2520kinases%253A%2520conservation%2520and%2520divergence%2520in%2520their%2520functions%2520and%2520regulation%26jtitle%3DNature%2520Rev.%252C%2520Mol.%2520Cell%2520Biol.%26date%3D2009%26volume%3D10%26spage%3D265%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Barr, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silljé, H. H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">Polo-like kinases and the orchestration of cell division</span> <span class="citation_source-journal">Nature Rev. Mod. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1038%2Fnrm1401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=15173822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVarsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=429-440&author=F.+A.+Barrauthor=H.+H.+W.+Sillj%C3%A9author=E.+A.+Nigg&title=Polo-like+kinases+and+the+orchestration+of+cell+division"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinases and the orchestration of cell division</span></div><div class="casAuthors">Barr, Francis A.; Sillje, Herman H. W.; Nigg, Erich A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">429-441</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Polo-like kinases (Plks) are increasingly recognized as key regulators of mitosis, meiosis and cytokinesis.  In agreement with a broad range of proposed functions during cell division, Plks are subject to complex temporal and spatial control.  Recent findings are uncovering the mechanisms of Plk regulation, notably their targeting to different cellular structures through interactions with phosphorylated docking proteins.  Moreover, information is emerging on the substrate specificity of Plks and the role of individual substrates in M-phase progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLN4E8Z5Hjq7Vg90H21EOLACvtfcHk0lhfx0vWbf4AiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVarsLk%253D&md5=8c11ac86d8b157dfa74ab95841e9eba0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrm1401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1401%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DF.%2BA.%26aulast%3DSillj%25C3%25A9%26aufirst%3DH.%2BH.%2BW.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DPolo-like%2520kinases%2520and%2520the%2520orchestration%2520of%2520cell%2520division%26jtitle%3DNature%2520Rev.%2520Mod.%2520Cell%26date%3D2004%26volume%3D5%26spage%3D429%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Schoffski, P.</span><span> </span><span class="NLM_article-title">Polo-like kinase inhibitors in preclinical and early clinical development</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=559-570&author=P.+Schoffski&title=Polo-like+kinase+inhibitors+in+preclinical+and+early+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchoffski%26aufirst%3DP.%26atitle%3DPolo-like%2520kinase%2520inhibitors%2520in%2520preclinical%2520and%2520early%2520clinical%2520development%26jtitle%3DOncologist%26date%3D2009%26volume%3D14%26spage%3D559%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Sillibourne, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornens, M.</span><span> </span><span class="NLM_article-title">Polo-like kinase 4: the odd one out of the family</span> <span class="citation_source-journal">Cell Div.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1186%2F1747-1028-5-25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=20920249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A280%3ADC%252BC3cfovVygug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=25-34&author=J.+E.+Sillibourneauthor=M.+Bornens&title=Polo-like+kinase+4%3A+the+odd+one+out+of+the+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinase 4: the odd one out of the family</span></div><div class="casAuthors">Sillibourne James E; Bornens Michel</div><div class="citationInfo"><span class="NLM_cas:title">Cell division</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> Polo-like kinase 4 (PLK4) is a unique member of the Polo-like family of kinases that shares little homology with its siblings and has an essential role in centriole duplication.  The turn-over of this kinase must be strictly controlled to prevent centriole amplification.  This is achieved, in part, by an autoregulatory mechanism, whereby PLK4 autophosphorylates residues in a PEST sequence located carboxy-terminal to its catalytic domain.  Phosphorylated PLK4 is subsequently recognized by the SCF complex, ubiquitinylated and targeted to the proteasome for degradation.  Recent data have also shown that active PLK4 is restricted to the centrosome, a mechanism that could serve to prevent aberrant centriole assembly elsewhere in the cell.  While significant advances have been made in understanding how PLK4 is regulated it is certain that additional regulatory mechanisms exist to safeguard the fidelity of centriole duplication.  Here, we overview past and present data discussing the regulation and functions of PLK4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQklC7aPJn_9mhHGZei4OW9fW6udTcc2eZASm_2CTKMYLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfovVygug%253D%253D&md5=bfde20a11fdea2a94976f97ced04e63d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1186%2F1747-1028-5-25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1747-1028-5-25%26sid%3Dliteratum%253Aachs%26aulast%3DSillibourne%26aufirst%3DJ.%2BE.%26aulast%3DBornens%26aufirst%3DM.%26atitle%3DPolo-like%2520kinase%25204%253A%2520the%2520odd%2520one%2520out%2520of%2520the%2520family%26jtitle%3DCell%2520Div.%26date%3D2010%26volume%3D5%26spage%3D25%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Bettencourt-Dias, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues-Martins, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riparbelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatt, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balloux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, D. M.</span><span> </span><span class="NLM_article-title">SAK/PLK4 is required for centriole duplication and flagella development</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2199</span><span class="NLM_x">–</span> <span class="NLM_lpage">2207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1016%2Fj.cub.2005.11.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=16326102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlahu7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2199-2207&author=M.+Bettencourt-Diasauthor=A.+Rodrigues-Martinsauthor=L.+Carpenterauthor=M.+Riparbelliauthor=L.+Lehmannauthor=M.+K.+Gattauthor=N.+Carmoauthor=F.+Ballouxauthor=G.+Callainiauthor=D.+M.+Glover&title=SAK%2FPLK4+is+required+for+centriole+duplication+and+flagella+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">SAK/PLK4 Is Required for Centriole Duplication and Flagella Development</span></div><div class="casAuthors">Bettencourt-Dias, M.; Rodrigues-Martins, A.; Carpenter, L.; Riparbelli, M.; Lehmann, L.; Gatt, M. K.; Carmo, N.; Balloux, F.; Callaini, G.; Glover, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2199-2207</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">SAK/PLK4 is a distinct member of the polo-like kinase family.  SAK-/- mice die during embryogenesis, whereas SAK+/- mice develop liver and lung tumors and SAK+/- MEFs show mitotic abnormalities.  However, the mechanism underlying these phenotypes is still not known.  Here, the authors show that downregulation of SAK in Drosophila cells, by mutation or RNAi, leads to loss of centrioles, the core structures of centrosomes.  Such cells are able to undergo repeated rounds of cell division, but display broad disorganized mitotic spindle poles.  The authors also show that SAK mutants lose their centrioles during the mitotic divisions preceding male meiosis but still produce cysts of 16 primary spermatocytes as in the wild-type.  Math. modeling of the stereotyped cell divisions of spermatogenesis can account for such loss by defective centriole duplication.  The majority of spermatids in SAK mutants lack centrioles and so are unable to make sperm axonemes.  Finally, the authors show that depletion of SAK in human cells also prevents centriole duplication and gives rise to mitotic abnormalities.  SAK/PLK4 is necessary for centriole duplication both in Drosophila and human cells.  Drosophila cells tolerate the lack of centrioles and undertake mitosis but cannot form basal bodies and hence flagella.  Human cells depleted of SAK show error-prone mitosis, likely to underlie its tumor-suppressor role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFoGUh8x0B_7Vg90H21EOLACvtfcHk0limp5sGaeS1Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlahu7fP&md5=31069d55e1b8e6ecdaaababd791b72a7</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2005.11.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2005.11.042%26sid%3Dliteratum%253Aachs%26aulast%3DBettencourt-Dias%26aufirst%3DM.%26aulast%3DRodrigues-Martins%26aufirst%3DA.%26aulast%3DCarpenter%26aufirst%3DL.%26aulast%3DRiparbelli%26aufirst%3DM.%26aulast%3DLehmann%26aufirst%3DL.%26aulast%3DGatt%26aufirst%3DM.%2BK.%26aulast%3DCarmo%26aufirst%3DN.%26aulast%3DBalloux%26aufirst%3DF.%26aulast%3DCallaini%26aufirst%3DG.%26aulast%3DGlover%26aufirst%3DD.%2BM.%26atitle%3DSAK%252FPLK4%2520is%2520required%2520for%2520centriole%2520duplication%2520and%2520flagella%2520development%26jtitle%3DCurr.%2520Biol.%26date%3D2005%26volume%3D15%26spage%3D2199%26epage%3D2207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Habedanck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stierhof, Y.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">The Polo kinase PLK4 functions in centriole duplication</span> <span class="citation_source-journal">Nature Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1140</span><span class="NLM_x">–</span> <span class="NLM_lpage">1146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1038%2Fncb1335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=16244668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1WqtrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=1140-1146&author=R.+Habedanckauthor=Y.-D.+Stierhofauthor=C.+J.+Wilkinsonauthor=E.+A.+Nigg&title=The+Polo+kinase+PLK4+functions+in+centriole+duplication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The Polo kinase Plk4 functions in centriole duplication</span></div><div class="casAuthors">Habedanck, Robert; Stierhof, York-Dieter; Wilkinson, Christopher J.; Nigg, Erich A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1140-1146</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The human Polo-like kinase 1 (PLK1) and its functional homologs that are present in other eukaryotes have multiple, crucial roles in meiotic and mitotic cell division.  By contrast, the functions of other mammalian Polo family members remain largely unknown.  Plk4 is the most structurally divergent Polo family member; it is maximally expressed in actively dividing tissues and is essential for mouse embryonic development.  Here, we identify Plk4 as a key regulator of centriole duplication.  Both gain- and loss-of-function expts. demonstrate that Plk4 is required - in cooperation with Cdk2, CP110 and Hs-SAS6 - for the precise reprodn. of centrosomes during the cell cycle.  These findings provide an attractive explanation for the crucial function of Plk4 in cell proliferation and have implications for the role of Polo kinases in tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqCnuaYPx-YrVg90H21EOLACvtfcHk0limp5sGaeS1Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1WqtrjL&md5=dda15e878cf410e2de8796a4345aa405</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fncb1335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1335%26sid%3Dliteratum%253Aachs%26aulast%3DHabedanck%26aufirst%3DR.%26aulast%3DStierhof%26aufirst%3DY.-D.%26aulast%3DWilkinson%26aufirst%3DC.%2BJ.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DThe%2520Polo%2520kinase%2520PLK4%2520functions%2520in%2520centriole%2520duplication%26jtitle%3DNature%2520Cell%2520Biol.%26date%3D2005%26volume%3D7%26spage%3D1140%26epage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Kleylein-Sohn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westendorf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Clech, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habedanck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stierhof, Y.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">PLK4-induced centriole biogenesis in human cells</span> <span class="citation_source-journal">Dev. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=190-202&author=J.+Kleylein-Sohnauthor=J.+Westendorfauthor=M.+Le+Clechauthor=R.+Habedanckauthor=Y.-D.+Stierhofauthor=E.+A.+Nigg&title=PLK4-induced+centriole+biogenesis+in+human+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKleylein-Sohn%26aufirst%3DJ.%26aulast%3DWestendorf%26aufirst%3DJ.%26aulast%3DLe%2BClech%26aufirst%3DM.%26aulast%3DHabedanck%26aufirst%3DR.%26aulast%3DStierhof%26aufirst%3DY.-D.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DPLK4-induced%2520centriole%2520biogenesis%2520in%2520human%2520cells%26jtitle%3DDev.%2520Cell%26date%3D2007%26volume%3D13%26spage%3D190%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Peel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raff, J. W.</span><span> </span><span class="NLM_article-title">Overexpressing centriole-replication proteins in vivo induces centriole overduplication and de novo formation</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">834</span><span class="NLM_x">–</span> <span class="NLM_lpage">843</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1016%2Fj.cub.2007.04.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=17475495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1aht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=834-843&author=N.+Peelauthor=N.+R.+Stevensauthor=R.+Bastoauthor=J.+W.+Raff&title=Overexpressing+centriole-replication+proteins+in+vivo+induces+centriole+overduplication+and+de+novo+formation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpressing Centriole-Replication Proteins In Vivo Induces Centriole Overduplication and De Novo Formation</span></div><div class="casAuthors">Peel, Nina; Stevens, Naomi R.; Basto, Renata; Raff, Jordan W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">834-843</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Centrosomes have important roles in many aspects of cell organization, and aberrations in their no. and function are assocd. with various diseases, including cancer.  Centrosomes consist of a pair of centrioles surrounded by a pericentriolar matrix (PCM), and their replication is tightly regulated.  Here, we investigate the effects of overexpressing the 3 proteins known to be required for centriole replication in Drosophila: DSas-6, DSas-4, and Sak.  By directly observing centriole replication in living Drosophila embryos, we show that the overexpression of GFP-DSas-6 can drive extra rounds of centriole replication within a single cell cycle.  Extra centriole-like structures also accumulate in brain cells that overexpress either GFP-DSas-6 or GFP-Sak, but not DSas-4-GFP.  No extra centrioles accumulate in spermatocytes that overexpress any of these 3 proteins.  Most remarkably, the overexpression of any 1 of these 3 proteins results in the rapid de novo formation of many hundreds of centriole-like structures in unfertilized eggs, which normally do not contain centrioles.  Our data suggest that the levels of centriolar DSas-6 det. the no. of daughter centrioles formed during centriole replication.  Overexpression of either DSas-6 or Sak can induce the formation of extra centrioles in some tissues but not others, suggesting that centriole replication is regulated differently in different tissues.  The finding that the overexpression of DSas-4, DSas-6, or Sak can rapidly induce the de novo formation of centriole-like structures in Drosophila eggs suggests that this process results from the stabilization of centriole-precursors that are normally present in the egg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKnYNfvOO9UrVg90H21EOLACvtfcHk0lhOSjn6EIzijw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1aht78%253D&md5=87c8bdd099a367778687396dfc030e07</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2007.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2007.04.036%26sid%3Dliteratum%253Aachs%26aulast%3DPeel%26aufirst%3DN.%26aulast%3DStevens%26aufirst%3DN.%2BR.%26aulast%3DBasto%26aufirst%3DR.%26aulast%3DRaff%26aufirst%3DJ.%2BW.%26atitle%3DOverexpressing%2520centriole-replication%2520proteins%2520in%2520vivo%2520induces%2520centriole%2520overduplication%2520and%2520de%2520novo%2520formation%26jtitle%3DCurr.%2520Biol.%26date%3D2007%26volume%3D17%26spage%3D834%26epage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Hudson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozarova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macmillan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swallow, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, J. W.</span><span> </span><span class="NLM_article-title">Late mitotic failure in mice lacking Sak, a polo-like kinase</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1016%2FS0960-9822%2801%2900117-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=11301255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXis1Sjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=441-446&author=J.+W.+Hudsonauthor=A.+Kozarovaauthor=P.+Cheungauthor=J.+C.+Macmillanauthor=C.+J.+Swallowauthor=J.+C.+Crossauthor=J.+W.+Dennis&title=Late+mitotic+failure+in+mice+lacking+Sak%2C+a+polo-like+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Late mitotic failure in mice lacking Sak, a polo-like kinase</span></div><div class="casAuthors">Hudson, J. W.; Kozarova, A.; Cheung, P.; Macmillan, J. C.; Swallow, C. J.; Cross, J. C.; Dennis, J. W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">441-446</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Polo-like kinases in yeast, flies, and mammals regulate key events in mitosis.  Such events include spindle formation at G2/M, the anaphase-promoting complex (APC) at the exit from mitosis, the cleavage structure at cytokinesis, and DNA damage checkpoints in G2/M.  Polo-like kinases are distinguished by two C-terminal polo box (pb) motifs, which localize the enzymes to mitotic structures.  We previously identified Sak, a novel polo-like kinase found in Drosophila and mammals.  Here, we demonstrate that the Sak kinase has a functional pb domain that localizes the enzyme to the nucleolus during G2, to the centrosomes in G2/M, and to the cleavage furrow during cytokinesis.  To study the role of Sak in embryo development, we generated a Sak null allele, the first polo-like kinase to be mutated in mice.  Sak-/- embryos arrested after gastrulation at E7.5, with a marked increase in mitotic and apoptotic cells.  Sak-/- embryos displayed cells in late anaphase or telophase that continued to express cyclin B1 and phosphorylated histone H3.  Our results suggest that Sak is required for the APC-dependent destruction of cyclin B1 and for exit from mitosis in the postgastrulation embryo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNr2bwHbpvC7Vg90H21EOLACvtfcHk0lhOSjn6EIzijw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXis1Sjtrc%253D&md5=c38f41a06857914e256fe2388c0d7623</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0960-9822%2801%2900117-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-9822%252801%252900117-8%26sid%3Dliteratum%253Aachs%26aulast%3DHudson%26aufirst%3DJ.%2BW.%26aulast%3DKozarova%26aufirst%3DA.%26aulast%3DCheung%26aufirst%3DP.%26aulast%3DMacmillan%26aufirst%3DJ.%2BC.%26aulast%3DSwallow%26aufirst%3DC.%2BJ.%26aulast%3DCross%26aufirst%3DJ.%2BC.%26aulast%3DDennis%26aufirst%3DJ.%2BW.%26atitle%3DLate%2520mitotic%2520failure%2520in%2520mice%2520lacking%2520Sak%252C%2520a%2520polo-like%2520kinase%26jtitle%3DCurr.%2520Biol.%26date%3D2001%26volume%3D11%26spage%3D441%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Cunha-Ferreira, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues-Martins, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bento, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riparbelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laue, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettencourt-Dias, M.</span><span> </span><span class="NLM_article-title">The SCF/Slimb ubiquitin ligase limits centrosome amplification through degradation of SAK/PLK4</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1016%2Fj.cub.2008.11.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=19084407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVamtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=43-49&author=I.+Cunha-Ferreiraauthor=A.+Rodrigues-Martinsauthor=I.+Bentoauthor=M.+Riparbelliauthor=W.+Zhangauthor=E.+Laueauthor=G.+Callainiauthor=D.+M.+Gloverauthor=M.+Bettencourt-Dias&title=The+SCF%2FSlimb+ubiquitin+ligase+limits+centrosome+amplification+through+degradation+of+SAK%2FPLK4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The SCF/Slimb Ubiquitin Ligase Limits Centrosome Amplification through Degradation of SAK/PLK4</span></div><div class="casAuthors">Cunha-Ferreira, Ines; Rodrigues-Martins, Ana; Bento, Ines; Riparbelli, Maria; Zhang, Wei; Laue, Ernest; Callaini, Giuliano; Glover, David M.; Bettencourt-Dias, Monica</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-49</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Centrioles are essential for the formation of microtubule-derived structures, including cilia and centrosomes.  Abnormalities in centrosome no. and structure occur in many cancers and are assocd. with genomic instability.  In most dividing animal cells, centriole formation is coordinated with DNA replication and is highly regulated such that only one daughter centriole forms close to each mother centriole.  Centriole formation is triggered and dependent on a conserved kinase, SAK/PLK4.  Downregulation and overexpression of SAK/PLK4 is assocd. with cancer in humans, mice, and flies.  Here we show that centrosome amplification is normally inhibited by degrdn. of SAK/PLK4, mediated by the SCF/Slimb ubiquitin ligase.  This complex phys. interacts with SAK/PLK4, and in its absence, SAK/PLK4 accumulates, leading to the striking formation of multiple daughter centrioles surrounding each mother.  This interaction is mediated via a conserved Slimb binding motif in SAK/PLK4, mutations of which leads to centrosome amplification.  This regulation is likely to be conserved, because knockout of the ortholog of Slimb, β-Trcp1 in mice, also leads to centrosome amplification.  Because the SCF/β-Trcp complex plays an important role in cell-cycle progression, our results lead to new understanding of the control of centrosome no. and how it may go awry in human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowKTYy51boqrVg90H21EOLACvtfcHk0li67IwURMsXmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVamtQ%253D%253D&md5=c838ab567d3d77767ed9979862649404</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2008.11.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2008.11.037%26sid%3Dliteratum%253Aachs%26aulast%3DCunha-Ferreira%26aufirst%3DI.%26aulast%3DRodrigues-Martins%26aufirst%3DA.%26aulast%3DBento%26aufirst%3DI.%26aulast%3DRiparbelli%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLaue%26aufirst%3DE.%26aulast%3DCallaini%26aufirst%3DG.%26aulast%3DGlover%26aufirst%3DD.%2BM.%26aulast%3DBettencourt-Dias%26aufirst%3DM.%26atitle%3DThe%2520SCF%252FSlimb%2520ubiquitin%2520ligase%2520limits%2520centrosome%2520amplification%2520through%2520degradation%2520of%2520SAK%252FPLK4%26jtitle%3DCurr.%2520Biol.%26date%3D2009%26volume%3D19%26spage%3D43%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Rogers, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusan, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peifer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, S. L.</span><span> </span><span class="NLM_article-title">The SCF/Slimb ubiquitin ligase regulates PLK4/Sak levels to block centriole reduplication</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">184</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2009&pages=225-238&author=G.+C.+Rogersauthor=N.+M.+Rusanauthor=D.+M.+Robertsauthor=M.+Peiferauthor=S.+L.+Rogers&title=The+SCF%2FSlimb+ubiquitin+ligase+regulates+PLK4%2FSak+levels+to+block+centriole+reduplication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DG.%2BC.%26aulast%3DRusan%26aufirst%3DN.%2BM.%26aulast%3DRoberts%26aufirst%3DD.%2BM.%26aulast%3DPeifer%26aufirst%3DM.%26aulast%3DRogers%26aufirst%3DS.%2BL.%26atitle%3DThe%2520SCF%252FSlimb%2520ubiquitin%2520ligase%2520regulates%2520PLK4%252FSak%2520levels%2520to%2520block%2520centriole%2520reduplication%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2009%26volume%3D184%26spage%3D225%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Guderian, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westendorf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uldschmid, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">PLK4 trans-autophosphorylation regulates centriole number by controlling betaTrCP-mediated degradation</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">2163</span><span class="NLM_x">–</span> <span class="NLM_lpage">2169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1242%2Fjcs.068502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=20516151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVWlsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2010&pages=2163-2169&author=G.+Guderianauthor=J.+Westendorfauthor=A.+Uldschmidauthor=E.+A.+Nigg&title=PLK4+trans-autophosphorylation+regulates+centriole+number+by+controlling+betaTrCP-mediated+degradation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Plk4 trans-autophosphorylation regulates centriole number by controlling βTrCP-mediated degradation</span></div><div class="casAuthors">Guderian, Gernot; Westendorf, Jens; Uldschmid, Andreas; Nigg, Erich A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2163-2169</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Centrioles are the main constituents of the mammalian centrosome and act as basal bodies for ciliogenesis.  Centrosomes organize the cytoplasmic microtubule network during interphase and the mitotic spindle during mitosis, and aberrations in centrosome no. have been implicated in chromosomal instability and tumor formation.  The centriolar protein Polo-like kinase 4 (Plk4) is a key regulator of centriole biogenesis and is crucial for maintaining const. centriole no., but the mechanisms regulating its activity and expression are only beginning to emerge.  Here, we show that human Plk4 is subject to βTrCP-dependent proteasomal degrdn., indicating that this pathway is conserved from Drosophila to human.  Unexpectedly, we found that stable overexpression of kinase-dead Plk4 leads to centriole overduplication.  This phenotype depends on the presence of endogenous wild-type Plk4.  Our data indicate that centriole overduplication results from disruption of Plk4 trans-autophosphorylation by kinase-dead Plk4, which then shields endogenous Plk4 from recognition by βTrCP.  We conclude that active Plk4 promotes its own degrdn. by catalyzing βTrCP binding through trans-autophosphorylation (phosphorylation by the other kinase in the dimer) within homodimers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2g342LYsoobVg90H21EOLACvtfcHk0li67IwURMsXmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVWlsLrL&md5=3354d6f7e9e4f9664fafa9e9cdf15209</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1242%2Fjcs.068502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.068502%26sid%3Dliteratum%253Aachs%26aulast%3DGuderian%26aufirst%3DG.%26aulast%3DWestendorf%26aufirst%3DJ.%26aulast%3DUldschmid%26aufirst%3DA.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DPLK4%2520trans-autophosphorylation%2520regulates%2520centriole%2520number%2520by%2520controlling%2520betaTrCP-mediated%2520degradation%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2010%26volume%3D123%26spage%3D2163%26epage%3D2169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Holland, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niessen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoover, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleveland, D. W.</span><span> </span><span class="NLM_article-title">Polo-like kinase 4 kinase activity limits centrosome overduplication by autoregulating its own stability</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">188</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2010&pages=191-198&author=A.+J.+Hollandauthor=W.+Lanauthor=S.+Niessenauthor=H.+Hooverauthor=D.+W.+Cleveland&title=Polo-like+kinase+4+kinase+activity+limits+centrosome+overduplication+by+autoregulating+its+own+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolland%26aufirst%3DA.%2BJ.%26aulast%3DLan%26aufirst%3DW.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DHoover%26aufirst%3DH.%26aulast%3DCleveland%26aufirst%3DD.%2BW.%26atitle%3DPolo-like%2520kinase%25204%2520kinase%2520activity%2520limits%2520centrosome%2520overduplication%2520by%2520autoregulating%2520its%2520own%2520stability%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2010%26volume%3D188%26spage%3D191%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Brownlee, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebba, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buster, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G. C.</span><span> </span><span class="NLM_article-title">The protein phosphatase 2A regulatory subunit Twins stabilizes PLK4 to induce centriole amplification</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2011&pages=231-243&author=C.+W.+Brownleeauthor=J.+E.+Klebbaauthor=D.+W.+Busterauthor=G.+C.+Rogers&title=The+protein+phosphatase+2A+regulatory+subunit+Twins+stabilizes+PLK4+to+induce+centriole+amplification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrownlee%26aufirst%3DC.%2BW.%26aulast%3DKlebba%26aufirst%3DJ.%2BE.%26aulast%3DBuster%26aufirst%3DD.%2BW.%26aulast%3DRogers%26aufirst%3DG.%2BC.%26atitle%3DThe%2520protein%2520phosphatase%25202A%2520regulatory%2520subunit%2520Twins%2520stabilizes%2520PLK4%2520to%2520induce%2520centriole%2520amplification%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2011%26volume%3D195%26spage%3D231%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Ganem, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godinho, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellman, D.</span><span> </span><span class="NLM_article-title">A mechanism linking extra centrosomes to chromosomal instability</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">460</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=460&publication_year=2009&pages=278-282&author=N.+J.+Ganemauthor=S.+A.+Godinhoauthor=D.+Pellman&title=A+mechanism+linking+extra+centrosomes+to+chromosomal+instability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGanem%26aufirst%3DN.%2BJ.%26aulast%3DGodinho%26aufirst%3DS.%2BA.%26aulast%3DPellman%26aufirst%3DD.%26atitle%3DA%2520mechanism%2520linking%2520extra%2520centrosomes%2520to%2520chromosomal%2520instability%26jtitle%3DNature%26date%3D2009%26volume%3D460%26spage%3D278%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Mason, J.; Wei, S.; Luo, S.; Nadeem, V.; Kiarash, R.; Huang, P.; Awrey, A.; Leung, G.; Beletskaya, I.; Feher, M.; Forrest, B.; Laufer, R.; Sampson, P.; Li, S.-W.; Liu, Y.; Lang, Y.; Pauls, H. W.; Mak, T. W.; Pan, J. G.</span><span> </span><span class="NLM_article-title">Inhibition of Polo-like kinase 4 as an anti-cancer strategy</span>. In Book of Abstracts, <span class="NLM_conf-name">AACR 102nd Annual Meeting</span>, <span class="NLM_conf-loc">Orlando, FL</span>, <span class="NLM_conf-date">April 2-6, 2011</span>,  <span class="NLM_fpage">LB-215</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mason%2C+J.%3B+Wei%2C+S.%3B+Luo%2C+S.%3B+Nadeem%2C+V.%3B+Kiarash%2C+R.%3B+Huang%2C+P.%3B+Awrey%2C+A.%3B+Leung%2C+G.%3B+Beletskaya%2C+I.%3B+Feher%2C+M.%3B+Forrest%2C+B.%3B+Laufer%2C+R.%3B+Sampson%2C+P.%3B+Li%2C+S.-W.%3B+Liu%2C+Y.%3B+Lang%2C+Y.%3B+Pauls%2C+H.+W.%3B+Mak%2C+T.+W.%3B+Pan%2C+J.+G.+Inhibition+of+Polo-like+kinase+4+as+an+anti-cancer+strategy.+In+Book+of+Abstracts%2C+AACR+102nd+Annual+Meeting%2C+Orlando%2C+FL%2C+April+2-6%2C+2011%2C+LB-215."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520Polo-like%2520kinase%25204%2520as%2520an%2520anti-cancer%2520strategy%26jtitle%3DBook%2520of%2520Abstracts%26spage%3DLB-215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Targeting the Cell Cycle in Cancer: TTK (MPS1) and PLK4 as Novel Mitotic Targets</span>. In Book of Abstracts, <span class="NLM_conf-name">AACR 103rd Annual Meeting</span>, <span class="NLM_conf-loc">Chicago, IL</span>, <span class="NLM_conf-date">April 1–5, 2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mak%2C+T.+W.+Targeting+the+Cell+Cycle+in+Cancer%3A+TTK+%28MPS1%29+and+PLK4+as+Novel+Mitotic+Targets.+In+Book+of+Abstracts%2C+AACR+103rd+Annual+Meeting%2C+Chicago%2C+IL%2C+April+1%E2%80%935%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DTargeting%2520the%2520Cell%2520Cycle%2520in%2520Cancer%253A%2520TTK%2520%2528MPS1%2529%2520and%2520PLK4%2520as%2520Novel%2520Mitotic%2520Targets%26jtitle%3DBook%2520of%2520Abstracts" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marron, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qaqish, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livasy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dressler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nobel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewend, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tretiakova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orrico, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palazzo, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perreard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olopade, O. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perou, C. M.</span><span> </span><span class="NLM_article-title">The molecular portraits of breast tumors are conserved across microarray platforms</span> <span class="citation_source-journal">BMC Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=96-108&author=Z.+Huauthor=C.+Fanauthor=D.+S.+Ohauthor=J.+S.+Marronauthor=X.+Heauthor=B.+F.+Qaqishauthor=C.+Livasyauthor=L.+A.+Careyauthor=E.+Reynoldsauthor=L.+Dresslerauthor=A.+Nobelauthor=J.+Parkerauthor=M.+G.+Ewendauthor=L.+R.+Sawyerauthor=J.+Wuauthor=Y.+Liuauthor=R.+Nandaauthor=M.+Tretiakovaauthor=A.+R.+Orricoauthor=D.+Dreherauthor=J.+P.+Palazzoauthor=L.+Perreardauthor=E.+Nelsonauthor=M.+Moneauthor=H.+Hansenauthor=M.+Mullinsauthor=J.+F.+Quackenbushauthor=M.+J.+Ellisauthor=O.+I.+Olopadeauthor=P.+S.+Bernardauthor=C.+M.+Perou&title=The+molecular+portraits+of+breast+tumors+are+conserved+across+microarray+platforms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DOh%26aufirst%3DD.%2BS.%26aulast%3DMarron%26aufirst%3DJ.%2BS.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DQaqish%26aufirst%3DB.%2BF.%26aulast%3DLivasy%26aufirst%3DC.%26aulast%3DCarey%26aufirst%3DL.%2BA.%26aulast%3DReynolds%26aufirst%3DE.%26aulast%3DDressler%26aufirst%3DL.%26aulast%3DNobel%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DJ.%26aulast%3DEwend%26aufirst%3DM.%2BG.%26aulast%3DSawyer%26aufirst%3DL.%2BR.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DNanda%26aufirst%3DR.%26aulast%3DTretiakova%26aufirst%3DM.%26aulast%3DOrrico%26aufirst%3DA.%2BR.%26aulast%3DDreher%26aufirst%3DD.%26aulast%3DPalazzo%26aufirst%3DJ.%2BP.%26aulast%3DPerreard%26aufirst%3DL.%26aulast%3DNelson%26aufirst%3DE.%26aulast%3DMone%26aufirst%3DM.%26aulast%3DHansen%26aufirst%3DH.%26aulast%3DMullins%26aufirst%3DM.%26aulast%3DQuackenbush%26aufirst%3DJ.%2BF.%26aulast%3DEllis%26aufirst%3DM.%2BJ.%26aulast%3DOlopade%26aufirst%3DO.%2BI.%26aulast%3DBernard%26aufirst%3DP.%2BS.%26aulast%3DPerou%26aufirst%3DC.%2BM.%26atitle%3DThe%2520molecular%2520portraits%2520of%2520breast%2520tumors%2520are%2520conserved%2520across%2520microarray%2520platforms%26jtitle%3DBMC%2520Genomics%26date%3D2006%26volume%3D7%26spage%3D96%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">van di Vijver, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van ’t Veer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voskuil, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterse, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atsma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witteveen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delahaye, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Velde, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartelink, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodenhuis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutgers, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friend, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernards, R.</span><span> </span><span class="NLM_article-title">A gene-expression signature as a predictor of survival in breast cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">1999</span><span class="NLM_x">–</span> <span class="NLM_lpage">2009</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1056%2FNEJMoa021967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=12490681" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2002&pages=1999-2009&author=M.+J.+van+di+Vijverauthor=Y.+D.+Heauthor=L.+van+%E2%80%99t+Veerauthor=H.+Daiauthor=A.+A.+M.+Hartauthor=D.+W.+Voskuilauthor=G.+J.+Schreiberauthor=J.+L.+Peterseauthor=C.+Robertsauthor=M.+J.+Martonauthor=M.+Parrishauthor=D.+Atsmaauthor=A.+Witteveenauthor=A.+Glasauthor=L.+Delahayeauthor=T.+van+der+Veldeauthor=H.+Bartelinkauthor=S.+Rodenhuisauthor=E.+T.+Rutgersauthor=S.+H.+Friendauthor=R.+Bernards&title=A+gene-expression+signature+as+a+predictor+of+survival+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa021967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa021967%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bdi%2BVijver%26aufirst%3DM.%2BJ.%26aulast%3DHe%26aufirst%3DY.%2BD.%26aulast%3Dvan%2B%25E2%2580%2599t%2BVeer%26aufirst%3DL.%26aulast%3DDai%26aufirst%3DH.%26aulast%3DHart%26aufirst%3DA.%2BA.%2BM.%26aulast%3DVoskuil%26aufirst%3DD.%2BW.%26aulast%3DSchreiber%26aufirst%3DG.%2BJ.%26aulast%3DPeterse%26aufirst%3DJ.%2BL.%26aulast%3DRoberts%26aufirst%3DC.%26aulast%3DMarton%26aufirst%3DM.%2BJ.%26aulast%3DParrish%26aufirst%3DM.%26aulast%3DAtsma%26aufirst%3DD.%26aulast%3DWitteveen%26aufirst%3DA.%26aulast%3DGlas%26aufirst%3DA.%26aulast%3DDelahaye%26aufirst%3DL.%26aulast%3Dvan%2Bder%2BVelde%26aufirst%3DT.%26aulast%3DBartelink%26aufirst%3DH.%26aulast%3DRodenhuis%26aufirst%3DS.%26aulast%3DRutgers%26aufirst%3DE.%2BT.%26aulast%3DFriend%26aufirst%3DS.%2BH.%26aulast%3DBernards%26aufirst%3DR.%26atitle%3DA%2520gene-expression%2520signature%2520as%2520a%2520predictor%2520of%2520survival%2520in%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D347%26spage%3D1999%26epage%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Miller, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeds, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergara, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ploner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawitan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, J.</span><span> </span><span class="NLM_article-title">An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">13550</span><span class="NLM_x">–</span> <span class="NLM_lpage">13555</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=13550-13555&author=L.+D.+Millerauthor=J.+Smedsauthor=J.+Georgeauthor=V.+B.+Vegaauthor=L.+Vergaraauthor=A.+Plonerauthor=Y.+Pawitanauthor=P.+Hallauthor=S.+Klaarauthor=E.+T.+Liuauthor=J.+Bergh&title=An+expression+signature+for+p53+status+in+human+breast+cancer+predicts+mutation+status%2C+transcriptional+effects%2C+and+patient+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DL.%2BD.%26aulast%3DSmeds%26aufirst%3DJ.%26aulast%3DGeorge%26aufirst%3DJ.%26aulast%3DVega%26aufirst%3DV.%2BB.%26aulast%3DVergara%26aufirst%3DL.%26aulast%3DPloner%26aufirst%3DA.%26aulast%3DPawitan%26aufirst%3DY.%26aulast%3DHall%26aufirst%3DP.%26aulast%3DKlaar%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DE.%2BT.%26aulast%3DBergh%26aufirst%3DJ.%26atitle%3DAn%2520expression%2520signature%2520for%2520p53%2520status%2520in%2520human%2520breast%2520cancer%2520predicts%2520mutation%2520status%252C%2520transcriptional%2520effects%252C%2520and%2520patient%2520survival%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D13550%26epage%3D13555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giranda, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span> </span><span class="NLM_article-title">Pharmacological and Functional Comparison of the Polo-Like Kinase Family: Insight into Inhibitor and Substrate Specificity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">9551</span><span class="NLM_x">–</span> <span class="NLM_lpage">9563</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi7008745" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=9551-9563&author=E.+F.+Johnsonauthor=K.+D.+Stewartauthor=K.+W.+Woodsauthor=V.+L.+Girandaauthor=Y.+Luo&title=Pharmacological+and+Functional+Comparison+of+the+Polo-Like+Kinase+Family%3A+Insight+into+Inhibitor+and+Substrate+Specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fbi7008745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7008745%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DWoods%26aufirst%3DK.%2BW.%26aulast%3DGiranda%26aufirst%3DV.%2BL.%26aulast%3DLuo%26aufirst%3DY.%26atitle%3DPharmacological%2520and%2520Functional%2520Comparison%2520of%2520the%2520Polo-Like%2520Kinase%2520Family%253A%2520Insight%2520into%2520Inhibitor%2520and%2520Substrate%2520Specificity%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D9551%26epage%3D9563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolinsky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heimbrook, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span> </span><span class="NLM_article-title">Small-molecule inducer of cancer cell polyploidy promotes apoptosis or senescence: implications for therapy</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">3364</span><span class="NLM_x">–</span> <span class="NLM_lpage">3375</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=3364-3375&author=C.+Tovarauthor=B.+Higginsauthor=D.+Deoauthor=K.+Kolinskyauthor=J.-J.+Liuauthor=D.+C.+Heimbrookauthor=L.+T.+Vassilev&title=Small-molecule+inducer+of+cancer+cell+polyploidy+promotes+apoptosis+or+senescence%3A+implications+for+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DDeo%26aufirst%3DD.%26aulast%3DKolinsky%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DJ.-J.%26aulast%3DHeimbrook%26aufirst%3DD.%2BC.%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26atitle%3DSmall-molecule%2520inducer%2520of%2520cancer%2520cell%2520polyploidy%2520promotes%2520apoptosis%2520or%2520senescence%253A%2520implications%2520for%2520therapy%26jtitle%3DCell%2520Cycle%26date%3D2010%26volume%3D9%26spage%3D3364%26epage%3D3375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Diels, G. S. M.; Ten Holte, P.; Freyne, E. J. E.; Grand-Perret, T. A. R.; Van Emelen, K.; Embrechts, W. C. J.; Bonnet, P. G. A.</span><span> </span><span class="NLM_article-title">Pyrrolopyrimidines</span>. PCT Int. Appl. WO 2009016132,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=G.+S.+M.+Diels&author=P.+Ten+Holte&author=E.+J.+E.+Freyne&author=T.+A.+R.+Grand-Perret&author=K.+Van+Emelen&author=W.+C.+J.+Embrechts&author=P.+G.+A.+Bonnet&title=Pyrrolopyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDiels%26aufirst%3DG.%2BS.%2BM.%26atitle%3DPyrrolopyrimidines%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Buijnsters, P. J. J. A.; Verdonck, M. G. C.; Van Emelen, K.; Bonnet, P. G. A.</span><span> </span><span class="NLM_article-title">4-Aryl-2-anilino-pyrimidines as PLK kinase inhibitors</span>. PCT Int. Appl. WO 2009112439,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=P.+J.+J.+A.+Buijnsters&author=M.+G.+C.+Verdonck&author=K.+Van+Emelen&author=P.+G.+A.+Bonnet&title=4-Aryl-2-anilino-pyrimidines+as+PLK+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBuijnsters%26aufirst%3DP.%2BJ.%2BJ.%2BA.%26atitle%3D4-Aryl-2-anilino-pyrimidines%2520as%2520PLK%2520kinase%2520inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">PLK4 Inhibitors of Novel Structure as Potent Anti-proliferative Agents</span>. Book of Abstracts, <span class="NLM_conf-name">241st ACS National Meeting</span>, <span class="NLM_conf-loc">Anaheim, CA</span>, <span class="NLM_conf-date">March 27–31, 2011</span>,  <span class="NLM_fpage">MEDI 189</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Pauls%2C+H.+W.+PLK4+Inhibitors+of+Novel+Structure+as+Potent+Anti-proliferative+Agents.+Book+of+Abstracts%2C+241st+ACS+National+Meeting%2C+Anaheim%2C+CA%2C+March+27%E2%80%9331%2C+2011%2C+MEDI+189."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DPLK4%2520Inhibitors%2520of%2520Novel%2520Structure%2520as%2520Potent%2520Anti-proliferative%2520Agents%26jtitle%3DBook%2520of%2520Abstracts%26spage%3DMEDI%2520189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Baber, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirley, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feher, M.</span><span> </span><span class="NLM_article-title">The Use of Consensus Scanning in Ligand-Based Virtual Screening</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci050296y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKltrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=277-288&author=C.+Baberauthor=W.+Shirleyauthor=Y.+Gaoauthor=M.+Feher&title=The+Use+of+Consensus+Scanning+in+Ligand-Based+Virtual+Screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The use of consensus scoring in ligand-based virtual screening</span></div><div class="casAuthors">Baber, J. Christian; Shirley, William A.; Gao, Yinghong; Feher, Miklos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">277-288</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new consensus approach has been developed for ligand-based virtual screening.  It involves combining highly disparate properties in order to improve performance in virtual screening.  The properties include structural, 2D pharmacophore and property-based fingerprints, scores derived using BCUT descriptors, and 3D pharmacophore approaches.  Different approaches for the combination of all or some of these methods have been tested.  Logistic regression and sum ranks were found to be the most advantageous in different pharmaceutical applications.  The three major reasons consensus scoring appears to enrich data sets better than single scoring functions are (1) using multiple scoring functions is similar to repeated samplings, in which case the mean is closer to the true value than any single value, (2) due to the better clustering of actives, multiple sampling will recover more actives than inactives, and (3) different methods seem to agree more on the ranking of the actives than on the inactives.  Furthermore, consensus results are not only better but are also more consistent across receptor systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGM-4XLoNCUbVg90H21EOLACvtfcHk0liP7J7V4mbyKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKltrzM&md5=712a51193b4a98a02b668832f6ff7b20</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fci050296y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci050296y%26sid%3Dliteratum%253Aachs%26aulast%3DBaber%26aufirst%3DC.%26aulast%3DShirley%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DFeher%26aufirst%3DM.%26atitle%3DThe%2520Use%2520of%2520Consensus%2520Scanning%2520in%2520Ligand-Based%2520Virtual%2520Screening%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2006%26volume%3D46%26spage%3D277%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Feher, V. A.; Lawson, D. J.</span><span> </span><span class="NLM_article-title">Approaches to kinase homology modeling: successes and consideration for the structural kinome</span>. In  <span class="citation_source-book">Kinase Inhibitor Drugs</span>; <span class="NLM_contrib-group">Li, R.; Stafford, J. A.</span>, Eds.; <span class="NLM_publisher-name">John Wiley & Sons Inc.</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Chapter 17, pp  <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1002%2F9780470524961.ch17" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=433-460&author=V.+A.+Feher&author=D.+J.+Lawsonauthor=R.+Li&author=J.+A.+Stafford&title=Kinase+Inhibitor+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2F9780470524961.ch17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9780470524961.ch17%26sid%3Dliteratum%253Aachs%26aulast%3DFeher%26aufirst%3DV.%2BA.%26atitle%3DApproaches%2520to%2520kinase%2520homology%2520modeling%253A%2520successes%2520and%2520consideration%2520for%2520the%2520structural%2520kinome%26btitle%3DKinase%2520Inhibitor%2520Drugs%26aulast%3DLi%26aufirst%3DR.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%2520Inc%26date%3D2009%26spage%3D433%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span>GOLD, <span class="NLM_edition">version 3.2</span>; <span class="NLM_publisher-name">Cambridge Crystallographic Database</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GOLD%2C+version+3.2%3B+Cambridge+Crystallographic+Database%3A+Cambridge%2C+U.K.%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGOLD%26pub%3DCambridge%2520Crystallographic%2520Database%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span>Glide, <span class="NLM_edition">version 2007</span>; <span class="NLM_publisher-name">Schrodinger Inc.</span>: <span class="NLM_publisher-loc">Portland, OR</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+2007%3B+Schrodinger+Inc.%3A+Portland%2C+OR%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGlide%26pub%3DSchrodinger%2520Inc%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Lackey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O. Bradley McDonald, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNutt, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peel, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutkowske, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, E. R.</span><span> </span><span class="NLM_article-title">The Discovery of Potent cRaf1 Kinase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=223-226&author=K.+Lackeyauthor=M.+Coryauthor=R.+Davisauthor=S.+V.+Fryeauthor=P.+A.+Harrisauthor=R.+N.+Hunterauthor=D.+K.+Jungauthor=O.+B.+O.+Bradley+McDonaldauthor=R.+W.+McNuttauthor=M.+R.+Peelauthor=R.+D.+Rutkowskeauthor=J.+M.+Vealauthor=E.+R.+Wood&title=The+Discovery+of+Potent+cRaf1+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLackey%26aufirst%3DK.%26aulast%3DCory%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DHunter%26aufirst%3DR.%2BN.%26aulast%3DJung%26aufirst%3DD.%2BK.%26aulast%3DO.%2BBradley%2BMcDonald%26aufirst%3DO.%2BB.%26aulast%3DMcNutt%26aufirst%3DR.%2BW.%26aulast%3DPeel%26aufirst%3DM.%2BR.%26aulast%3DRutkowske%26aufirst%3DR.%2BD.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DWood%26aufirst%3DE.%2BR.%26atitle%3DThe%2520Discovery%2520of%2520Potent%2520cRaf1%2520Kinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D223%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Braud, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duflos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nourrisson, M.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonnerre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Baut, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, G.</span><span> </span><span class="NLM_article-title">Potential Inhibitors of Angiogenesis, Part I: 3-(Imidazole-4(5)-ylmethylene)indoin-2-ones</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm400380m&amp;key=10.1080%2F1475636031000106575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm400380m&amp;key=14506915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlt1GhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=243-252&author=E.+Braudauthor=M.+Duflosauthor=M.-R.+Nourrissonauthor=A.+Tonnerreauthor=C.+Picotauthor=G.+Le+Bautauthor=P.+Renardauthor=B.+Pfeifferauthor=G.+Tucker&title=Potential+Inhibitors+of+Angiogenesis%2C+Part+I%3A+3-%28Imidazole-4%285%29-ylmethylene%29indoin-2-ones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Potential Inhibitors of Angiogenesis. Part I: 3-(Imidazol-4(5)-ylmethylene)indolin-2-ones</span></div><div class="casAuthors">Braud, Emmanuelle; Duflos, Muriel; Nourrisson, Marie-Renee; Tonnerre, Alain; Picot, Carine; Le Baut, Guillaume; Renard, Pierre; Pfeiffer, Bruno; Tucker, Gordon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">243-252</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The synthesis and pharmacol. evaluation of new 3-(imidazol-4(5)-ylmethylene)indolin-2-ones, analogs of SU-5416, are reported.  The final compds. 20-51 were obtained by Knoevenagel coupling between the substituted indolin-2-ones 1-15 and either the formylimidazole derivs. 16-18 or 2-formyl-3,5-dimethylpyrrole 19.  Methylation at the nitrogen atom of the indolin-2-one and/or imidazole moieties was carried out in the presence of the couple NaH/DMF.  A Mannich reaction afforded the 1-dimethylaminomethyl derivs. 43 and 48.  The antiangiogenic activity of these compds. was evaluated in a three dimensional in vitro rat aortic ring assay.  In this test, compd. 20 induced a decrease of angiogenesis comparable to that obsd. with SU-5416; the vascular d. indexes at 1 μM were 30±18 and 22±4 % of control, resp.  The compds. were also evaluated, in an independent manner, as inhibitors of the human EGF-receptor tyrosine kinase activity.  As expected, only minor activities were obsd. with four compds., out of thirty-one, exerting inhibitory effects in the range of 40-55 % at 10 μM concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-ry4RtIrkrrVg90H21EOLACvtfcHk0ljgtUxL8YHYQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlt1GhtbY%253D&md5=0d2657ea2a41d61bbd366834c0a328b1</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1080%2F1475636031000106575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F1475636031000106575%26sid%3Dliteratum%253Aachs%26aulast%3DBraud%26aufirst%3DE.%26aulast%3DDuflos%26aufirst%3DM.%26aulast%3DNourrisson%26aufirst%3DM.-R.%26aulast%3DTonnerre%26aufirst%3DA.%26aulast%3DPicot%26aufirst%3DC.%26aulast%3DLe%2BBaut%26aufirst%3DG.%26aulast%3DRenard%26aufirst%3DP.%26aulast%3DPfeiffer%26aufirst%3DB.%26aulast%3DTucker%26aufirst%3DG.%26atitle%3DPotential%2520Inhibitors%2520of%2520Angiogenesis%252C%2520Part%2520I%253A%25203-%2528Imidazole-4%25285%2529-ylmethylene%2529indoin-2-ones%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2003%26volume%3D18%26spage%3D243%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Krishnamurthy, V. V.</span><span> </span><span class="NLM_article-title">Excitation-Sculptured Indirect-Detection Experiment (EXSIDE) for Long-Range CH Coupling-Constant Measurement</span> <span class="citation_source-journal">J. Magn. Reson.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=1996&pages=33-41&author=V.+V.+Krishnamurthy&title=Excitation-Sculptured+Indirect-Detection+Experiment+%28EXSIDE%29+for+Long-Range+CH+Coupling-Constant+Measurement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnamurthy%26aufirst%3DV.%2BV.%26atitle%3DExcitation-Sculptured%2520Indirect-Detection%2520Experiment%2520%2528EXSIDE%2529%2520for%2520Long-Range%2520CH%2520Coupling-Constant%2520Measurement%26jtitle%3DJ.%2520Magn.%2520Reson.%26date%3D1996%26volume%3D121%26spage%3D33%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">App, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2588</span><span class="NLM_x">–</span> <span class="NLM_lpage">2603</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2588-2603&author=S.+Liauthor=H.+Tranauthor=F.+Tangauthor=H.+Appauthor=P.+Hirthauthor=G.+McMahonauthor=C.+Tang&title=Synthesis+and+biological+evaluations+of+3-substituted+indolin-2-ones%3A+a+novel+class+of+tyrosine+kinase+inhibitors+that+exhibit+selectivity+toward+particular+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.%26aulast%3DTran%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DApp%26aufirst%3DH.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluations%2520of%25203-substituted%2520indolin-2-ones%253A%2520a%2520novel%2520class%2520of%2520tyrosine%2520kinase%2520inhibitors%2520that%2520exhibit%2520selectivity%2520toward%2520particular%2520receptor%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2588%26epage%3D2603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Höttecke, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebeck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubenel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span> </span><span class="NLM_article-title">Inhibition of c-secretase by the CK1 inhibitor IC261 does not depend on CK1δ</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2958</span><span class="NLM_x">–</span> <span class="NLM_lpage">2963</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2958-2963&author=N.+H%C3%B6tteckeauthor=M.+Liebeckauthor=K.+Baumannauthor=R.+Schubenelauthor=E.+Winklerauthor=H.+Steinerauthor=B.+Schmidt&title=Inhibition+of+c-secretase+by+the+CK1+inhibitor+IC261+does+not+depend+on+CK1%CE%B4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25B6ttecke%26aufirst%3DN.%26aulast%3DLiebeck%26aufirst%3DM.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DSchubenel%26aufirst%3DR.%26aulast%3DWinkler%26aufirst%3DE.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520c-secretase%2520by%2520the%2520CK1%2520inhibitor%2520IC261%2520does%2520not%2520depend%2520on%2520CK1%25CE%25B4%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2958%26epage%3D2963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Walsby, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepper, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, K.</span><span> </span><span class="NLM_article-title">Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts</span> <span class="citation_source-journal">Haematologica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">662</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2008&pages=662-669&author=E.+Walsbyauthor=V.+Walshauthor=C.+Pepperauthor=A.+Burnettauthor=K.+Mills&title=Effects+of+the+aurora+kinase+inhibitors+AZD1152-HQPA+and+ZM447439+on+growth+arrest+and+polyploidy+in+acute+myeloid+leukemia+cell+lines+and+primary+blasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalsby%26aufirst%3DE.%26aulast%3DWalsh%26aufirst%3DV.%26aulast%3DPepper%26aufirst%3DC.%26aulast%3DBurnett%26aufirst%3DA.%26aulast%3DMills%26aufirst%3DK.%26atitle%3DEffects%2520of%2520the%2520aurora%2520kinase%2520inhibitors%2520AZD1152-HQPA%2520and%2520ZM447439%2520on%2520growth%2520arrest%2520and%2520polyploidy%2520in%2520acute%2520myeloid%2520leukemia%2520cell%2520lines%2520and%2520primary%2520blasts%26jtitle%3DHaematologica%26date%3D2008%26volume%3D93%26spage%3D662%26epage%3D669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span>MOE (Molecular Operating Environment), <span class="NLM_edition">version 2005.06</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">1010 Sherbrooke St. West, Suite 910, Montreal, Quebec H3A 2R7, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MOE+%28Molecular+Operating+Environment%29%2C+version+2005.06%3B+Chemical+Computing+Group+Inc.%3A+1010+Sherbrooke+St.+West%2C+Suite+910%2C+Montreal%2C+Quebec+H3A+2R7%2C+Canada%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMOE%2520%2528Molecular%2520Operating%2520Environment%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Ewing, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baber, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feher, M.</span><span> </span><span class="NLM_article-title">Novel 2D Fingerprints for Ligand-Based Virtual Screening</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2423</span><span class="NLM_x">–</span> <span class="NLM_lpage">2431</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci060155b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm400380m&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsF2hsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=2423-2431&author=T.+Ewingauthor=J.+C.+Baberauthor=M.+Feher&title=Novel+2D+Fingerprints+for+Ligand-Based+Virtual+Screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 2D Fingerprints for Ligand-Based Virtual Screening</span></div><div class="casAuthors">Ewing, Todd; Baber, J. Christian; Feher, Miklos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2423-2431</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes the development of a set of new 2D fingerprints for the purposes of virtual screening in a pharmaceutical environment.  The new fingerprints are based on established ones: the changes in their design included the introduction of overlapping pharmacophore feature types, feature counts for pharmacophore and structural fingerprints, as well as changes in the resoln. in property description for property fingerprints.  The effects of each of these changes on virtual screening performance were monitored using two types of training sets, emulating different stages in the drug discovery process.  The results demonstrate that these changes all lead to an improvement in virtual screening performance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUwDfGYUmJrrVg90H21EOLACvtfcHk0ljgtUxL8YHYQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsF2hsLc%253D&md5=623e7efe2668bef2fdbbce5b4fe5381b</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fci060155b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci060155b%26sid%3Dliteratum%253Aachs%26aulast%3DEwing%26aufirst%3DT.%26aulast%3DBaber%26aufirst%3DJ.%2BC.%26aulast%3DFeher%26aufirst%3DM.%26atitle%3DNovel%25202D%2520Fingerprints%2520for%2520Ligand-Based%2520Virtual%2520Screening%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2006%26volume%3D46%26spage%3D2423%26epage%3D2431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span>Wombat 2007.01; <span class="NLM_publisher-name">Sunset Molecular Discovery LLC</span>: <span class="NLM_publisher-loc">Santa Fe, NM, 87505</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Wombat+2007.01%3B+Sunset+Molecular+Discovery+LLC%3A+Santa+Fe%2C+NM%2C+87505%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DWombat%25202007.01%26pub%3DSunset%2520Molecular%2520Discovery%2520LLC%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Olah, M.; Mracec, M.; Ostopovici, L.; Rad, R.; Bora, A.; Hadaruga, N.; Olah, I.; Banda, M.; Simon, Z.; Mracec, M.; Oprea, T. I.</span><span> </span><span class="NLM_article-title">WOMBAT: World of Molecular Bioactivity</span>. In  <span class="citation_source-book">Chemoinformatics in Drug Discovery</span>; <span class="NLM_contrib-group">Oprea, T. I.</span>, Ed; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=223-239&author=M.+Olah&author=M.+Mracec&author=L.+Ostopovici&author=R.+Rad&author=A.+Bora&author=N.+Hadaruga&author=I.+Olah&author=M.+Banda&author=Z.+Simon&author=M.+Mracec&author=T.+I.+Opreaauthor=T.+I.+Oprea&title=Chemoinformatics+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DOlah%26aufirst%3DM.%26atitle%3DWOMBAT%253A%2520World%2520of%2520Molecular%2520Bioactivity%26btitle%3DChemoinformatics%2520in%2520Drug%2520Discovery%26aulast%3DOprea%26aufirst%3DT.%2BI.%26pub%3DWiley-VCH%26date%3D2004%26spage%3D223%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Fancelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bindi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappella, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpinelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catana, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgini, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantegani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsiglio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pittalà, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roletto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soncini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storici, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianello, P.</span><span> </span><span class="NLM_article-title">Potent and selective Aurora inhibitors identified by the expansion of a novel scaffold for protein kinase inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3080</span><span class="NLM_x">–</span> <span class="NLM_lpage">3084</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049076m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3080-3084&author=D.+Fancelliauthor=D.+Bertaauthor=S.+Bindiauthor=A.+Cameronauthor=P.+Cappellaauthor=P.+Carpinelliauthor=C.+Catanaauthor=B.+Forteauthor=P.+Giordanoauthor=M.+L.+Giorginiauthor=S.+Manteganiauthor=A.+Marsiglioauthor=M.+Meroniauthor=J.+Mollauthor=V.+Pittal%C3%A0author=F.+Rolettoauthor=D.+Severinoauthor=C.+Sonciniauthor=P.+Storiciauthor=R.+Tonaniauthor=M.+Varasiauthor=A.+Vulpettiauthor=P.+Vianello&title=Potent+and+selective+Aurora+inhibitors+identified+by+the+expansion+of+a+novel+scaffold+for+protein+kinase+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm049076m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049076m%26sid%3Dliteratum%253Aachs%26aulast%3DFancelli%26aufirst%3DD.%26aulast%3DBerta%26aufirst%3DD.%26aulast%3DBindi%26aufirst%3DS.%26aulast%3DCameron%26aufirst%3DA.%26aulast%3DCappella%26aufirst%3DP.%26aulast%3DCarpinelli%26aufirst%3DP.%26aulast%3DCatana%26aufirst%3DC.%26aulast%3DForte%26aufirst%3DB.%26aulast%3DGiordano%26aufirst%3DP.%26aulast%3DGiorgini%26aufirst%3DM.%2BL.%26aulast%3DMantegani%26aufirst%3DS.%26aulast%3DMarsiglio%26aufirst%3DA.%26aulast%3DMeroni%26aufirst%3DM.%26aulast%3DMoll%26aufirst%3DJ.%26aulast%3DPittal%25C3%25A0%26aufirst%3DV.%26aulast%3DRoletto%26aufirst%3DF.%26aulast%3DSeverino%26aufirst%3DD.%26aulast%3DSoncini%26aufirst%3DC.%26aulast%3DStorici%26aufirst%3DP.%26aulast%3DTonani%26aufirst%3DR.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DVianello%26aufirst%3DP.%26atitle%3DPotent%2520and%2520selective%2520Aurora%2520inhibitors%2520identified%2520by%2520the%2520expansion%2520of%2520a%2520novel%2520scaffold%2520for%2520protein%2520kinase%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3080%26epage%3D3084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span>Corina, <span class="NLM_edition">version 3.2</span>; <span class="NLM_publisher-name">Molecular Networks GmbH</span>: <span class="NLM_publisher-loc">Erlangen, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Corina%2C+version+3.2%3B+Molecular+Networks+GmbH%3A+Erlangen%2C+Germany%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DCorina%26pub%3DMolecular%2520Networks%2520GmbH%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><div class="note"><p class="first last">Analyse/visualise H bonds for database with DBV Browser, SVL exchange,</p></div><a href="http://svl.chemcomp.com" class="extLink">http://svl.chemcomp.com</a><div class="note"><p class="first last">(accessed April 12, 2012)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Analyse%2Fvisualise+H+bonds+for+database+with+DBV+Browser%2C+SVL+exchange%2Chttp%3A%2F%2Fsvl.chemcomp.com%28accessed+April+12%2C+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Dubinina, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chupryna, O. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platonov, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borisko, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrovska, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachov, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shtil, A. A.</span><span> </span><span class="NLM_article-title">In silico design of protein kinase inhibitors: successes and failures</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=171-188&author=G.+G.+Dubininaauthor=O.+O.+Chuprynaauthor=M.+O.+Platonovauthor=P.+O.+Boriskoauthor=G.+V.+Ostrovskaauthor=A.+O.+Tolmachovauthor=A.+A.+Shtil&title=In+silico+design+of+protein+kinase+inhibitors%3A+successes+and+failures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDubinina%26aufirst%3DG.%2BG.%26aulast%3DChupryna%26aufirst%3DO.%2BO.%26aulast%3DPlatonov%26aufirst%3DM.%2BO.%26aulast%3DBorisko%26aufirst%3DP.%2BO.%26aulast%3DOstrovska%26aufirst%3DG.%2BV.%26aulast%3DTolmachov%26aufirst%3DA.%2BO.%26aulast%3DShtil%26aufirst%3DA.%2BA.%26atitle%3DIn%2520silico%2520design%2520of%2520protein%2520kinase%2520inhibitors%253A%2520successes%2520and%2520failures%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D171%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewing, T.</span><span> </span><span class="NLM_article-title">Global or local QSAR: Is there a way out?</span> <span class="citation_source-journal">QSAR Comb. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">850</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=850-855&author=M.+Feherauthor=T.+Ewing&title=Global+or+local+QSAR%3A+Is+there+a+way+out%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DEwing%26aufirst%3DT.%26atitle%3DGlobal%2520or%2520local%2520QSAR%253A%2520Is%2520there%2520a%2520way%2520out%253F%26jtitle%3DQSAR%2520Comb.%2520Sci.%26date%3D2009%26volume%3D28%26spage%3D850%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span>ADMET Predictor, <span class="NLM_edition">v5.0</span>;  <span class="NLM_publisher-name">Simulations Plus</span>: <span class="NLM_publisher-loc">Lancaster, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ADMET+Predictor%2C+v5.0%3B+Simulations+Plus%3A+Lancaster%2C+CA%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DADMET%2520Predictor%26pub%3DSimulations%2520Plus%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Su, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naughton, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arfsten, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCowan, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakubowski, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruterbories, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sall, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, R. M.</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">4308</span><span class="NLM_x">–</span> <span class="NLM_lpage">4318</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9704863" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Su%2C+T.%3B+Naughton%2C+M.+A.%3B+Smyth%2C+M.+S.%3B+Rose%2C+J.+W.%3B+Arfsten%2C+A.+E.%3B+McCowan%2C+J.+R.%3B+Jakubowski%2C+J.+A.%3B+Wyss%2C+V.+L.%3B+Ruterbories%2C+K.+J.%3B+Sall%2C+D.+J.%3B+Scarborough%2C+R.+M.J.+Med.+Chem.+1997%2C+40%2C+4308%E2%80%934318"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm9704863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9704863%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DT.%26aulast%3DNaughton%26aufirst%3DM.%2BA.%26aulast%3DSmyth%26aufirst%3DM.%2BS.%26aulast%3DRose%26aufirst%3DJ.%2BW.%26aulast%3DArfsten%26aufirst%3DA.%2BE.%26aulast%3DMcCowan%26aufirst%3DJ.%2BR.%26aulast%3DJakubowski%26aufirst%3DJ.%2BA.%26aulast%3DWyss%26aufirst%3DV.%2BL.%26aulast%3DRuterbories%26aufirst%3DK.%2BJ.%26aulast%3DSall%26aufirst%3DD.%2BJ.%26aulast%3DScarborough%26aufirst%3DR.%2BM.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D4308%26epage%3D4318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Usansky, J. I.; Desai, A.; Tang-Liu, D.</span>PK Functions for Microsoft Excel; <a href="http://www.boomer.org/pkin/soft.html" class="extLink">http://www.boomer.org/pkin/soft.html</a><div class="note"><p class="first last">(accessed November, 2008)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Usansky%2C+J.+I.%3B+Desai%2C+A.%3B+Tang-Liu%2C+D.PK+Functions+for+Microsoft+Excel%3B+http%3A%2F%2Fwww.boomer.org%2Fpkin%2Fsoft.html%28accessed+November%2C+2008%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DUsansky%26aufirst%3DJ.%2BI.%26jtitle%3DPK%2520Functions%2520for%2520Microsoft%2520Excel" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span>ACD/Structure Designer, <span class="NLM_edition">version 12.01</span>; <span class="NLM_publisher-name">Advanced Chemistry Development, Inc.</span>: <span class="NLM_publisher-loc">Toronto, ON, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ACD%2FStructure+Designer%2C+version+12.01%3B+Advanced+Chemistry+Development%2C+Inc.%3A+Toronto%2C+ON%2C+Canada%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DACD%252FStructure%2520Designer%26pub%3DAdvanced%2520Chemistry%2520Development%252C%2520Inc%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK','PDB','3COK'); return false;">PDB: 3COK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BMC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BMC','PDB','2BMC'); return false;">PDB: 2BMC</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i84"><a href="/doi/suppl/10.1021/jm400380m">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_17812"></div></div></div></div></div><hr /></hr><p class="last">Double reciprocal plots of PLK4 inhibition by compounds <b>7</b> and <b>17</b>; purity and MS data on screening hits; inhibition data of 274 member kinase panel by compound <b>50</b> at 1.0 μM.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400380m/suppl_file/jm400380m_si_001.pdf">jm400380m_si_001.pdf (174.62 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400380m&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-15%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm400380m%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400380m" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a7de09613db8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
